var title_f23_33_24080="Fusarium hematoxylin and eosin stain";
var content_f23_33_24080=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fusarium hematoxylin and eosin stain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 384px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A hematoxylin and eosin stain of a skin biopsy showing septate hyaline hyphae branching at acute angles of 45&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24080=[""].join("\n");
var outline_f23_33_24080=null;
var title_f23_33_24081="Squamous metaplasia";
var content_f23_33_24081=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amniotic squamous metaplasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24081=[""].join("\n");
var outline_f23_33_24081=null;
var title_f23_33_24082="Hodgkin lymphoma skin";
var content_f23_33_24082=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Secondary skin lesions in Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5YzRRRXUSApcj3pKOtACilxRTgOaaAQClxyO1CinAHvQIQClwaKWgBKKKOtABnJx3PtRk+gpxGaOaAEPHufWkH1NLg5FL3zQAmOKTHNOoPvQA0AUuOBS446UooGJS0d6WgBKWjNFACGlHSkxS44pAFJTgKQ0hjWyBx1oQk9adz3ooAB3oNKOlITTAPbtRigUtMQmP0pQKKMHr2oAAORS9eKAPelA596Yhp70LnHIwKXGBk0MOcCkA5eDincYzTA3NOU9DVJgxwBPp7UhB74+lKD2HHc0HIHHNWSMbrzwMUh9qeeaaeKhlCBuaAeMjrTSOvPWnj9aQC8EdMUDGPakA696Xr7UwFA4oPIGKQHr2pe/PagBo6UdvfNOHQcUmOnFAwxSgCnE/L0pFx6ZpCDGKQ9/Sgk9aACxqHIaQDLkmnBMmp7W1luJFit42kc9FUda9T8GfDch4bzXAGDfctgOp9W9qyqVFHc1p05VHoc/4N8D3OqRpqOoK0Gmg/LuBDT/7o9PevctDjWIwWh2lguQvQ8e3tU9pZNcOZHQJChEcKL0AHtWvp+hpJfLcmMF1yFY9QO4rgqyc2j18LShTTudTo7NDEqDkjtRVi0tRHA4+bIGOTmiuunGy1M5SSZ+eYoxSkYxS44rrPHEAzS45oGMUuOaBBj1o496KKQC984p2eKbil9KYCj0pcYBNIOtLn1oASjNFHfFACjg0o6800daXmgLBRRRQFgpw+lNwe1Lii4xaKSlAouAUo4pMUYouAo69aKKKVwAUtJg+lL7UXADSUuKKQxKKX60UAGKQjA+tLQR60xCAcUtGKB1NMA6ijvQPpS4zz6UAAAx0pw9aTj3pR7/hQIM9R2o7cH60vbigg4x1oAY1APGKXGRSYIoAep65peM8GmZ4PNOUZIwcGqTEOI2/0puDg8/hTvajHXBzVNCI2BHvSDjnFS4zUZWoGhQeaXgj+dIAc08gZ5poGIwBP40dW6UppdvtQMCBjjrQBxTsDjPSmHkmk3YYvbGaaAT1wKci559a6bw34Q1LWnBijMUJ6yOP5etYzqKKuy4wcnaKOaSMscKMn0rrfDngu/1SSMyRmGJsEZHJH9K9F8P+CbPS4fMZfOuCwXzH52/Su3tYUgjLRIQSOMj9a454m+kD0KWB6zZj+F/C2n6GBHHCkl2QCxxnFdpYWG+QPKSZTwB6Cszwxp9wL6S4uWJDsCFNd5ptosbl8AntWMU56s6XFQVkVrfRREAFBBJ3bc9627S2SMDA2nNWSMum0nHWpowhJyOf0NdMaaWpDloRGQLHwvA6kUUXEIbI3DJ60VsRY/OLHvThknmmqMHNSAZzitbnkiYpQCaXHHNL2xTHYQLRjIp2M/lRt9qQWEAxwaU8UGnU0FhgpQO5p+31pMCncBKTBzmnDvRSFYQiil/KjAoAMYo69KU0UBYTjtS4pSKAMGgLCYpRS4pcD3ouMbiin4I6UmOaLgNANKQRT9uBmk+pouAmPWjHqKcB+NG3H40hjMUnPNSbSOtDLmgCOlNOAxSAZoAQUp5pcdOOlB6GmIT9fakP4UooouFg9KUA80UU7oQmKUdaXp15pAOPencQoo/SjtTu1ADTwKMccjmnH8KaR34oAaR3xxQMY/rSkc/Sk6Y9PSgZIh6jrTgO4z+XWmL0yKcCcVVybARnkd+1BBI6c0o559DTuqmgCHHB4pwFPmUIcAg8DkUwk5x2qb2Gh3APXkUrEZ9qaCe361YsbKe8kCW8bMx744/Gk5jUSv8AeNaOi6RdatdCG0jLHqzY4UeprqPDvgSe8ZXvW2Rn+Fepr1PQNCttOtGhsoQEzhn7n61x1cSl7sdzto4SUtZaI5TQfAtvayRGVVnlXks/QnsMV6Xpem+RYxLKirL94iMcD2qxptij3CsSDGAecdCK35Ei2qIk28cDufrXFUbnqz1aNONNWSOceDL/ADj5FIG31q5aQFmKnvyB6D+lX1jXeUbl+hJFWYIAhxklj71MYSauaSZa06AKgA6+p6mt3TgNwABJU81n2sYyuOwxxWnENiM2dre9ddLRXOSW5pbY1jyV+Y9ahSaMsyqeBxg1GJhJt9R2FMmVYwXQ7Tjr61vHUm1iZpWRWLbSKKzLm6CxFWPvnpRV7BY+AobWWZtsSMxPYDNdJp3gvUbkK0ipEp5+Y9K9F0DwtBaoDgBsgnuTXTrYKFCxsDxg571zzxL+ycUMI7XkeRnwFKsbO10OM9qrL4HvZfmgljZeBk8V6/NaBgYyrM+PTg1MbSVI44YIUXn5lPBHvWX1mSOhYFSPKIfh5eA5uJlAx/CKu/8ACvUdEMdw4J65xXrMOmkrunBJxxk9KekDDbiIMg6eoFCxM2P6nFHjTfD+RWwtwCewK1Sk8EX+SE2HFes3tpc/a8RqI4SCSx5IPpin2FtN58qsm5eCpB6/UdqbxE4q7Y44KEloeLS+ENUjz/o5Y+oqL/hGtQ4Bt5FI6nFfQ7aVGE+bk9OOtCaTaQZLAZbjk55pLGy7GbwK7nzynhu7fcI4nYocNx0NL/wjOoFiBb59s4r6OXRoXRgiqGb7xPGaydR0eKNvlDKVHB96bxkgWBT2Z4G/h3Ud3/Ho2cVG+gaggBa2YV7lJaxzRhmARgcZz3pz6Z5kKOyKYj6DmmsY+oTy9x1PBDpF4WINvJ+VOTR70g7IGODjpXtp0KJpGVgcHuo4xUMXhfexaBjgeoqlizF4SR4+mg32Afs5yeh7VYh8NXzlQUAOent9a9eXw/MHJYqMc4PpWtZaPGVORkqeg4xQ8U3sP6pbc8ctPBd1MwBYDJx0z+tacXw+mBxK53egFesHTwYQYI3V856cfnV62sZpIAWVNx9AeT9an6xNlrDRW54//wAIAAcM5z6U9PAKL2ZgP4RXrU0UWCpKhhxk9/oRUAgCxAqy7SfvJyfpR7afcf1eJ5TJ4Li8zaW2tjgA9aH8Cl8MjduuK9MXTwJDNgg56NT1guC2YkVgTjaf51P1iY/q0WeTSeBpSu3B3dyKrP4NlU8Sg+2P617QND1N3LmJAh98VHJod4Qym3iB78/1q/bzRH1ZHikvg7UB8yBHOOwqs3hfUIyFEAJx0B7V7LNYXNtH/qoVb3fj8KVNPvRt8yKNeM5Iz+tCxMkV9SvqeGPod4pI8khs8qKa2iXqjL28oH+7Xu8ekPIf9SuTwWPeorrQrlJABEMn8c0/rT7EPCWPBH0+5ViDDJ/3yaY1nMo+ZCK92Ohlk+eHa2Mciqx0ZQSFjQkcYYU1iu6F9UfRnhrwshII6UzY20HBwa9putCBYB7WIAckNjNVH8KW8ys0lqkZHQEYprFRvsJ4Oe6PHypFGPevSV8ErMzlImWLOFPOQary+BOyO6n39a0VeHch4aouh59t/Olx7iuzm8EXK5KSDOf4lNVV8IXm7BePPUVSrR7kOlPscsR60Diunk8HakFLKisB2zzVM+GdTBVfszknpTVaPRidKfYxKTkcCttvDWqK5H2STPoOaQeHtTyP9DlJP8OOar2q7i9m+xi85ozWw3h/U0OWs5R+FPh8Oam5z9kdR33cY96PaLuLkfYxMkU9W6cV1Om+CtTv5mSMRjaMk7s4FdLb/C+VEzfXDxkjICJgY9ean2qSuWqE5bI8y3EgDjAoJOK9X/4V/p1uMH7RcyEdv5UxvANvPKqpaNb467pCaTrpaj+rTPKwpY8ZJ9q39O8I6peKrmEQRtyGlOMj2Fep6P4T03SiHitlnuSQAznOD7Cuts9IBjE9yFeRjtFZSxD+ydFPCN/EeQweDLeyjV7gSXsxOBGgwP8A9X1rsdI0doY4IhaKjH5nxwqL2Hua7Z4FhVWWEY7E8fjUWi288tzLJcGGO2GcIBlmJ71zSquWh20sLFalXTbRo5ZZtm9SuyOID7p7sTWvaWigvG38R3Nnt7D6VLEC23YwjXuMdcU+axeZ423OkaHcNpxuPv7Vk3bRHXGFzU2NDCjIDk/dXHJpsJu4rt2lKGFl+Vf4i2e56YpBdtEVQ4y/cc4q9bxnOTyzAc042SD4CRbdnjLt8pY+lSRWz4yWG71HepI/NyFfBHbnirz7U2FgcDqQK1jG5zymMtQYuGzir8kyFULrnA4zVVphGoYtlT0BXNZl5cYDMjgj+6cg10xVkYN6mlPcDChOCfmYg9Ky7vURCwDueOxrC1HVlgyVWSPjGc8f/XrmNU8QMEYhyarYXtDoNb8SLHCQG45orwfxl4zfdJbWbBpujORkJ9PU0VPLN6owliUmemWkaOvyLknjrjP0q/O0dnaGV0AA/E1PDbrZRxkRllTgt2xT7+BLm0OASfU81xWtsd976dCpBdRzIHK4VunHNSysJImkiQmRP1p2mwqkixhR06dvrV6OMR5GU2tzntxTlC6NE1FlWznmnt1ZomU5+6wwaSYzxqz7PlPHPUVLLfhJVhYhl654BNaMDRsoCsx3DPXqKyUdNRvukcld3Lrcxq+VVzhSozk+9bNhHHKjBgVcdSBj8KfcWyzM5ERHO7gVYjSK25kdtx5+b1pyjoir6WsOGEAUlSDwAeuary2a3sJilBCscgKxByDkc1M8dtOM5LoGGdp6Gmy3yRXiRxxtnGABn86XIRbSyLH2NkhCIr7gMZLZNZ97A3kvFcDIA4AOCfet9pMQIJE25XqODVCVoEcSFGdSSCc81ooJExk0Y1jpNvcvuJbJbaA564FbMmntGgVGXgccdKjiZWmXy4mTAyRjmtCK6d90LCMlhkK/b6VUoRlsi51JNGEkEcbCNmUDPXHB9jUj7FmDIBgnDADj8K1v7JjkP7yT93kHBToaujSyoCGJJCOemCB6UlRVjCU0YdtYpcq+QTIASqjt6VItk8FnI7AhV42jjml1PFm80kELxTsfmJzjFM0q7lkjKXEeAx3YJznn+VWoLYtbXRZ0eOaW23FXVQ2Bkfr71oPYMI2dPNA6bSBzVuGS13IuScjjGcVoq8CHO0liNq7+lNRV9DOTOcvLWOGMf6IHmYcsuP59qqrpy3KeYY0jhBwXxzW3rtylkBI9v5g278Ac1C032yzG6NkZuVB/h/CqsluJRlJJmb/ZkZjDRzKseQCzgE/Sty306CCEMAHIHU9KyktyYmRbVVj6KD1HuauaXpMjArGrRgjDHecY+nanyxexq4pLciEpkuXhQSDYcs2Dj9KtukbxFW2Og6AnbzW/ZQJbshlAMfTC9M/1qGe2jmuZGTZtA5GQMewqnTjYlyTOTvNFjmj3/Z42nx8oIJXNWNM8KyXVrB9tWPemSNp4HtiuqsLTMqqqI/qAcce1ay2iQkMhKMeSM1SpxtqhOu0rI5aXw+bd1kGGYdMgEYpptEdBuhCkH72K6OU7ZD5h3ZHJwBWfcRRyrmJlYKcD5uRj+dS4ozcubcwJ9NtfmYOwfOcbc5zUH9mWs8pAkiWVPlKuOordklNrExdEmVeuODipLCWxvY281VGRkAdfyqORPQqKdrnM3Xh21mYDYOBwCeTWfd6Jm2ZQgDICQD3Fd19iwjSqdrocDI7VRurd5Inch0AGHUjk/hS9mr6lKR5xa6TLKCDuhUkkLzWgLGKFQjrh84O4Z/Guws2tHnMK7o5FGcNzkeuaXVGgRY1YoTnABAJyfSolTtsU229jiZNLzlfLBRuhXiqI0NGmBeFQo5GRiu1SyGHeKYgHqGHyn6VV8xZ7pbcuw285AqVE0ic22nINo8nYc/e7U9tKVd0nlBlB2jjFdqdOi8g7U3k8cnJqCSxjkjwd4xjK4x+lLksTzXOGl0//AEgoqBuD93qKng8O7j+8QAddwrsLPRUWUPt+QfdJHUVZ+zrsYA7doIz/AEoUe4mjgptBgjk+cs3PAHb3zUkGkQbhshBzwWNad1OyXK4cCJn2Z29Pc1qgLJGvIRuhIFU3ZXaK9mYcVgtlOHt0EeOpHT8qZf5fdh97dCx5zWrcjyLd8H7oIHesu1YXCM4OdrYYHjB9Kz9o3oV7O6ukUvIldwN2yPOSq9T/AIVLHB+9VVyqg4baOlb0caTQAxsVJyu08EVPaWJiGUXIJ5AGfzq1Pm0ZHIlqzPh0yMSiUBvMxwSOn0HrV1rQkA7hk9zz+lXrvECF9pLjjAPT1NOs2D26PkNyc49adm9h9NDHvrYbUI5Y/KwNZbTSxXyQKhIY7TjGE4+8f/rV01/HGzAnucbsdDWc1kHuVwM/NwQOtYy7GlNrqXLe1RIldhvbGeOlG/zvuqXi+6RV1UcpsQFV/I1Fa6bsn3LnA6+wrWMF1F7RIdFAuFQqAnYelXjiJVBVjgA4FMms5okLQEM3pTLC8uk3faLVgmePWriraGU5X1L9rNblA0mFAPK7cUPdWrSbGYpnszYJpj3VrIy+bF5bepFUb9bB2L/JIAOrGuiKOdy7k17Jb7Ti5Q5z/FjFcpq9/bxZC3W9hxhSTUmpzWEaMZFhI9B3/KuO1PU13FbZAvYhBirbsZNiavf7dzP8i9fnOW/KvNPGXiJoVMEDHzmGf90ep9/ar/izWxp8JkkKyXD8Rp2B9T9K8uuJ3nleWZy8jnczHqTVRj1ZyVZ30GSMSSWJJPOTRTG60VrYxPraAh1VDKxDAg56Gqto89vPIspDJuwoH93sKoR3bLkAhsHI+lXLPUYrhmikXLDgMRx+FeWnY9uDexO8xiugyIdrnBx/B9astLHNA4tyHUNzjpWXfJKzb4G8tgM8cg+xp+nam7RJHcWxVsncyfdrSLTiaNGsLKN3R3RHZhhQR90+tX1iWO2CqAHUZDY6+1NtGVYgy5ZW6n0NSLLHNIFPpjbnqaTfM9CG3tcYqeaPNhKpIw+6TwT6Vl3EkrXeGjG70JyAa2liijHXDdfm6ms6/gIHnR4KsDyPWo6FRlqVrRTcSkJH5TDkcfrU2q2rQRqxAVz0cH7p9ferWnyW8oQyKRxjcnr6Gtf7KHiQlcoo43cAGqULiqVVzGLFIws0DSeYXGCfpTHuHmRh5OSBjevy1u21rFFM/wAoO7kLj5fwqSS2gWFS0QCE5IA5/Kq9mzJVFc5ttQMV/BBHbEo4ALgZyfWtdbNI7hppSFl28A1Jb+TbSsI1yuMDGMmke4EsMqmAqAcZZufzqnYfvNsfidSclTG3OM9D9atwrcSKXjuAYx/A3OPxrmop72ORh5jNDuwBIOK1be4EnzuFHb5DgGkmhypFq+thPZsjZMpHG6sKxt7lJHhuNpcYCCMH5V98106MrKBlxngZGcfWntaxHMkTkH+IqelPzJUuX3TOijeAGR0ZgBn7wGaoPqj3NwbeJTHJjIwMhfejUZ5Jb9PKmbCnG0d8VPZWyyyq6heWyz9AMdvrUqRskkrskitzdx4u5W3L/wAtM5PFMu72z0+J1lJLFTtC8mtQWCqfNjcqSM5U81Sk0tbreGViTzlzyabfYmM7vXYoaLqUd+zOZhntGeVx/Wuris1eDId42brt4yK5yDQZbNvNtI0Vsg5I646CuqtJMeU0ijd1ODwfpVRaasxzcehTtrWaBSCx2njJPP1zT7ySSK0JmXIHI8sZNX728hUqrsQRx8wqBUjcFw3B/u8VTMk7u7I9Ks2jia5WecNJg7XY4H19K0kuLbd++nO7PI3H+dQWI2bvNQyxk/K33sD8afLDCfNMYKK338Ac+1O4pO71JZGRJRhWLsPlyeo+tRPbGdmeQGNBwqp8pPuayC8kcPlwycIMoHOcfjWbrOt3NrEixIZHIyRt6n2qHOw4w5nZFzXLRpWVFR+4Vt3K/h3ql4bEdpJKiRO7hsSu7fcOO3+FPsZn1CKNrh5IHDbmUenpn+tb62UccZfzUZHOQo+Yk+/rVL3TRS5Vysc1w7Z2Z+zkdWHP51InlSRhC+D/AHg1c/qUlxJMqNfLBGB8zdCfYelS20UCJHCJZUXdkFHzu+pNS3oLk6mjNDDA2NyLITuEmOvqKyNXeFPnKx5HcqeK0b2ZIo2YqHRBkk8nHqTUFlPFqlqNhby84HmJipd2VHR3I9HWKW0AXLpnog/SrttZQRnzfKxnpgdKeCLeMLG2B0I/rTF1GPcqhg+OhJ6/Si9iZS10JpUjwW2yInXcvPPuKzWu1bJIJzkEgYxU93dXEkTGOMYxxv4B/rWG010N5NuDGeoX5Rn2zUSaHHU3XSa28lkmDISA4J6D1FQ30xAbykDjHOeprLtbq4dScHg4KZHB9KutdgfI6uoHX5gaz5uhWt9TFljBuQduznlCM/jU6253iOJ9y5wCx6d6tZieVGiaNsdM9vxqC4tiGEocBzydg71m9dGa891YiuoSscisSWJGeOCKoQW4bT2jxtYueew9qsyXxeRYZFG1T99R1pJWKxAw42E9M1N+V+6UptKyLelRCO3CyEFl5DZzjnitIXHlqMIvzcHJxWbbkm3buCMADvVa5nk3oWyUB+Ybea1jIzcXJmpqcLXKMp3A44IPWqtkjW1qFcnj0qaOciLdgtiqyXiTZGUJPB5qk+xKvsVry9aA7yjMAei8mtm0ZJYhgAMPm59KZFBFJEYzj3Bom/0PAUYAOOD60+XQTl0RoyquzK5GKiWdUf72D0xmorW+MRxIoZOuOhFaWLK6RmAwWHPFWlcn1K/2h8nP04qR5lYbt4BHHSqhtVjLhHIx2PQ01FkHI2gH361qlYzY68niKncUJPrXM3pRSx8xTngACte5WaRyCq8cnFZF9E6qcoTnkZqkSzmdRO52GS2OPTH41y2r3KxQszEJGvZe5rq9UjJyHPHZQcf/AFq8m+IWp7bcW8ZAMnyjb2XuaunG7uzmrS5UcVr2oNqWoyTniMfKgHQAf41mN1pz9DgUyt0cVxDRQaKBXPoi7BV0jgO3j9amtboWrqkuFLDqOeabPBHJ8uSSRkE8UltblVQTjcBzz1ryXY9iO5tkllUHHI456j606HaZTuyjH3yPxqtBdIyvFMoTA+Q5ByKY+VkDRYGOWLVGptdo6SK42kBSFGByOBmqeqSfOJlBGOjDrn6VHalvldB8vU1piOGcbzgbuoHrVptaoE9bsp2upSNbKcEg9QOcVo27EQEFfkbgjseP51Th0yJJuP3fmEhdvrWvZr5Ea+YDlcnPWiLfUqo4390q2Vp5Y82NMBuQ+f5itGyuJo5niJ2rjJG3I96mS5R3BABBGeKjusIx3LhDjDZyBWxzu73LEk4hmDMp2tg/IeBVw30GAGIbdwrFe9c/dX3you4EAcqf6VzaasYb7ybuUbJDkDnH4Vpz6FU6PMrnoNzbR3HyysNvTHQfmKq3MccCqh2lAO3aqEd28sCqH3AjbtPDZrN1SeU2zoCzImCOP0zWU5aDUbO1zTku4nj2SIGjJ6HgipRBC21o0XcBncK4aKW+jut8nzWr9AOuOwrqrEq6rJuw0eR82eahS2KnG2zNO3n2u0ayZc/wjii4NwqtgHYRyQOfxqpLJvYYiUTA8HOP1qIX9xHMsLjMjep6/jT5jLlZpWiWkiiWYFZumD6e9TqFMxLDYD3HSs62vEEhXlHJwQwq+tyGQIgAJxgnoaEO72ZNczrFbu6Y3xjPXmsnTtfa5umhaNwFx1GOD/Orlxkg+Yg6/c6n8Kqpa2qAtGc55IPai5pGUUrM6F1LR7k3KSOhNZaNcWs20yB0JyC3OKntLw+WAxLKPlLen1qjq9y9vGDGGdc9Mg02+qIhq7I1pFNxCEKhh0Zzz+VWLWKOyQhD2AyT09uawNDv47kHLmCQYyjcfhWvdXKx4ZySPRhVJ9yZpp2JzdXLKfKUhsYWQDirH2xVXNwuwFRyTgk1gLqjRXLGHewxyoGR+HvVo3jXBUSxOyjovHP1B7000LXqjTby52+URnGCpJ5qjqcPmhVLRkuccL/Wm7lk4jkdT/d44+hqsriEttkeTpuBPJPf8KGClZli3heyRssHZV4yMGsa31sy3zR+Q0YP3iT3q5JdlWydyg/3zlfwx1rMuTbxXAkcKZW4UdMZ71LlymsHzepev1e6j+Xy9uef896bbzrHIITuU/wvjge2aeJEMYb7PzjJII5qoJZ1LLbQhjxgE5A+tS27WGptKxpeZDauyl8knLDGQc9c06CdJvltgu3+HYfmBqss0ccYMqq8hPPYA/1NMu7mGBGEbLGcg5B+6fSi9hJNmosruhF3iVR1EfB49qdvhU7wBGo9Rg1m2t5bSFW3BXAIYg5P0pBeCR2EZTaOcnqP/r0XE4tbl2e4L7Qh2qe7Hr7Vk6hqC21w29VZc46805rtYw6zHKt0Oef8Kz5GjuXztLAd2GcjtipbZcLJmg1wUt1leFCjfxA1GLqOZAqsVHqecmqNwjSAxqWG7jAwMfhVay0traUjeTz07ZrO9jePKy1JM3zRxlkjAPbk+1NF27RCNN2MeuD+dPaJssBnk5J6EVSeBEkbfnOOorPdiuMmky+7Gxwc9Ks2NyGjcjdnPJxwDWciFZCWJb0yMmokkkidhnYG67quKjcasdZbSoANvAxkDFVdRPyB1ORnnA6VmW9wBk/MSvAOe1Otb63dpPtTMDnA7CqprmaQrLdGnBcEx7FBYDjPqKqW+m/6U0kfyyHGR6in2lwjL5YODkkFehq1ENjqc89Mmhu0hO5FNHcjJhcjOAfr7VrW9/8AuhFdw4JH3v60MI3j+6QfXPWljRCVJJ245Pp71vHUxk0TC7tMKE+d88r3qxbX9uAVkEqn+E4yPoaY2npIoYL8w5VxViK0kIIbBXODx0rWKM3rsxHnVl3KrZPbGaqTyB5BhGXnrjFaiW7pkQ5BHG0jNI6jjcmR3GO9VYFqZHKk/u89/rWPqb7Qd3pgD0rpL8KEGyPB965vVVBPy5Y+9UomctDhvElyY4nGecYbBrwrxZdG51iXn5YhsA9PWvZfGb+XGIs8nLufYV4LcSGaeSQ/xMWrdKyscFZ3ZAetIenvSk8U0jg1okYXEbgiikIyMUUxH0NIWwm/O0cZqxEFI8wtuXr16U/ZlNqbWz296rG3YYdWwepHavDue0PkG9mx17Z61ctpnmCo0RRh3I7elZoCRZaJ/wB6Byua09LuvM3BjtIHKkdKpSdrIuO9zasUMCbdueeCOoq1EBFcF2OUIweeM1Qe7CJvXPy9hUsF+siKp+63BHpUrYuxoNLggLk7Tlc8YqK/1Q2piALYI4YdcnrUK3EfnMsjfM33Wz19qjuSixbW+ZcYAI6GmpC2Zb0rUA5dH3BHJKMOhI61fmuSnyu4xj5WHoe1c/aXDR24VRyhypHUH0q696k9sSyEMOT2OaqMiZLW7M/WLxmlX5DGYjuBP3W9vrWJbFJZX2DzvMfLbm5BB7e1aF7IbiEo4J6EnpxWZZxwwKizZDhiVI42/Wmnc3i1ZHTWUjvbBFRiVGVYHpUjXsisv2obEbgnGQKybe98iTcjMEYZKg9Kklv4mIDSkMOOtJmMpamlYXKJujmC8NgFRxjtUN5q0Wn3BOHWOQjK7ScH1HpWO2pQZ+c4YDrnrTpbouoLOGUDjFFwUl1NqTVoWAdS2BjB96tzX32m28yJRJIg6D+Vc1A5KYQhcdA3Sr1qc7nxiTHO08Uc1x80UzRsb2WWRPOV9rDkD7y1vRSxShkfGMAnHceo965xJmKRSeWCFyMngilEpkcuGw6YOAad2TKSlsb9zM1t++hdm28f/rqxZXTPGxkVNrAdRwazbcC4UHcdxyGycDFWkKEFM4K8AhsU0TfSxZkjNlcNJtfyD12tnH/1qUSRuMsw5xlSQOPWqlzctHAFdCHI24DZFc9cTvHOpA3Ieqngj8alz1sXGF9TrUhtAMjyy3Zl4wfenXqM9tjdIxH3doBrC0u+CzKso2MeCAMgH0zW00wZjkELgHg4/lQraoJXTKmircRSOkqsYs9HXBH0rcEUKorMvXup6+1ZDFFIxIybvr61XllCPsDv6jJ5/wD1VS0FKTlqzWe6tY3KrGpy2Mjt+NR/bPmPkxDy1IwXAGT3rEMxgcOjbx/dYYGfWqt5qwRf33lo54IBzjNVzIlxNadzPcgMFGDgbTw319qq3MaMxE6IcfdROtc1NqsLupWXDdcBuv1qlc62sGT8rd+pz9Kh2kF+XqdhDqKWzAyGMxAY5OOR61IussU3JIqbsgLjOK87k8QlotrRbQerk5qpe+LbWNTiZMjjgjP50JS2SJdSC1bPQ/7SjSR0RQ8gIJdzkAj/AD0rM8QyG7iRTMFyNrY9PavOW8f26qVDEgckjnJrPufHQkwcytgHIxiqdKb2RKxMI7M9b024jggjjEgZEABOasm8i3naUAB7t0968RfxxgfJA+cdzTB46n4/cZA/2sUKhO2wPFw6ntN/dxzxMjSc+xxj60kF4iRhFKDAwN7ZzXiT+O7vPyphTxjNM/4Ta5UkmJSCckbjk/jT9hUJ+tU9z3OLUl5AlSR1I+UVZj1eTGHVC2eue1eExePZolIW2B54+apo/iLcocm0U/8AA+tS6FQuOMpnuR1EtGGkG49RsqrNeuULjgnt3xXjkfxGl3Ze1ITHQPVhPiJbyHa9vKoONxzmspYer2Nli6T6nqsepQypsRiGXk560PcYO9xuX6V5afGOnE5VnBz3U1NB4ttyyhL5VHdSMD86PZ1FvEuOIovqekveIrZtyOcZBqhfSnfnBVTyWFcwniCCbaftMeU5+Rxz7GrltqfnwHeGUf7XQD61i/aRNVOm9mdVYXMYVfKkDeuO1WxfFJB5rH2yetcnFpjzgtbXTRbu61tWVpLCR9om3445HQ0K7BM6WO8kZgOWX0q9DcNuAdQVbk4PNZFvJhBt5X9TU8bNjg54zgdRWsZtbilBM6iKAuA0LleeGQ8H6itOzN1EAMkrjaeM/nXOaVcOjjG7yz6nGa6OG8SRPm+RuxHpXbTd0czWpc807MADcP4qYw37t+Cw5J9aEkH9/PHUU4lZMgcY4yea2TEzEvyWduOT2NYF8VhGGIPUk+9dHdxDeWycj0rj9em2RuoYHrnFZOdmOSXKeTfEq8EVteOpIypUD3NeM9Biu/8Aile7pobZT1Ysa4Hgmumm7q7PIrNczsMYdaa3FOYYB9KZWxiNP1ooopDPoaW4igdTMrqufmOOlX0WCSP5cYbqwPWqWYZM+Zz3yeRUsL+S4QAPHjBA7V4aR7d0Smzh8zdhQTwDT3tkR9ylQzcfWnEoEPlYOe1N89FI35yPXkUnEcWRjfg+SxPGCpqtArwTyStvBk+8Ccge9aMUqyDJUYIz0xRPJG2ASAR2PT6U1eK0L5yzaXUbpzkgHIarDTRspEhLE++K5y6uwu7aNuO4NUk1COJsl8OO5bNJIUprqdTJKsJ3JhvXmoW1ISHoVxxknFcZqHim2t0YSzLj+6DXPXXjmNA4gQuD36c1rClJ7I55V4rqejXd5GjFk3bx36hqyb/VFdf3m0EenOa8wu/Ft9Lu2hUB/GseXVruViXnkP44rojhpdTCWKWyPV5NXQx/fwF6kkCk/ti2UcldwPUNk15E1zI2dzHJ75NN81z0Y/nWiwq6mTxMj16XU7K4YGVgCv8AFuFXra/gBKrOrKRkZNeJ+c4ONzbfTNSJeSx/ddsA8DJ4o+qp9QWJfY9vhuMzljMvrgnrWvFfrAuXA2gcmvBI9ZvIyMTuQOxNalp4rv4B94OD1BrJ4WS2NI4tdT3PSdXCBlkYspOc46Cr0VwrMTAQVPp1FeKWvjLDozqYzxkrz+ldFZ+LrOUKZJwpAxlsqazlRqLobwxEJHqdtdPEPkw8Z4wRmrKXUiuZR8pAxhjxj3rgbPxFbS4ZJ1PB78VrR6xH5YfzAykfdJ5qEpLc1UovY6SWdJZAZTkAZ+XoaETGVCErjj5eR9a5+LU7RlDBSv1NWP7ciRQvnZJ5BqHG7NFURtDy0KSNtUocgZwcVLNcRunyuFX64x+Ncld63FjI59cnrWXeeLrW3JWaSFQRnAbn8acYt7EzqxXU7Q3gUMpclQcAg/oazbnXAnLHjPQHgV5rqnj2LaUtmeQDPOcCuW1DxXf3JOxhGpGMDk10Royfkc0sTBHrd34mjXLCXaMHmuX1Txfa/MJrrzAf4EXNeX3N7PcH9/K749TVcseSK1jh11ZhPEtvRHcXHjEKzi0gxjO1mrDuvEeoTMWEuzt8orDJJHBppNbRpRXQxlUk+pbmv55MiWaV8nOGY1AZcqBjmoqTNWo2M7kvmZPWk3nPJ4qPODijIzVJBck3etG44wOn0puaN1FguLnsKQtyeeaTPekH6UWC48HijP4U3OKQ4NFguPzgGkyeo4pD16UhJxkCiwXJdxA60Zz6VGSeAaB1osFyQMQeauWWq3llIjW88g29FJyD+FUKDScb7jUn0PTPDvj+MlIdTTySB/ro/u59x2ruNJ1+G9eR4LpJFBx8nIz2+lfP6dBVi0uri0lElrLJG4ORsOM1yVMIparRnVSxk4aPU+n4LaaePdvbcvTH9a0rCJ5QUbLMOvOCa8k8IeP457u3/tBhBdRjGd2I5AePwNewadbx3rx3SO4UrnhuDn1FcLpuEuWR60KkakeaJoWsLxttkgk2HnKjd+hrXtRjGwCRQeflwwqGK1EXBXKHkNvP+RU9soViYn75wa7IRsY3uaVqYZCN8bIR3PFXEVIGyCDkdTVO1V2VdwGBTiCZ2Jc7FGemK2voRIyNXmCM/XA96838T3gihdy2OpyTXX+KL4Lu2NxyK8L+JPiAxWbQoR50uVAB6D1rm+KfKhVJ8lPmPN/E19/aGsTzA5QHan0FZRpT1POTTa9GEbI8eTuxrcE0je1OILHCjJPAHqa2dW0ey0nXLfT7/UWZVCi9khiz5DHqqj+LAxVCMSeOSF9k0bxvgHa6lTgjIODRWl4stLuy1qSK+uzet5cbRXBJPmRFQUIz0G3HHaimgsexNqEeNvDA9QOtNa9TP38DofevI38RXTHcqxj3pj+ItQYY87H0rz/qsjreJR7ANTii53Eex70n9sxlPv8AH9a8afWb5zzO3PvVdry5f708h/4FT+rdxfWT2STXoY1OZlT2zWVd+LLSINmcM2Omc15Y0rsPmZj9TTCaqOGihPESO2u/GZZCsQbJ9eBXP32uXt3kPLhfReM1le/86M+hraNKMdjKVSUt2PLljkkk+/NJuH502itLEC5yfahaaT+VGadgHE/jRmm5o59KLAO6UZ/Km0tADw2Bxil3ccA0wGlzQA8Ngd6eHYcBjioQfyp2aTAspM6/dOPcVPHqV0mNtxIB/vGqOaCaTSY07Gsut3oGRcy+3zdKYdYvG63EpH+9WaT2oB4pcqKu+5cmvriX780jD03GoGck5OSfeoyfSjPvTUUhXHFmIJz79KTJ9aTPrTT1p2EOzSZ96TNIKLBcdR1Oabng0Y5FOwrjsjFNNFHPpRYAxk0Z5o5/Gkx+NADhznNA5FPCgil244xTsK5Gfu8mmnpUxHB4HTNJjOKLBcjAJ9qNppxNLkHrQFw2+/Wjb9KCCD7UvGeKAG9KeuM8imnAFKO2T9KAFH05oJGcDkUh7560i5HWmAKeTzUqn0zUJ4INPQ1IyT5cdPzrtfCHj7UdBCwTs91ZDGELYZB/smuHB4wQacCaznTUlZo0hUlB3iz6m8L/ABC0vU40WO8QyY+4/wArg+4P9K7C1vIpvmDjB/SvitGIYMNwYcgg4xXSaJ401zSVVYLx5YgeElO4D8etYum1sdUMV/MfYMNz5eMfMPWqutaulvbEBgCTk5PT/GvnW2+MWqRIRJZQs3TIcjNZeufFDVdRB8uGG3yMZGWNJwk1oU8RC533jjxXBYwvI7gsfurnlj7CvCNVv5tSu3uLhiXboP7o9Kbe3k95OZbmVpZT/ExqsenNXSo8nqc1as6noNPtx/SkBIBwB6c07PamnPeuo57jCccg4I5BHb3r0n+zLjWki1LVfBd5PeyIrNJDdiFLjjhmQ8gnvjrXm4ba6nKghgRu6de/tXc+KNPstY1mfUIvFmlp9oCsYnkk/dnaAVBA6DtUyGjmfGL6hLr9w2r2q2dztQLbr92KMKNij2C4oqlq1qtpfPDHewXyqAfPhJKtkdBnnjpRVICh1pR603NKfSsxDs5oHtTcnFKDQMfz6UDvTfxopgOopuTSjnNADs+9GabRQA6kJxSUU7gLS0lJQA4UtNpaAF7UvFJ+NHegBw6UZx0pOtFADwR6UZptLSFcdnPajPpzTc0vNAxxPBOefSkzz0pOc0E8n2oAXOKM0meBRmgBxI64pM5pOaUDIzTQgzmg9elKF4p4UDuSKAGBeaXH4U/HQ0mPWnYBuO9IetOP3sCoyRnHekBIuD0qTk96iViPxqTIC+5qkJgRgY/SkNL1xgn3zRxwMcUxEfYUq96GGQOelJ2yKQxxo69qB0pD+VIYhpVx3ozxgUMABx0NAC54OBSD72aABj6Up5HOKYCOOAaQHilxxTAelT1H0J1GW9qePpTVPyZHU0E88jA7UxbkmO44oI6elM7cUof86TsMGB4yaYV5OKkBznPr1pxGOtKyHcqnIOccUjN7VZKg9BUTJx160JdhXISR3NBPY0jKRmowxB5p83cVjV0XVhpLzFtOsL4ygDF3HvCY9K0z4vT/AKFrw/8A+Ax/xrlyw9aax4zTsmNFvV74ajftci1trQMAPJtk2oMDGQPeipdTttPgjT7BqLXbfLvUwGMDIycHJzg8dvaimBlZ45opuKcKzFYKWkA9aUc0DFoIOOaXFHFIBAOKXn0pce9FFwsIKDSmkpjsLSA880tFO4gooooAWlHekPA4oBzTuAU6kpQKLoABpaSlzmi4C4oHSkpRSAAc9KXNJjnNL1GKB2CjnvilHXk0UCCgcHNIaWncBykdR0ozn8KbQOetArEmaUcdcYqMEA+9L/EKAJCKRulNDetKTxwadwEK00jByPpTtwppxnj9aQCrxzUmCRg4qMckVKDx2P8ASqTBhk4ApoPf+VBOBkUgGOaZIdR/Sk6fzpxwB+NNP3vxpDF6D6daMZpM5bBpcgYzSGHtRikoyBwKAFBXnrR0OWxTOc0uSeDii4WH8d85phHOe1LnHejHzdsUmx7EqjKgUYOORj0pc/KM+lXNK0y71W5SCxgaR2OOBwPqaU5JLUIxd9CmF7Y5rW0PQNQ1ucRadbNLnq3RV+pr0jwx8OrOz2T65LFcSDnyFb5R+HU16VY/YrCKNLaGKCPjACgH8q5ZV03odsMJLeR5zoPwgO4Nq92Wc8+TAOPxNd9pfw10ayT5LOI8YJcbj+tdBbXgc4VmYnk7VwMema0YLlIhhs89sdalNvVs6PZRitEeZ+Mvhrpc8Qe1t/IkI+9Fxg14h4j0G80ScpcLviY4WRRx/wDWNfX8xWWP7rFTnivOfGmhwX0M0ckQIIPHTH/16am4MwqUE1ofNbDnAqJkHrwa0tc0+TStSltZuxyreorOzwRXZFqSucL0diMKC6hjtUkAt6D1r0280uDQbjVtQt9HiIgENjpcUkZlW5kfky4P3zj0rzXBdlRQCzEAD613WradYabpNyjXOqXF5otxbpJN9o2oCxJdYl/hxjAJ71MkCZz3jy1hsvEs0MEKW7GKKSWCP7sMrIC6D0wSeO1FV/Fumx6ZrcsUE0k8EyJcxSS/fKSKGG7/AGueaKaTsIqjRr09ITUi6JfHjysYr1ZLFeCQCh9amW1QnYEAbPWuL6w+x1fV/M8nTw9fuMiMfnU8fhfUGUnavHvXqvkIqny0BbOcEUrQAMoIAHrij6w+xX1bzPKV8M3zdFXrjmlbwvqQ/wCWYI9jXqbwqynJVVzgjHWrVtb25YFiXOOc0vrD7DWGPGpdA1CPlrdse3NUpbO4hOJInX6iveJLeALnA6dMZqpd6favHiVVKn8MU1iV1QSwzWzPCypGc0V6jeeHNPuJmjRADydwPFc9f+ECAXt5MDsGrWNZMwdKUTj+1JWteaJd2zEFN6juBWe8EkZ+dMe1bKSexGxDRSmjFMAApaKKBWAClpKWgLBRjNLjPelVSRntQMTFOpQvH9acIyaAGYpQKmEDYzjNL5D9djbfXFK4EOKQjAqfyHAyVOPcVGynIzjFFxDPrQBTivTGaCuPamFxvSl6UY9aXBNMGJS9aSlA9RSFYD0pKdRTCw3+VIeKcQOxpMUrjsJ0I5p4P4fSm4z1pT93gU0wAnmkJ70uKMdc0XFYM03PpTjQQO1FwsN+tHFOxmkxz0pXCwgpadtHagLwfWi4xMZoCgg8VPHA8hxGjN9BmtK08P38+SIWjXrlxgVMpxW7KUW9jHAyelW7Cxub6cRWkLSSHsB09ye1dfpHgt/NWW5BmQH7gHB+tdrp2iS28RW3iS3Q9VRcVzVMVFaROinhZy1ehxOkeCWdg2ozAf8ATGM5J+p9K9H0e1h06FYrKPZjjbGmM/U1NZ6XuVV8uQzt/Gc4ArcsNHbIPK+2a5J1JSep6FKjGktinbROzhS7Kc4ZVGSfxrc0y2HmZS3EzH+JzkZ+lKsMNqdjOjsv/LJATn61o2tzNIFVVjgiH3VJC/8A16uEdbjlItQ210+NzFEHphR+VWxZoqg4BIxyT1qus0A4edM+zZFKl7bgkm4BHvW7ILgKYIUjAHTPIrnNaTcrYIPJ/OtOS4R23wlGJ6nP9KyruVh8zqdoPOKTTegrpO54r8UtJ3xfaY0/eQ5J9SteVEd6+jvGMUVxZyBgCCpBGK+druLybmWI9UYj8K6Kd0rHnVklK6IMljgHBz1zXq8Vvr0tm8eq+FLG/uLry2klN6sf2goPkZlDcnB5xjNeUAYYEqGAIJB7+1drrdnpviHVm1e18S2VnBJtPkXJZJbbAA2KoHIGOMVbbMUZ3jPTdfW7l1PXbQR+c4QvGytHHgYVPlJ24AwAaK09a1zTbmx8STW90ZPt/kW0MLKQ8hj25uHHQZwffJoqlJisdlc3pLqsYGzOScc1Eb8JKWRiR2Ld6yGuSxO3CgjNQK00gzjCnuBzXmct0eh7Q3vt8krK6rkgc+lIJZXGZCSTwMHAFZltDd7eEZQemaviynIPmOQQOMDpSskWpNlpOX+dwx24Az0qaO6Ea42ZOefrVO1tGDYYkt1HrW3ZafG6lpwB6CpkzSMWyCymN24+YBM8/WrlzYF5FVSCO+adY28UQAtFBCtyPU1seWHjUBcyE8gHgVDa6G3s7LU5u10uOFpW3F9xwF96tGwUR5K7Wx+FbkNr5Tnfgt19qWaCMPlzuH3QKamTKJyN7ZIAoCbhnPHasu70O3vAqNEgZuxH65rrNQSRGfyEXd0UVTs4LiRwblAhbkYGSK052jGVJM881LwiqgmHII64ORWLP4au40BWMMD74r2oWG1dzsmO27qapyJHLmPyfpgd62jiGjB4a+x4pJo90jYeJlxxnGaiGmT943A9dpr22TSo9u5hu29QR0qtPp0LEKELbvxFUsT3RH1Z9zx1dKuWYgQuSBnp2qe30O7kY4iZVx1bivW5tLhXYqBt5HK+gqaHS4QCVK5GAcdv/r03itNhrCvueVQeGbuTHCjPTmtex8Gysx3vuUHpjGfxr0uOwiC75GVz3OOn0q1FYBjvBaODoB1LVm8RN7F/Vkt2cLaeCbaLDzne7HhRyK04fDFk8gRbdM55JHWuzt7QCXAibcBk5rRtreNCwGN2MlqmU5S3ZoqcV0OUTw5CyLHJaoFTqSgz9Ksf2PZL8phVl6nKj8q3J2aORgFBJ7k04RZRQ8ezPG4jPFRd3LsuxzUuhxSsFjt0aM9ines+48I2spJaziC59MYrsfJwh2SPgD5dp4P1rOuLeeVwJT+75wMYGafM0Lki+hw994LsW5RHQjqUNZMngcblxPJGCM/OOPzr0q1sVVnMe8r0C5xk++auS2oDBZA3PJ47U1VkRKjA8Zl8G3SKxSaNyOxByap/8ItftyiKy+mcGvbpLZHjxFEcDOSFqt/ZfmKmY23d/l4P41oq8jN4ZHiT+HdSjG5rdiP9kg/pVV9KukJHkuMe1e3XGkwKzPtcewHWnR6JFKWQbiqjnCcf/XqvrLQLCN7Hho027PS3lOP9mgaddY/1Euf9017xp+gxXEJdYiiZ4yOTjuRVj+yVgzuhUIM7jjA/CoeLfYf1O2jZ8/HT7pTzBIMeqmgaddHJ8h8ey19DPosYi80Rhf4gCOlZEkVuJljEeyVjt2YGfwpPFvsVDAuWzPEBp12xwltK3/ADUi6PfkArayn/AIDXt1xpQYFPunHXOCKS00SJXZJJZpScYBGCPyo+uO2xX9ntbs8XXQdSOD9klA9cUiaFqEjHZbMccZFe8nSMAqp3J0+brUI0dQrGMB1DYO045pfXJdh/UF3PEf8AhHtSGM2x5GeoqePwrqbkgw7cDJy1exNZF5fKMJBHKkDr9KvtYNbsXkRAMck46470vrkgWAXVnjVv4JvpEJklhQe5NWovAcwIMtyNnXKLXq4sgwZmKlQPmwMg1CYhEqo8gKc7RntUPFSKjg47HnkPga2Uhp5mZB2PBP4CtOHwxYhv3Nkrc9W7fnXTxQPPKxYbYs/wjJNXksHusIgdIh1I6moeIk+ppDCxXQyLHQ4YU3RxqxHRIh39zXR2Hh7eg82NcEfdx3rW07TtkMcUY+4Mbj1P1rQLTWNv8zrJKWOMDaFHoaV77s6FCKWhFDpMECAuBwOhHSl8qIFfmXaPQVDdTTywZ6sRxjpWfaWV5jzJ5d+DwqjGBSaDlaN6OWzthlmPA4LZqlcTSXbNsJhtx0buajWBwRhST69hViGF37Lx3NarYyYlnZxbAcSOo5xnYo9ye9WBDDn5I4Np6cbj+dOaGEhRITK+RwSQoFWTKgG1IgFA4JrVMixQmhj3Ehht7hI6oSyrCT+7lIH+xwa2nSaTO7IAHAA2jmq0ls5ONygYxycAfiaZJiS6igIO14z6bSKoz6sBEQZC3bg1uXUZdSpmQ4HQfNiuevNGklyY1PrnbinZkNnLa1qMjoyhiVPQ56ivIdaiZL5ierV6/q2i3gVgEJ/CvOvE+mXcQVpLaVdp5baSPzralK+5xVY63RyyqpkUOcISAx9BnmvWb++lsW1+1sNG0/bpqQTWcZtFczQEgM2cZbOc5HSvLBEXZVA+8QMnpz613F42jeHNZFvJqniJtSsEEPnwuihRjJVM87eeBWrMUYPxERh4pleRVQywQyiIIF8kNGDsIH93pRWbrs1vd6rPc2ct5NDJhjJeMGlZscliPfpRTQj1rTtAeZd7A7ByeOTWrY2MMk3lRRABTgtjvXV6bbxiNMKctw3+FWJoIrVQsYAB/ix92vMeqPZhCK3Mm30WNVDSt8x/hxziqNxGguRE8RKsSu49MDtW3JcSxPGBbsyMPmcdvSmLJvfy2Veecd/rioNeS25jX2nrFFi1iVpMZ+voKnt4Jiibm/eY7D7vtXS21ruhX2HU9T9Kr3tsyxHyOHxg8d6XLoOLVzEtoTv8oqVHcgctWxBB5EZJHz46n9KoR2c6KjOxDn7xUd/XPpV4OyABjg4545qZxcXqVLVaGZf3Nx9pjiijbcwycdhVpNM+SN5ZGJHI+p9ajnZYmX5Wd3bls9BW5BBLtLKA2QNoPalBdRS2Kq20CgDHI9B1pIba3QeaVB4wAK0mjEETZYMwHzHHelhUNCCEEa46jnJrbcxu0YNzCCJMqVXPeoI7UmIuUWMA/e6k1vvGFuVIYMSOQecGq14xVWI5PbA707Ik564URybsZYevQe/1prWE0iHY+Gb+LFWJtKlknVjId5O4ZPBH0rQjtpII/nc4A5Zh1/8ArVm7s0SjHUoQaeeUlZjn+I9R61PHHaWcIiWMDk/e5z/9etDaEUqpJbuQOtc9qktxJMogjZl3YYgY281W2wk3JamksL3ILRW4wCABjvV8aSFcBmBY/ePofSqNpLc28oj3ZJ6buB+NWY5XDl7rcn93A4o57boThqWvsMsa7fNBdjwAMnFWI4opYyWiZiDtyvHSoE1CKP7uQD1Ydf8A69SwrPIuY2ZVJ+VWGc0+dA4Nbj12wRl5ogxfs2M1m3WoQglmRig4AHGfc1fa0uJlZmTkc7ieCP8ACqEtrFJkTgliMbV4Dew9qG30FCCb1Eg/0iYSW52x47963LfSI3jEsg3seRx/SqelW0NukZVMKoyO+3/CtCO+IYojg5/lQtypQXQbJp6LuaZRxwExUDWqg7mTaCOFUY4981bmvpIISfKL8cMemPf3rnDdy3F2QZz5RB+6vT8ablrZCjTcjTRLWY+VHG6Y7KcZp8kEiRFlRYh0wT1/z61n21ldSXjSvc5gZQI1A+6fb3rae2nIC3GGU9WC4obK5FGxzU1/DaSB51CvuGAWGD7Vegv2uE2pbCNccHGMg1Yv9MtZvkZVkjyCFPOT+FalpprfJK+1XXpGATj2pI0lGNtDOSyuOfJAFu3JOeVY0wRb4fKYMjNkNnn8hWulysd7t2lQQCw6haniiJnbLbVJJU44ocbkLRmfb25aIRTqWKrjJB6Vk3Oj+Xcq6rhicEjocV1klrKpBQl1x/fHy/8A1qqvhsgGUOOOmePpUygioTa2OeGjRq7zyRjzf73U/hRBHF5hjiCu3IJyMita5huPMxCudy87uwFRQWC2kisVGGBzxmpcbmqlfcpSwrFnft2YwCKpiIKJN7hecgZ7fStG8niWX7hKnKICehqjNGvmYc8bePTPrWTV3YuKK87RJNFK0p2nhT9aW1IvVZ1yUBIzVvT7UCDHlmTDY3deK0YkSJCYIsMONo4A+tQ42epTcUttTmJYDBPsjZ8uSAoParVloWYxI4D54yT93FasmnJLM04QhvULlj61d0eCV02hldCC6tjp6L9aqELq5HS6OcvtLliULbAeeRlVbgfjV/ZLCsaQxfvGABXPA/8ArVsXdq8CtIzgZGMnk1mTpNLcRYkeJVIGU6/rWsYxWjJjqb9gqJCclQxHeoZWjjjLynOO1PjKKpf73AwB2qW/Vby0RIyMeoFPlXQVtfIr2hju0eULwo6AYqG4dYt2dqnPAq7Ai2enFVj2tGOgPUZrntaFx9nLWmJLhjnYa1SQna5YMknAjRpBkAgHFXiqQxKWb5j0B4xWNpRuIWkNwMiRsgA52DFXS+++VpRvVB0FEpLSwOC6Fy1RXLvJgjHp3qRzHHk/KAec1SkmdVOOp7VmX0skjKElx/ez0FSpPZEuCZqXVyzBVif7x5PTio7Sx8yfLfO38RdifpS2QZoi7Y2+461cSaNeIVzgfMe1aKpbQUqaWpMI4omAKRr/ALWOB+FQyJHOMySEL1AFRmRnGdv0b1qlJKyy4GWznjHT2pqoZukF1ZwSuRg7PYdaqp4fglOWVQuclQM/r0rSsv3uS45XqCOlagkRVxgfQDrWimmYyhY55fDOnhfmt0Pr8g5+nFaeqeH7aSUL/YVlcQhVWNpbYOxXHGTWjbQxMzm7n2Y5GBnNWCISQE1GYE9MKTV3uTyxPI/Ffw/0u/uJJG0yKxmIHywKUA44O2ivU7q0Z5CWczKRw7DBNFGvcPZwfQ5W2aKGNED84zmpXIlUhiAvUD+pqsmfJEgVSh6AHmpDNHGrGTbkjnHp6fWuW50K5cNurxA5AbHHHWorXTQkhndV8wghfYUi3Dy2wERy/wDDxj8KvxO72q8Df0OBiri7DadrksSoI8EEKOh9TUF8wghRXB3OentT7WUB1Zssw4wex/pT7qUNIPMVWUcnnrQ2hLR6mRvnlQ7I1VV46c4qlNbPK5VQcnkbvb1rQMsWWYypHEnOM4FTLt+8rYXHHbJ/wrNxvqaXKSWibo2kZTIBgJ0FaMbMigFsYBwAeM1i300KzJGG+cnp3b8Kiu7h443XOFxnaKhvlKaurGvPfiFJEbJ3f3e3tSC98m2SPg7jhRjpmuYsjPNcpvU+Up6f0NXTHLc3oc/LEnYUNu4lT6Gw0gBd/nZmI49akdYxbsJVbcxxgnoKd9ot44UGFwQC3v7VQlupLiTy0P7o/eIp8xn7MtW8ce9ZHRWJPGeSPrU00sZI3AE4+VCOlMkURkYRxGRzkd6sxQ7o/OYKu4cAdqu5PLdmddO4CuYTIh67eAvvim+SJd5RPmIHJPBq2LeS6lcGTFsMMQB1Na1vbYG1iBEB0A5PuaVr7lv3Ucqum3s+pRyIcRxjoeh/CruoweaQoJLDk4GMV0jRSGIcfLnAK8n8Pesh4Alz84+Xseufc07BzX2Myw01IZF3yM0X3irNuOT71rLI1uzPHGWUdvSqai4W4YuR8x+7tqZ5RCha4kVRnHPT6VL0YSTZLJdy3MhVTiRuAu0gAVWNgFYNMNznhcHCj/Cp4ZYXKiRnDk5Ujqadqck4jX5RsUZKbegprUcU72RJbxxQqwMoSPBJKjO41Wmt5kDSA/uiM4Y5x9KbpN0JyAY2TJO1GXsO/wBK6ZLeLarshYjkccVST3Ll7jsYAtnurCNQJCjct5owfbIqLSNGhs5WzKdrtuKSNnFb0sp2ySIUYLzjoP8A9dZtpdSTyHcgVR1IBbJoSd7IFexdkEMUuAEkReRt7VHci4uUdUZlOPvdv/r1PPC3mokQz3wBjH1qyLNIRuJJZh94ngZ6cUKJnq3c5i0sZLW4MkztIc42BRjNdHB57x7Qnkh+hB+YfSnwwwLt8uRTt5Mh6D6VYtYZJHJjbCkEkscd/Smop7BJvqQSWEDLGGUDb0HqO+aiIMcpiTLovQN0H0NXJmXIB2F8euMe9RLEbhmkkDKqH5cHAx61LiCZT2ysxkkH7tTjIPv6U6YM5Yw5G7hecE+5qxfPGI13yBUHzgf41FZXlmyF3KlgO55LZqfZtu1zRPS6RDFFskw2WbGM0y4WUBgCfLYdGBPPtV7U0jFwrYZw2Bwe/rWTf6lJuAWIiQ9Nx4OOtY1IqK1ZrFOT0MqW1yz7nfeDnAH8qq3Nv9mYMzyRrwATVz+0pHVTvy+c4VcZPp9KVBJdkyyoChzndwB7c1MZN6m+qevQm0LYkJtid4JJ3gcqDzgfjVssDMVk5IHyn+Ij0NLZYgICsue2Rmp7ma2jIIhyR2Az+dayi3qYTnzSYyO4MUbEw+axBBK9h9KsWnlxQBYo2QH7u0020k8yP9yQo52jGR9KY0oSTCyY3feVhx9KqKaM3LoWrhJW4IBOOe9Y98pR4grZYn5vUcVK98BKscUgLE87jjBqHUXUMGQZJ4yDkGlJXBXW5nXTyNE0RlyJAR8pwR71oaM8lrAY5GDRJgRknoPQ1mHIkBcfdPU1MXWJcqX2g8+hqIUlHU0lVuuU6EsZw+GUDp7VQliVnfJ+ccL3rNkv4w5ydpPPJPJqGDUczvGzcnkEDpWl0Z69DVhg2qFLAHBqOCWLzWifAYDd9aoXGq+XIGdh5ZIyQOlC3CG53BgzYG0k8MKhq6uVF3dmSai5Cbty/McYqjZyLNKpY5wdvTAq1eBJvmYEdxjvVRY0Q5SQrnlh71KdhGyS3lYDfuxz+FCHeY92EjcZHOB+FY9vdON8bcBTjnv7/Sr4kE6ZZs8jyxk/lWsFdWBal52ESNvdQoAwCOffmqccymQkDGP4j3zUF4rGNicHnDj0HrVK4nSG1LgHencd8f8A1qzGtjpIpUGAmd7dDWjaRBgZGOFrlNIukvLeC5jLKr8/Nwfyrcub0sUSP7o44PU1vBpM56qsakKtcySLAgOByc4qdbS6ViIogMjruFcndXr/AGyK3STDP3/Gt9ZLC3S6DrM32YhWO/Gc9SK1VQw5WtSS5jvYpGV/JJAzhjz+lFUNVmhjkZbZGCFQynOSQRkGitUxanL2sisvysQM9BTrsD7rgHjhia5vRtXSSJR5q9Onettp454gCQecjnkVxX6M1jJbmnZZES5OT1Jq55qRqAoy7cD1zXIpfS29187jyyflPp7Gtq1vQ8YdMF3PBPanexUma6ERLs48wkEnPT1qFZkuJAu0FVOeTx7DNUGuiFyBmRef941myzTJfxyK5WJgd4B4NNSV1cIq5b8R3IKrHFGcMw3EDOAKJLhnsmJzFxyO447U+32zIoUqFxmlitVlk3Mv7tW2k9z60ue5rJqPulC3LeXEzWfm4+7KT8wrqLfSlmtwzRkK3Jz1+pptvFBFKqHA+npV43e2FI1cY3HBJ7d60bUtWYuT6FG8shCWjiGWAzx79qpPHHHN5fJZzs68E96df3rxzeVB8+WLSOepHtSWI3zl5CpKcgHtk9qLRerNIt2uQXlkzQbFBQEYGOo96tabYpp4h8xjJtBzv6nPc1syyQGB1A3PwOTjH1qi9zHErmQ79o5IHGe31o0WxLm2W7tYEi2OS7EcAnAHeuZ/tItJFC5kAkPyMi8fnWxdXaz6U6hfvHcM9Say7aEFz5b+XEozjryRyBUuceZMulaxftUltoGYuWUt61bgguru6CNuXHIwOo96fYSDywz/AHR93I5b39qv2l0y5n3AZG1QBk+xq009TKc29Caa3eLJlkZ404wKrxWyuGdGGXbG5ufwFNW5jkd0mkADfMxc8t7VI/ltCs28Ihx8qc8CnoZtPqSCOHe4iQmQDaXPGBWTeaRbXbILqLzUD4VQf1NW/tMNtEdrkFzzubj86qCVVnEkc8gXow3fez6Urq+ptTlZO7NT+y4orqOZUOxOgDYHtmrT2sBz5zAqe1RC4CouGTbnGS2TUdxPE427d7HuFOSfWqTt0M3JvqaOn2cBug8aE4yW46e1aV1YmeMmRhGjdFQ44/xrmxqLW8YEbMhHQE8//Xp8es+eDh/nHXnAquZNak80kWk0uOF2B3EjjBP3vrSiVLOMRRpFGRwoHOT9Kz7rUQeAwB4y6n+tLDfxIpZcBx0B6n3zWb30NOe+rJ4Z2RvJk5kzljIACD1/CqeqN5g3faQpJGSTmsLXNQvWmeRE2p0B7/4VmWF3K1wrt5shbBII9PSobi9zoXLujqbe/wBJKi2kbLj5fvZ/DHbmtyHECIqFip4BLc49TXFWNmIriadkRZHJY4OcH+taEd0ETeXyQP7x4oUna7Jk10Nm8lCFngUEBSpyccHqCTTEnmjTe8hK5CfNyMe1Yk2qxIPm8tOR33frUKaihlLb9wGGCjpUt82pWrWps30U90x3yhFbnanBx/jXHtpjW2oPcFTI7ZRAG+VR/U1093qAlt1Cvlj3UY49zVOS7RWAXkqOvXFJq+wQrSjoaluv7oPKVyABk5wSPQd6fFbo+4MWKsSWPGFH+e1YbX8TqpdmVAcqnSq0+r4YqkpWLHAB/nRyx6mfO+5tO8ds5jtVjZgQT8uOPrWPrE7P+7jDJhcls9TWMuqsCXMgDbskFs1Tu9YCSqxZV98cD2pemhakovV3NPR5L50PnyRq6naDHnpn1Nb0NzCIyJhv6/nXnd74ssoQd9yit1I3ZrBl+IFpHJIUaY+gXOK25Zy3OeWIgtL2PXpdWFrCTFGAO2T0rPudbPlk70D9ckcmvGL34gTSn5IDj1ZutZ0nje8b7sSj6mqVGbMXi4rU9v8A7aik+dsZ6nOCKX+3Tu4CAdP8a8MXxpfBj+6jK4xjJq7aePJd6LdWcTRBv3hU5O3/ABpqhMHi0z2W41FJwdkgAI4HYe1Yr3rxEjzsrnlM5z/hXlh8bT+eSlrEI88DJzjNTyeOT82yxB+bIy/b0pqhJE/Wl0PRTrGxiH37T3IyKkN/a3UewymM9Q44wa83Hj5ywLWS8DGA3/1qkPji0fPm6ewPopHNS8O3sgWK8z00uGkO9i42dd3BNPhn8okRAMCM7d38v8K8nfxsYs/YbVk/35MirVp47jwEu7Qp6tG2TS+ry3SNPrcXuerHVhGm4q7AdgMnH0qIXok/dsxDdV7HFcNZeJ7S4wIrhck8bjg/lWrDdxzzRM7AxHqw52+9YSptPVGqrprRnWvcLA2QwYkDmrsUo/dtCFAYbmGOc1yEl4pHlwt5ojbkgk59/akXUTCCyysnJwpHeiUXF2Q1VR6DbToz7Jh8zHJqvcQRLO6qo/vLzxnv+NchFq0siB92cZ6c4PvT5tclVQzOWIHUHp+FQk09S/aJ6pnbWMQUrhNqgdumfWq2ou8d/b+UNylvmrB0/wAT5nVC3mLtzu6ZH06ipNSvWmVZrRjjcCwGOgOSB9a10W5Llzal/UZ/st4HOfn+TgetWpr65XXba1ujayT3KCGcMMoq9R5mO9Yeo6zFqEfmRKyvFgnKnCHPGfSujtEtJdaW/nt9QhuZApeNItyM2PvA9qtIy5rHSx2Mnmn7YEMxAHy/dAxwB7YorTMwY5KFAAAA3UCirjfoUopq7PkpHurO4/cktGT8rZ4+lbFn4kurRwJY28wetV3mVEXfgxHn2FWPLhuY/vAsnc+lOST3R58W1sy3J4hguof3jEOO3TFLZ+I0ilRZJSADwCDWPcRwCYAoMkfMe1O228UPyqMnp32+1JQiX7SXc6+PxHHJ/Hkjo2Rz/wDXqa01SKZCJWIY9Tn73+FedZiR2Ecm09enFXLG4XnFwUJOSpNJ0Uy44ho9HGswwhUU4HYZqaPXE8vCHoOmc8V51uiLqzXDg9CetW42ZA3kzB3I6HqKylSsae3bZ2ja40b72R+2TjrVi11+O7YgKyKRwSMVySXkstllSPtC9CT1q1p2ofJiWELKo57c1Nmka81zqPP2P9oJYOTyDyatw3aIPMUs28cZIrk7jUo1X5pxGo45H8qhi1eJ5AkZ3KO5PFCuxOou52qX7hh5zcY4IPI9qY9yLjAX5VU7iW9a57+0sNkyfL0x1zQupc5IDc4K7sZqtRc6OhlV1VtpO4gEHPeqlvM9uCrRsSevOazBfys7N5gG08qOePrU6ajGEwfnHTg5pOCepUKtjpLa5MsQGQuBzg9far5ucooUgdOB7VxgvUDFoeARyOx/+vUsd87NlWxjr2waI2QpO+xvanFNczK9vhR3Jq9C9ytuE2JgjBI7/SsH+1DsBYk9uvenR6xHyFUuQMHB5q+aw+ZtWL+qrl0dkEidCF4IqhpzTJMX2sePvgBR+VPGrwMBjgt0yvT2oXUow+0KgPQBT1/ClZtWRaq20NPedobeeR83fFSw3iwPh5Sy4z83FZp1GKVAVHbGM1C90U+dkBI/lVpNGLaZtrqsKkPsGf8AZ7ioZLmG4mVvLOP9nA/WucuLyCXYWLRZ6EHimfaQiZWdmwcg5obdxpxsdDcywQtxAxHUZUfzqmdXhXd+6lT19Ky31N5FU7x06bs0xtWSJC37oqPvAgCk3qCatqaq6j5h+VJWXtu6VWm1WIsFwV5xu6c/1rJfV7cpvIDZ9G6VTudVhBLkAcckkZpWux86RvC5dyWVsjsSCKmmuJTx5mFPTtXE3HiWygUAXCDPLBm6VlXHjm2jchJC+OmB1q40m+hlKvFdTuryKGaJgTkknq3FNt7k267OHwOGBrzW5+ID5zDBn3JxWTc+NNSmJAKxqT90c1SwzbCWM0tc9oF+mwGSQDPO0k4NVb3X7WIMJJFGOM7q8Oudf1CctuupOc9OKz5bqafmaWRz05Oa0WG8zF4rsj2DU/FtnG2ftahumFO7FYN748hVCsHmS+5GK843Y+tNz61Sw0VvqQ8TN+R1M/i24Lu8UYWRu+T/ACrIu9Yvrz/XXL4PGBwKzc85pua2VOMdkZSqSluyZpMjqSe5NRlsmmE4NHWrIHZ5FKfamc80fTFAh5bikJ5pCPekwfWiwXDP0pc+mKbg0Y/OjlC48mmlqTBFIASf8KGhDuTzTiSBmge9GafKFxN3r1q5a6jdWe029xImDkDORn6VUNIRxwaTiNM6G38VahGwLMjnOd2Np/MVu2/jZLpFivoVVuFD47e/+NcBnB/rRurN04vRI0VSS6nq1vqNtKMwyh1YfNsbqPwq9BEshMkTFgepPavHopnicNGzIfVTitjTvE2o2bEecZI2GGVjyw+tYPCrozZYlrdHqOxSRuOG6gjrVq2LxH5WOPT1rz3TfGQDbbuNgpPVTuArq7HU7W9j3W8qNx2bBFcs6Uo6M6YVoy2OoiZJ4pI2YhZcbghxux0z61uXU0el3kdrP4l1EOgDkGMsE/2Sc1xYdk2sxKleVNdXtbUFW61DQ5HuJgGyt0sSzHpu2nnn2pU4taIc5J6s7+e5RrCVkumnkjVd5cYJDfdYHuPeiuEOpXscE9vNbYlvpkhUrx5CAjEYX8OtFVKcU7XLhJ2Pms6zcEnDcGkGs3S5xKRxjisok/8A16M9s8V6dkePqa41u8OMuD9aVdbuQc/Lz1rI7cUv1FPlQXNn+2pP4o0OKT+2Gw2YUwffpWRRz6dKLILm2mtOh3bCfTn+dOGuTLIWjJVj1OawwfrShsUuVDTZvw+I7pWxvyuehq23i2+fqwHviuX3cUbu1T7OPYfM+50UniS5YABsj1pY/EDfx5UZ/h7/AFrnDz9KXPFPkj2C7Otj8RlOVmKHuMcVZi8RRlwZJ2zn+IHNcTuzRk0nCI+ZnoUPiKPfhbojjk+pq6niWE7QHBGeqnBrzEH0NLvPcmodGLGqklseur4gBIC3EXPdqm/tWNk3NcLn1HFeP+YcAbjx708TyAEb3APvUvDRZXt5Hqy3gW58xbpSRx14/wD11aGvW8oEc7jeOM9K8hFzKqlVd8Hng01biQYJcnnuaPqsSvrEj2Q6pCCrGSNUU45xmlHiC1XlZYwQc/fwRXjT3Lu6kk+hpN+eeT6Ulhkuo3iJPoexyeJLR0O+8t19feqbeLLOJSq3YYA8lcnH4V5PvJ9DQJCD6VSopdSfayPTrnxpYqSMGYN6Lis6fxuE4ggJXoea4EyZ9aATjjrVKlEj2su511x4xuXwI40QH3qhceJb+ccsoGMYArC5OM0dfaq9lHsLnl3NJ9YvmHFwy/7vFVZLudzmSaRj3y3Wq3rk5oPPSqULbC5mx+8k5JpN/Tvj3pgGDyaD7U7CHFs9KNxPPT2pp7YNFHKAZJ70oyfak7880vvTURXAg9zRjAoJ6Uh571VguBo246UGnA4osFxpx6UHGeKQnnrSd+KLAKTSZo7mjtQIeBx7+tGeKbnjpijNMQZPfmkJoPTjmkzQMX2oDYpCc0ZpDH9Pek5NJupR0piHcg0hNKeeO9JnqDQAjDkdsU0jB9aXNGefUUWC40E+lHfNLk98UhqXEdxQcnmpYZXicNHIyN6qcVCBnijGOlS13BM6jRfF19YSKLgLdwZ+aOQ8kegNexGG08XyPquk6rZy2km0tFPLslteANpHXA7Yr5/srK7vSwsrW4uSmCwhjL7fc4HFbmh2+v6RfLeWumagGHDr9mf517qeOaxnST2NoVGnqfSGn3UE2qIEJkhh8sxSv/HsGGJz3yM0VUvHivLm1WICAPbxMoPGxygypHvRXA1FPVHpwd4qx8ldqXpTR70ueK9U8cUHHSncd6YDmjvQA7Ipc/rTenWgHmgB2CBmlGM4/OmE4J/SnrQhMXtQOOaQcZpQfWmIUn3oDDHWm5BNKOnNLUY8D1NFIDSiqsK4opaSjP0p2GKaD06mk3HPtRnniiwCng0UmfWilYLinmlBx060go4zSsFx2cnFGKQmjNFh3FAHenEgU0HIoppCHbsd6M54PSm+tKKYhQADkUE4opCeDTAXI7UlJ6UlIY7NBJpuSfSg+1ADgfype1NPSm0wH5HrRkf5FNHWlNAhwwQTTS2Tx1pDyOOKXoAaAEwaTIozQDg+tIY6kBo70gOetADj2pD160jE0gPHNMBc+tIcHmge9IaQDs0DoPWm5Ipc0AKfpQCcYpM9qeuCaYCDPQ0HOfalPFJnNAgJHY80KCetBx0oGQOvNAxSOKjzinM3HWkU0AOUdzS9AAKRTxSH68UMkt6fqd/prSHTry4tTJgOYXK7sdM4q8vifX8/8hrUcj/puak8LWtibXV9T1K2a8i0+JClsHKh3dtoLEc7RVy503T9e0qe/wDD1sbS/tVMl1pwcuGT/npETyQO61mWb/w18WyJ4gW2167kmtr0hHmlbJRv4Tk0VzPjS1t9P8QiKyiWGD7NbyBV6bmjUk/iTRWM6Kk7o3hiHBWOT70Y4pKO9bGAoApabR+FADutHSkFIaAHAc04UnTpzSE5PrTFYcScUZpuCfpTsUAOxxS038KXOKoQ6jNIDQaYDqMgUnam55oAd9KUU2jJPWkA6lzTc0Uhjs0o6UwUuaAFpRTAfWnCgBw4o4z0NNpc1QDh0FAIzgU3JoFADiecUmaQ0nNACml6U2lpAB6UCiigBd2aBSUUAKD0ozxSDgUc0wFPJptB460tLYAopoOeKKAF70UnSjmgBaRRk0cnqaQ+oNIBTgHviikHJpx56UAJ3oyM4o5FJxnmmAvenL164xSKvOaWmA7AI5poPIpM+xpB94UCHkDNNOfTikJ4ozxQAhxnnpQM59qQnNLz+FIBwoPXHalzxyKYx+amwNvwpJrdvfS3Hh+3muHVdkyJD5qMh/hdehBx3qxZ6J4psb9Lyz0nVYLlGLo6W7DaT+HT2rN8N6te6Pq8V1p+9pM7WhGSJlPVCB1zWnfW/iTzZbiO01y3tGYsiM0jbFPQZ749ahDKvim71K81qWbXIDb6gUQPGYvLOAoCnb2yOaKypppZ5S88kkshwC0jEtx2JNFWhFKiiisygooJzSCkAtKBxSUZpgKaUdKaDS0wHDpSimjpSg9e9NCHduvNJmkzRnincQ7PHSlLUwn3pueaVx2JM4oHQ0mRx1o70XEOB4paaaOtFxjqCT603NJn5sUXBDs0oFA7YpTxSQC/SlFNFLTADz3pe1J3o560wHdhRTSwzjvRmncB1JSZo+ppNgLQOtJmg8GlcLC0ZpPegnjigdhRS/hSUmaYgHfNL3pKKABuvWlzTTzQeopNjsLRQcA0ZPpRcLC0lJn2o+lCYNC0hooPT3oEKvPSjOG4NNxyKXoaADvSgc0meehpwAHJFNAKOOvFITQzUzrTEO685NHekz2FGePfvSGKfem85zTiemRSUCEpQMDrR2NA6UwHHBX/ADxUZ7c0ucDFMY8cCk2COs8ATGP+1orK6gs9ZmgVbKeZgoHzfOqseFYjoa0odG8dx3Kyi7u4WBz50moKEHuSWwRWD4WsbCS11TUdXjluLSwjRvs8T7DK7ttXLdlHc1cvtKsNX0ebUvDazRPajN3pssnmNGn/AD0jP8S+ueRUDK3jq4tbnxNcS2bxSgpGJpYRhJZgoEjL7Fs0U3xtY22m659nsY/Kh+zQSbQc/M0asT+ZorRbCZzNFFFY3KCgUUCmAtAooqgHdulFNooAfxRxggUygc0risO60ZpMUUAOzk/hScCkx6UYpjHA0vbNNooAd1PPSj8abmgZNAxx7+tLgcfzpo605T2PSgTHLS9qbSjpTEOpozRmgfWmA4HtQSAM03r9KbIcCk3YATli1SZpiDC9OadQgFpD7GkJ4oz2pDSHD3oBphPNL0GaBjufSgcCmjrS5oAUUUelJmmTYWjPamn6Gj+LpRcaFo6UgyaDmkMdkf8A16TgDigfWk6fWgBe2aKTBNITjJoAd60UnUDPSlz0oAD70dRSevNKPamiWOx3PalOMYpOfpim5561Qrik89KOO+KaeWz2pW6gUgE9xSnHrRjHTNIABn/GgYdDS0hxk0hIHei4Cn+dGe1JkDkkZNN3DnnNFxCk+vemA880EjFIDzUt3KRraFrN1o1zJLaeU6Sp5csMyB45V9GU9ah03U7nTdRS9sJvIuEJKlenPVcdx7GtHwlp8N5LLcXMP2hIWjhit920TzSNhFJHReCT7Ctm1vWvNUvtOlTRbyCBWMcEdqIlnC8ssUgAZWwDgk8470cyFY5zxDrE+uam19dxxRyuiIViXao2qAMDt0opniCzi07UmjtneS0lRJ4Hf7xjdQy59xnB9xRTUkIyM0uabRXPzMsdmjNNop87AdmjNNoo52A7NGabRRzMB2aUMKZRRzMB+73pN1Noo52A/dRuHvTKKOdhYfu+tG4UyijnYDywzSh1Hao6KOdgSiRe4NHmD0qKinzsLEvmClEoGeKhoo9oxWJxKuc80eauelQUUc7CxOZV9DTS6nqDUVFHOwsT+avocUeauO9QUUc7GTeaOcjNBkHbNQ0UudgTeaPejzR6GoaKOdgTCUZzzS+avbNQUUc7AsGZSc4NJ5w9DUFFPnYExkGO/wCdL5wx93moKKXOwJvN9jSGX2qKijnYE3m8dKTzBnOOaioo52BL5tHmZ7VFRRzMCUydcUnmcVHRRzMCXzSKTzPzqOijmYWJN/qTSb/rTKKOdgO3Uu80yijmYD99G4ehplFHMwHFqM02ilzMB2aTNJRRzMBc0uabRRcDofCepw2jz213M1vFM0ckdyq7vImjOUcjuOSD7Guk22kE015s0PT3lVle9gvDPtDDDGKEHIYgnGeme1edig0XA0vEGoR6jqTS28ZitY0SGBGOSsaKFXPvgZPuaKzKKLgf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24082=[""].join("\n");
var outline_f23_33_24082=null;
var title_f23_33_24083="Transphyseal fracture";
var content_f23_33_24083=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57926&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transphyseal fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 305px; height: 597px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJVATEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Uooq3a26SxF3LDnHFAFSitJbK3ON0p9/mFTJp1sTgzHJ6YYf4UDsY9FbR0mLIG6Tk/3h/hT10i3OcvL+Y/woCxhUVvto9vtBEkufcj/CpRodqWA82YAjOTj/AAoCxzdFet/Cz4b6N4s1maz1O51CNETcpt3QHr/tKa9vtP2WvBs0Ss2r+IASM4E0P/xqgR8a0V9kW/7Lfg6SR0fVvEAKHnE0P/xqpp/2V/BkcTMNX8Q5H/TaH/41QB8Y0V6t48+HWk+H/EV9p9ldXzxQNhDMybjxnnCiuW/4Ru0AJMs5+hH+FA7HJUV082gWqKSJZiPXI/wquNHtsgeZKfcEf4UBYwKK2pdKhjz88h9sj/Cohp0ZYDc/vyKAsZVFS3MYjmdFOQD3q7FZwtHGzs65AJ5FAWM2itZbC1P3pj+DD/CrcOjWjrnzZD9GX/CgLHPUV0n9hWpIxJNj6j/CnroNo3R5+e2R/hQFjmKK7rQ/COnX12sVxPdBD/cZcj81r33S/wBmzwbe2ENydV1/DqD8ssPU/wDbOgVj5Ior66u/2afB0Q/d6vrxPYNLD/8AG6oS/s6+Eomw2qa56/66H/43QB8qUV9Y/wDDOHhEKWOq66VzwfNi/wDjdUtc/Z48LWenyzWeqay8ijI3yREH8o6APluiut1nwzb2N5JCjTlFOAWYEn9Kzm0iLOFaXPuR/hQOxh0VtnSYR0eQ/iP8KY2mQjbiSTPfp/hQFjHorRexiBwGfr/ntTGtEHTf1wDQFijRV/7JFkAs/wCFUKBBRRRQAVesifs8gwCMknJ9qo1oWX/Hs/I6kY9eBQNH2j8SdXg8I/DzwsnhzQtFuvEWqJFHbx3NqjAosO+RyOM4AA69WFYXxmudH1/9nrSfEel6bY28l9LayMbeFVKOSQ6ZA7MGH4Vn3PxE+E2uy6DdeKIdT1C40zT1s0tJrTfbqSF3PtPVuAM56AcVzPj7xn4Gk+FUvhPwS+qlW1IXkcV1FhIQWLMinsoJOBz1PNAjxpkAEZyRzzzUuQHPqRxmopAwxhueM08Ix3lgvXA5oKJGyAA4DZ6elSjDOuOmOfaoxkKBggjn61ImPk+Y7fSgD1X9npmHi2443AQ/gOa+vdNJ+wJnINfH3wB3jxbLtPJj69hzX1xYZay+9xtz16GhiHRfJMXXJG6r9wMxng/lWSqsJOrBQcfU1qld0WNxPGc0CPkD4spE3jrWFdxvV84P+7XnJhX5G6duvSvRfi9bxnx9qz7juVlbpz06GvPI1Q7mPy4Y+9MpFS6VQWwSQRyc96z3ZcJjJJrUuVOHHCqB+dZjqfKQ5wR3JpDKsu7c4IGSKgwygBeOeoqzL/GQRzVdWyVJHPpSAxr45u5OvXv9K9f/AGZrWC8+LehQXlvDPCYJyUlQMp/cseQeK8fvf+PqTIxzXpXwN8T6f4P+IOk61rPnLZQRSq5iQu3zRMo4+pFMk9duPiJcW/izUbZrHwr9mtPE0mj/AGObR2jH2YSbfOa6z5akA9DzkZxg4rmP2nbS0sPin5Nnbw20R0+AhIYwi53Sc4Fb1x4l+EV3d6k1zqXjGWw1LUH1O70wlltJ5mcOdyADIyF4z/CPSuF+OXjHTPGnj06tobTm0FnDD++j2EsrOTx6fMOaARxIJOMH8DU0TfKCD8vTGKgThuv0qWPnueOMdaBm14XlI1uElwoYFSSa+yPBbGfw3ZEckooyDwK+KtKlaLUbbZgjft56V9h/C68E3hG2kXOxV24I9OKBM6PU2A6kYfjkVi3CF9okYBlPGK0b9gcsw6D86ooE+xtcKoDFmHPWgRZtSJVKYOQOVzzUd3GZtPkUMFwCM44FJaSebtcNtkXk4HWi3wYp0kJyxJ29sUwPkT4j2jWmv3KhSArkHPeuMl+YnbjHfmvWPjZYSRatJI0ZVGfIwOMdOTXlMgx15APUnA/+vSKRE2QQD1ApjAdR8vqDT5NoYYbIzyKiLB1+bseuO1AyGVSrpzxnOCeKgYdSrA4P3cVPKfm3NwexqBiGHzDI9KQDmB3en4Vj1rsBxtGeOOeayKZLCiiigQVpabnyG29dx/kKza0dPz5LEZ+8en0FAF8c/wAKj6VIu8nGenH41XKncrBT9CetWVOWGMgdefegZKyvtxz8pzxTkIGd3GSOajRsZBPBGPXJqeMZBBBHPQUAOUlSMqdxzzmpQ2CCcc9xUSn5s54OO3SpkxxgcntQM9R+AQY+MJCUBHlZJz05r60smP2VgDkn+VfKf7PIL+Lbhduf3PX0GelfVtsdkTdNuO9DJFGSxxuHfFaMODCAPTFZHzDc5JY4HAPNaluWMa9MY/rSA+TvjFFt+IOonozYbJ7jHevL2RQwCkkbic16p8cYrlPiBfldmCFOF64x3ryty+0ZUfePIqikQ3AId/lOcYyfSs9hmMc4we9XpyVdwchcYNUpBvADcDH4UgKUzHEm0r71VRmGAQcj0Harc+wg8bTmq+9SFPb0ApDMW/GLuT61p2h2xRA55UcfhWZfDF3J9f6Vp25zDF0ztFMSLSDBJP1xnip1PAXAwQOarAAY4wcfnU8bFT0x/jSGWYyF3eg6k9qnUHaCOmcGq6EkEkKM9fepVyEAGOeOaYie3ys8fHIYEHPWvrr4OyGTwlGOQy7lP0r5GOF2iMEEct9c9q+svgm+7weCSeWJwf50xM7S7UmwxgEjoKyJgBYqoXcpbPuK2b8qY0UHg8Dng1mCASTKithQCPl7mgQ5YxagM5C+UOcj17VHDMV1MoeFlHynsKk16zY2V2IywdkXaw7YrLhZprW3Lk7kUAg9cigDzb476d59mlwFJ4Kjnoa+cpjuA9OfrX118QbQan4anAKu6ruPy+npXyZfwNFcypsxtY9T1oZSKTHJA4H41FlgG9Dxx0NTll3EnAOOKhcNt4IK+npSGRMDuwMNkcg1DkcZXAzjNWJgckjqcVCynPIBB55NIQ0EpkYwc/Xisitgg9R0BrHpiYUUUUCCtCwfZA3GSWIxjnGBWfWjp6sYGZeMMf5CgC2XBCfeBFTxsN6YB+lQKhDEg44zz2qWPbg7TgkcmgZPvIU8Ng8Y96njcqBgEccjNVxkDvz3Pap41XZ3x1470DJFbHX9OanV84HA96hjGc5ypNTABmwcYPegD2H9m6Mf8JLeyKclYhx+NfT8LHayjGQOK+bP2aYydU1GRlGFVVyPqetfSFq2WkIIB6Y70MTHKj/Mi9OCea1LdshQccDisyOYgSfK+M9RWjZtkEbeRzmgR8yftBR+X45klXKb4FJPr1rxwOwhQEA4bgkV7p+0qqweIbVwsm97c4bbkcGvCd4a1ACsSG5z6UykVrojD/LgHkMKz5AxA2529eavXa/e3L97vntVIn93/CAKAIJyyqcAZz3qoWZQMc5xwBVibnrg5qArySmVOOc0hmNfnN5ISMc/0rTth+4QHJyo4z2xWZff8fcn1rQtlZYY2BxwDyaRKLK7SPQ+tSjA+Y9ueaiGQgUHPFSr0GAR9aZRNC+5yc89MVbVs9hVOPO0t7+nb0qyjAY5wfSgRY5XPcdMelfVvwHYP4MVsMSWO3J7YFfJyn93tBI45BNfV/wILR/D+HK7RvOB60xM7rUrlEjiVow2CTx1qlpz7AxJwobcGY4Iz2qDXLg+apT5JAPXr7Uy3RriDzijbDtDcdPegRpXFws6sSdq/dYN71hwlVVUHRXK/hWlIYnYn/lmueh+8azbqOZLZmHDFd4AXjNAFSVW8y5s5RlJEzGy9ieua+XfHWmvp+uXERGPmJr6Wv703GkLexLiWEnfETgmvHvjJafa1TUYIigBw2DxmgaPIpMkkDGDz061Fzt49etSyMAd3BPb2pjrlCBmkUQOvzAkkYHpUG4cZzgnpip33YRSAPxqBgNwOR170gBjuOBgEHqKxa2WbqSc9s+tY1MlhRRRQIK0tNz5D4A6nOfwrNrT01QbdvZun4UAixExHOdvv61MmS3Qj3ojGMEEZ+lTwna/zEY6ZPSgYgwRgj1qaP7uMHrk49aQABiu3AxzTwQWOwEgDLelAx6oMDGePwqeHbgjaSO1R8BVAJ3HnpU0ajeOvPegD3z9me0K2+pT4OTIBnp2r3kDZ8yn3LeleP8A7P8AB9l8JNKQQZpWIJ79sivWQu4og+YdCfemyTQbfgKhPADbcdat2EmZWDhQ5HQHmqW6TaCoIAGD7VLaskDiSR9xxnP9KQHkf7Tls7WOmXUaklS0bHHQEZ/pXzYyv9kQrgKCfxr64/aEsXvPh9PPAAWgdZOR1Hf+dfJKELZSGQLg/dyeM00UijdtlshSMjvVFjlQ23kce9XbmVHXDZGOeKqOc8gdegxSAqzg7eTj1GKrZKn0J9asucoxPBzgjNV/mUE4Az/jQBiXwxdyZOea07Uj7MijPQHIrN1D/j8k+v8AStS2GIItowdgOc+1AkSkFgW5644pyAZU85Pr2pMADoeeRUoPAHByeh60FEsOT8pXA6ZNPjzuGF9sn1pIwwY7gBt4zUkfc857UCJMHDdCOpr6/wDg9AIvh7YoQACm/k9jzXyKBudQOckV9leHIRo/w/0yF12yPCo255yR0oEyHUozeuQCir0V/wC7UmlNPboyvMBEAQFB/nWW915BlVH8zZkbV9f8adp9yslq8V0WwrqPMbv3piNHzGULGXXGPmBHfr+dLfsYmCs+6N2G0j+DjofxqhNc75JgcqxwE75pbi7iZJWmlRBD8jg9CexoAqizaO9ltzIFWeJww7sT0xXAeItPafTLuwmcOW+5vHcdhXXXV6XjYCTdLEmUZeNyntn2rK1sw30RCKfORQzsOOfrQNHzZeW0lveSxuPmRyGB9qpN8vzHjcMiur8a2rLqQuFQqspw49xXLygHaB93HTNIohbOB83Gc5qtIu3nJbsMVZkBHUHH161Cc4HTNAiMqSSAMetY1bmPnJx8v5cVh0CYUUUUCCtXSwPszkjjd/hWVWnpufsz4ODu4/SgC7gtgdMelWFDEDceMdzUSowjDZAOcYB5/Knr0+bp1570DJyhIOSRntnNPXJfqD7imJHgDsvUe5qWBMtg59cUAS4IHUjHSpI0JbLHlhwAetCJuJPIAHIFa3heyF/r1jCQSC43YHYc0wPpX4X2Uum+GtMhbkrHuxjue1eg2kjCTceEIA/HvXK6VEYLa2jLEYwWresnZ1wHyqEjPfigRtRSsUPPyBsHNQzkBiVICnGO3NQR5IGHyrKGwTwBSySZJOV25HLUgJNctk13wvqWnO2XeFlB9Mivie7tUiSWF95KMVLZ7jrX2vYS+VcuzMo3YHsR3r5j+NehN4d8V3ZjjAs75vPiPYZ6/rTGjzGeKNSAQcEDknNVWGNuBwOKsXUzlvmUDAzj1qojlk+VCBnqaCiGUjnoWHOKrvxnjkGpGc5+6FHU1E/UEk8joKQjC1DH2yXHr/StGNsQQg8KVHb2rO1DP2yTPXP9K04OYIiMZCAZPTpQJbksRO1huB5z9KnVxlRjIFQxqVGcD8KlOeMAZFIosKwLEHBxjkVMF6nIyKhTI5IHPt/Op4xwOcf1piN/wXph1jxZpVhGvEs6lsn+EHJr628R3MBjMJDCGEKmAcEe9eAfAe1hj1i51a42q0EflxccZPWvXL6+SdX8sF5A+0o3fjOaYmZ1+7waidq5U5kVs4BqxcxzXOkyBGGwoVHGe/XNYfm5lVJGKZJO48lPXArR0tzDYXCtuMQfg9S3vTA09Od/Kja7++FAGemccc1lX0qkS7M/aGJLrnhs/wBK0ZZBJaiJVy6KJGwOhrPupDcyZtnhES7chlwQO9IClHCxjRAC7sCoAHT2rPZ2WERbAHJwMHk4rTmnDR3GVaGYFXXaT8yjj86oqiTXEZQFY1+Y7hjk9qYHA+ONOFzbmVVzgZBz/nmvLpQVYkHjpgjmvbtcgR5FRGwMsNmccV5Rr9k1tdSEIAu4j2JpMaMN93BBLEVCQMHB6kE1akA3LkcH0qB1JCgYOeelICFsbhlsjHesGujfdk4GOnNc5QJhRRRQIK0tNwIGOfm3YH5Vm1paZnyWxz83T8qAReXawHJyMc1PtP3eu3oeuRUYfK5RQrEAcDinx8ZYfoaBlgqqkvubAxjHapoxtbK5B7kVCGGCScexq0MZyrgnsPSgCRVJJ2nr1xXefCixNx4jinldxEq/KVHf39q4OFWZ3G3cTjt+VezfDSzNnb22xcSy8tu6rTQHq0lv5tw3mH5HxkHPUYrYssoSehJyR6VlRESTgAthOpIwTxWjBKqSlWKncQue+KBGnMFeIxAmNRjkHrTJyyr8ucgYx2NMtbhHAjDoXOSADgtjpin3EhNtI2GGD3FICEt8zqF5OCOe/euT+LGkJ4l8GsTGjXtjmSInuO610rzRJHkqWBHDVha1fqNNKCVHXG1wBxk9qYHyfdLyBt2suRgDFVRuHGT15FdR42toYNamMJVUk+baOgPpXLCRRuyxx1ORQUVXUlnJxg4qFyfQA5NTu7Ftvcdcniq5Pz88Y6GkBg3/APx9yfX+la1qcQRYHVQM/hWTfZN3Jn1/pWraDMUPTGB/KgSLCgbMqRkcc8VIAvGSADx9aSIBhycn+VPCkSEE5xxxQUSIn8W4nP61PGoOADzjgVCvX5snAxwRVmyO+5THTPOe9Aj1TwX5ltocEUTGMeYGfHfPQ13VhcKXaWVmMm5guD1PvXmOgzO8wTdnPJBPFdrY3DybslGCnChe+e1MRdviwuo28tlByGDHHHtWto7hrK5jjlR4wu+MOM4x29OtYU0RmAeTOCpbczEDPetjREtY7eVF5naPO48baAL+o6m+h6M9/cKs1zcgRrEOPqRXGpqSTT7raZ2IBbptGfSsrxJdtfXjwtds6RgRxscge5o0uEKjBmG5BwV6E0AdHBfzD5ogPMLABjz+B+lTeVOU23BB8z5hz8qtnuKpacA8ZRWDswJIAwc/Srwjl8hHaMfKx+ToeeKAMHWYnllnQqQYyMFeh+hrkNbsjLbSeaoUKC2TySa9CvYWjklCkxooBJ68emK4bxdcDT7dtrbriTI25yFoA82ljKS8MCPWqzoMZzk+1XJgxYl8YPNVXj4JB9KQyGRRkBQcDk1zddM+AORnv9K5mgTCiiigQVoaeR5Dg+vX04FZ9aOm52HHILYI/CgC8u3BAbBqaIMGx1yMkEVEqAgDbnDcYqXjkjIz1B7UDHD58qSD61bQ54GVwO3WqScg45I696u2sFxciQWtvLcMilm8pC21R1Jx2x3oA2fD8YfU7dGI5YYyM17r4d0Oe2iEkcz4lk38jOwccAeleB2BI+aIlXI+Ug817b8LvG0DWsVlq0mLhCFRyPvD3pgz0K2huwWLOOmCTzx9KimleSN3id4yrAlmGcjpXR/u3iWRiu3acEEfNWNdQO5eFWV1fAGTjH4UCMCS3nk1GBY7x4th3BlHAH+PtXoFpIk2nSF5mMij5z6/hXF20P2W53zLG25/l+f+YrT02e5XUpQzIIXVgV68duaBjZdUj8ySMqFKnYCTwe+a5nXtbje3ZYo2jkG7ecYBPb60zxm8NpaLIs4VC27cvY+leUa1rkjuw8/zADjaBxj1NAGP4v1WO7uJIlSPKnGQMVygYDbg554qzdP5lzI5XCkk89h6VRLAryM8/TFIY2Rsu2eCBxxUDHowyR0HPSnZG9ty/hSYwMEY+lAGDff8fcn1/pWrbEiGErkZUAY+lZN7/wAfUnXr3rUtRmKLLclRxnkcUCRajLBV55HFSb2yMdCcHPamoQIydo3d8UoPzDoT+QNBQ5TtQkkenHpUsEjABh+NREjsMADPNOQN5XHQ/wCNAHTaTqTeZv5BwAcnpXb6XqbiKMRTfvNwOTwAfTNeTwzsjMx6+hFdPpWuxQxETDZk7cjkChCPVvPJjHmMpL5/A/Sp7W9eDTLmeVUaZojGoOehrkrHXIJ4CsVwgD8sT/jWhHqMIdyCrfKAFU/e9qYjCspvMuEYoVUE9QcY9/St3T5nO8xEJlud44b2rJDx+ephZl5OFI6Anp71oabjeGKuIwd7Z5HXgfWmB0+moJH3D5jjovy/UVr3aQxWYkVjhRvYYzzmsqHVodPtDmQAISdzHpXF6/42AinSzzLKcjk4C59KQHU+IvEEGmwCe4K+aw3hB/F6HHpXjmsajLqt+9zMeSe3QVDcXdxcupuZpJnxyzHNV5DwpQZ9qBlaXkng9eMVXbLAg85OM1ZkL7cAAZzx1qsyZQ5PzDnOaQys2QWAx6dK5qulb+EcA44z2rmqCWFFFFAgrS0zPlk8fe/pWbWjpv8AqmIBJBPT8KARfDZI5znqPSrlsYBPELhXeHd8yowViuecNg4+uDVJVOQ2MA+nrU8Z3MvT5T0zQM9z+HOofBW2MP8AbGlaol5/z11MmePP0jwD+KV9Bwat4Mu/Bmrw+HrjTJNOWymM1tpjRo4TyzkBBjacdMivivRPD91qBZoyiKeAzHNd9pvw0Vo4nnu38xscKRz707CEsLz4WLIrQ6b4tBHczwcVk+LrjQWvbeTwtDqMNoE2yC7dWdm3Hkbe2MV0F54DtbGOVrSbzWC4ww4zXIa3o8ukLAWbcp4GByD70DOy8M+PbrSQLcyeZEB8sUwyB9D2q5J8Qp/3kq/vC7FSmOQT6V5lcylJQy4dmXnHYVB9q2OxRiM8nHSgD2i28f2jFI7u327VOCzct7Vi6p8SZl8yGxAhiJ42NksD715qbhpG+Y5IHBxzzVSVwsrAMfmGPxoGb2sa/dXaIsj7woIG5s+9c8JXZBvcnP8AFjv6UzeQMN0HHXFQFt0eemCaAGzsA74IJz3NVCQccseeeakkUAOW6/Woh6E5Ht/OkMQYDnAwT+tRu7EnJx6Z7U/ALMQScn1zmozwCNuAD+VAjGvyDeSlRgZ/pWpaKwgiORggdvasq+yLuTLbjnr+Fa1sM28PXhR+HFAkWxyuAePp0pUGWz2xzmmxg7CSw/KjbwSSATg46UFC5B53DGRnjFSjaIwAxz1AB/nURUluMdBTjuG1sqDjOOlAhSSy5HJ7g96n5wqg8mq27c2c9uoqVQ2FGM46knvQMmQshYBiD7djVgXkyurNcSKMjkc496qKQTg5+cfjRkA4bJz04oEbUGs3SDy3cSKBwSavp4nu4osQlFGMev8AOubRQEw3fue1DdtygNTQGtfajd6hnzZ5GbqDnj6VSfHG0FmPPXvSohZkUbmJPQVpwaLIUUOSGJ4A5xQBmgfvAC20k9T2pJPkjAJ75zWu/h27Rt9uplXqBjB96ybmOSJnWVHjcHoRQBXmUEKe31qnITjIXJB6GrEnzH5uPrVVjtj+Vgcnt3pAQOVLHOBnsK5qulIDYwPpXNUCYUUUUCCtCxz9nbHUNn9Kz6vWLFYzgE5JHAoAuISQWY8DrmrKEAA4VcdDVeJi4LYLADofSrEJ3MOGxjGeOaBnfeEpRFaH5vm2jgcfWvVdJvzCIXhweQMsDwcYI9q8q8JAPaOw2mRQBivUNCgVzH5nzAnlG6A44piNSe33G4A+ZmbII5HTmuD+IEL/ANjLIAF2PtI64969Ht4/MkWIum1t2e2B06+tYfi7SGudBuQ0I3FQyybuv4d6APEHOGHJPy4+X1qm4yTjJHfFW52aORlYjcvUVBHISWOQCfWgY+MlG+bjjHPSo2b96CTxjHWm5ypJ69+etNkcgqVwMjPWgYZPY5PvULuCORwefpTmY7yGXjANQSMTj2HegCGRjubv71HHweCpOeOelOl+Y5GTTBg9Bz0yRSAehO4knFI3Od3Ibmmqyj7xGepApGbcuACQp4wKAMfUObyXp17fStW1GYYsddg59OKyb/8A4+5Pr6Y7VrW2PIgAzjaCT+FAkWo8nHzFj6UbtpIA4J6U1RuOQOvepGC8KOSO+aBiZ6n+E9aCMfNwNw570D5Tt4AyCfanN8q5KjpjI6UAQsgIP3iD71YDEj5SOOSKgwBwRjvk1YjI/h4/DrQMXeQNqtl/TH6VJkEDk/jSRkYXPHPPGDU+1VOQQORwfegQwuMjjHrzSxgN6+2RSlVfIAKgnpSIpXO0dsYNMDe8LWzTzybFG4AYOfSu3t4/LhUvsjc85A/CsbwNYlbGS4dCu/oewArqozHHFbsAT5jFSx5I9MelAixDKyxZaHcuMGTGP0rO1S0tryIiZI5CAQTj37VomNoyiyB5N6/Kew68ZNYurXaRmWRUKg56nn8KYHIaz4cjjd3tpCh64k5FcXcjysqSSVbnB6V6Fq11I1uzYYdDyefpXnty++VwcAlsk0mMiZs7Sp5HNc5XQuVBGTgdlxXPUhMKKKKBBV6wB8tsev5cVRq7ZsREcEj5qALwDZAbjtU0R+dQx4XiqqY5IY4/2hUyFiw4yPUUDPQvAyJLFMwGWAGORgc969t8PW0U9yISpKqgYAcYPrnvXh3w4kj86USLuXcEI6ZBHBz9a948Iv8AZFmdQSfLUBs8AZpiOkt9MUmQHahJyNg9sVO9jHeWEsMybl5AqW2lLxzrgGVCDn1Bq9ZRocMQR+7JIP17UAfHniS2a31q+jwQUlZeTnoayUU7+MkgGul8cIU8UaiACB5zsAx9zXPRksWXHJ6gUDI+R8qgEjjmmKCcBcAEnvSqdqseue59aYhbzgeAD1oGDn5yCO2MGqrNhBk89vapZCPMOcYPXjrUBPy4J/CkA04Zzls+gHamA4GFzyeg707cGIOecYqPaG+YY25waAHMM5G7r6DpTH6gAn605wMgOTnGSuaY3OPXHAFAGTff8fUmRg5/pWzaEtbwrz90cDqeKxr3m6k/z2rXtGzBAOSNoyKBItRqcbgOnT/9VKFw43jI71Gm7aCMg9qeCFXccc8YxmgYjjgDGMUjk4PXHpmlcgkFiajIBByMjNADcbuXOSD2qcA7M78d8UkaHGQMAd+4p75XaFJz6UATBwAAx/HqafxwF7dM1GRl07Yz8vvUgyWAJx3AoQDzy3JAwOav6Jp0mpXax4JReW+lU8AMccnua9U+EeirqN1KcHeAMMRwB70wNvTtOSC1WFY5EDDsOgHerYsBmJYWLrEOXcYDN/k16CmmxwTKGTJijKqwHU1QvdMhjsZHcsC4XqcYNAjjJbRiXeV2WVBtKg5UZ9K5PWrfypyTuc9A4HBx6V6x/Y8avIpUSFFLKA2eNvGa898SRKsQABUI4ZlIyQPrQBwPiYBY22EDPzYU1w0gBAyQfXjvXaeMJeEOFy56jvXGTElCFyH3E0MZESABxjmudrolJBI5DVztITCiiigQVctMiFsDqcZ9OlU6u2efKOBxnnnigCyuB0Zs5IB/CpoQfkIGQRg8/rUOcMCw5z+dSpjAPOc0DOy+HjhNQvFyMGLcq9MspB/lX0c0UiabbywokazxqrAdee9fMfgqUw+J7IqR+8JjP4jFfUfhmN7nwzDucn7OpG8nOMHrTEzWtJJIVnWeIGBE2rL68d/fNbliC1jIdpzHFtweprE0sxxWconZZUdsoy9+9bSP5dg2Cfm4P5UAfHni25Nx4l1SZsnMzAbuvBro/CNrYpbmV4t3mLuBIz7c1yHiF/8Aid328nPnuOmO5rq/BV0r6TJHMW2xNgFV6D0z6UDOisfDOl6pGYxtV88DbjH4+lc/rfgWRJZJLCSML3RjnGOuK6jQbueybzEEfPCspBJH+TUmoXEsELS/dGN2COnY80wPGLmyktrwQXTJCSdpkOSoBPXgE/kDXsPw6+DfhrxGUa68e6dcSvgG00/Al/DzcN/45Xk/iiXz9VuCCCARyDkdKxT3znHc1LGfbNr8EfAmh6ReOmmJNcLbv/pd+5l2fKfnK/d468LXzh/wrzw4FC/8LK8OgE5x5Un+FcxpPxB8W6PZSWdjr1+loyNGYJJPMj2sMEBWyBwewrlWyODlR2oA6XxhoFhoV1bRaZ4hsNcSRCzSWqsBGQehzXNrxuA3AA8nr+lN3kqCTzjt2NGCJBgEkjJ5oAyr3H2qTByM/wBK17fH2aLg7tgx+VZF9/x9SfX+lbFr/wAe0JxjCjkdelAkSoTgYIOB608bS2SfzpqgkMDgjjoKcV52g9+goGSW+V2umNynI3cg/getIVK/fwST1A6U9SB0B6en4VPDaTXI2W0bO2cjH+NAFaVcjJHFIuVIGRkcZNdVp/hK9uVEkgRV9C2CK0pfB6qpbKlV5OTTsBwgDtkjuPzzT0wAP7wrqbjwyAWEcoUr09KwL6zms3MU6gPnjHQ0ALaZa4jVsntxya+ivgtprQaPNMcr5zADnnNfP2hxtLqkKpxtOT3yK+pvCCwWnh+2nClQse0Ko+83rQJm3apI0lxuUiNcrHk8t6mqeosDGnmhCm0HaevXk1pSE2yIcje3HHJP4Vzer3Bja0kRI5FRjleuQD0oEWvLaOG7ubhTkHcTnGB2FeZeI3AkZVO5CxySeSxOfxFej61KfsFrHvCq6hgvX35rzPXZY7SzurvAYQgt/sl+w9qBnl3i+4Z9WaMY2w/Jjrz3rmJjjAG4HOOtXLiWSaWSRzl3JZjnJyaovkMTj6UhjSDj5sevPeudromUbsEcYzXO0CYUUUUCCr1iMxEEn72ao1fsTiFjjI3dM80AT5XcdpBPvxU0OcqCuCM8ZqAAbd2ct6k8VMoHmKMY+poGXdOle1voZ1OGjlWQH0wa+udDeKPRJrW3Zf3luJv90N6V8fqN0Tdia+nPAN4J9D0G4fJElnsZg3RkJGDTQmb8DSsdiNmNAGyBjGBXQ/as2CSRSEqpIG0e3euW06Z5J7wkeWO+49vStWSdI9KUwsfmVyQvGOPegD5X1tmfVLxyMnz35z/tGtjwZORLdQbhtZM7fU1i6owbULoY2/vmIB69aseF5fI1lCCAGBU596BnpHgaUX0klpIwEisdo46d6vavAjkQsxdRuBGME4rN0OP7Fq1tdQ/InmHdgYJzxXR3dqjTSnfk53cfwg0AeI+JYxFrd0qE4yCAfTFYpXOR2rpPGsIi1+Yn5wQDk965tcqWIGM9s0DIZycHqO3FMBydvoOTVhgWzx16c1EwHl5BIbntxSAaFBHOfbikKgeowMcDtSseAB29DTTtbpkZPHPagDKvDm5k+tbdvxZxHbn5Vzz7ViXpzdSfX+lbVp/qYtwyTGMZ+lAkWFwEHOTn8qcAOSce5pi/Lww/KnMVwOuMdaBkgzt+9nntW1oLN56GM5OcAViqQwJ/D61u+F7f7RcCNR/iM96aA7K1Zyg3yOWAz8v86tNIzOVkjbaRu3FuntjvSQRFSYmJG75RgY4AqWK2WSBJlZljXIJPUD3oEZ0iyMSMOo7sFHIriPEFyLnUJBnKodox3rt7rUY7RbgxyFikZxkcHivOJWLgnoCdxoGjb8Jo7aplSVKjhq+n9DBfw7prPHtAj3kdM57189/DzTjc3LyptbOAqnjJr6KiGUeOTGy3jSJI93B460CZbe5Z2iAUtGqlmIHT05rDZWneFYY0GG4Qt6/e4qzokrTJeIrb8rncBwOvFZ+hxxNrLBfNKOxKHdzkdT+YoEWvE6iJY5HRtuMDHIDY5/SvGfijerb6PZ2MaeWbtjcsD1AzxmvY/F0DS3dnZhWCR/vHwfz/AEr5u8ea02teKL25KhY1PlRjOQqrwMUDRzjk789h1x3qrKQQN2euandicYJ96gcN0AywbnHpSGMYkn9SPauerom6nGOR0rnaBMKKKKBBVyzAMZyO/WqdX7EEwNjGc/4UAWgSxO7Ax2AxUwGAmMccc81AgJDZOMnrU4UArjZuPPI7UDJQDjKjGBjA6V7x8G5xdeCbcMoY2l40R7nDc14Gp3ISARzjivZPgXcsNE1+BVJaNophgdOcZpoGenwNFHLKjKw2SFMZyMds1f1Nh/YMUqxlCu5cDjIIxWQ6PHbTMSAZHEgZj1APU1c1Vz/whkMsYYsZC4OexOKBHzBfkLe3IOeJGxn61HaybJVcAhsg5qxrKmLVrxXB3CVhwPeqKYOSfm5/EUFbnsnhKRr21gyrMC4G3HOK6VwYbu4G1EA+6M+1cx8MmaXQ0JUgq5OVHT3zXRamHTU5GVflCgKDwPrTEeQeP4/J1v5pA2VyxX61yC8gr0PX2rsPiDEyajA5UBip/HmuNwVAHPrnrzUsY5zwcDk96jlwoYqMk0/Ixgjg96hfkcZPf0oAG5A4wTzgd6byMDOR3yOlKeHbnn3FKFwhx8wB4oAybvP2l89c1u2gzaQ8j7g7VhXoxdSd+a3LXm1hz12AfpQJE8W3IY/NkYIp3OSoOeOOOlEQ2jdxg56nvTsZA5DY6n0oGKMFOQdw4/Guy+GlqtxqlwCxX92enOK485GFHU9TXZ/DZxDqkrBsMy7Rnp9KaA7Q2qlraIvuRlYFiOScc0uqQ/2bo6b8xtKduO3rmtuWzSC2ecvznaIwMDOM/lWH4lB/0aJxvwMuWbPNAjg/ET4hceuAW9a5X+HnBxntXXeKv+PcbOU5PA71yOMsCSTx0FAz174VRCDSEujHgmZQM9yTgV6nFceXZ3M0jlpfOY7iMrwOlcT4Nhhs/DenI5MUhHmNnnIAzW5qE1xFp1lEpCo7FivQkmgQzSNRltZrk24CpMhX5ueSewrrPDNl9lsEunRQIgXz6Z9M1wbny7mFWLBw+0Y5wfpXc6/cyrDY2Ue5pJ3C/IMAKByaAOX+IuvNpmg3moO5jnuQ0MAxyARj/GvmY5ZSD94nnPevUvjprkd5r9vp1tKWhs02n/e715U5OC2D/wDWoGiKSQgBc4z6+tQ7icqCSSR+H41JLy2OBkZHHeoQvAUtgdetICbHPU8Dn3rm66NWBJUGucoEwooooEFXrE4iY56GqNXbIgxlD/E1AFoMcHkYxninhyy7geByeaiUsSdp5HQHvTkLbVztx6GgZaOCWB+XP3R616n+z6+/xBqlruJM1ocLnhiCMA15THIGU8Ac9vSvRvgVc+T47iBcKJIXGfwzTA9inucaZO7kh1lKhHGSPbHpWhfyKfB/lsVyhwAvUDjoaoXHkpHfbXBEkh8vjnnrU1/vTwcEZ0eSRd2cdf8APSgR85eJVH9t3o3Z+ckVmByc8ZwOg7itXxOzHWrnzQACeF2jmsbofl5wOeKRR618PrloPCwfIU+cACDz+VdLJPvmcFndyrAt2WuN8Byo/hKVX3Ao+QMd+1dLHK8tzN8oEhTBY9M1Qjz74kmRdRtVlKhgh4xj8a4hQSzHdzjoa7f4mq4u7aXgllw2eQPauGEnzkd81LGAYtkYGMdc1GAWcEAdOaViDlc5A59qZHgkddvuaAALu+YfrUhIHU4IxxTR0K5z/Omg7TjhOeT60AZd7xdScY5rcsxutYQT/CDz9Kw73m6kwMc1tWh/0eA5zhBx+FAkWBwo59zg1IGYuuCPTBHSmgAN1O0cjFB6kksMHjjvQMk8zKkhlIz2rtfhojSanwBgEEjGc1xSEYYMV9fpXcfC+Fn1OXa3IXPtimgPV9YIitCwXlcEc4Dewrmtely8kkjAKijKoe57V1evxRmztwdpZV3EHtXI3MKyxhFwU8z5j6d6BHA+J2cRIrJtB4Ax2rA0+Lzr6CJcku4GPWul8YoUw0jEhiMVV8B26z+IIHcDEOXORk0DPa9BihC3MkgRls7MRhX5GT2p2pzqstp8rBiu9l67eKtQGG38KgpGPMuGyXYHkCsHV7iNl86Q8mIKvYZPQ0xFvw5G2paoA7YG7cMHI45rdvdWSy03U9bugqvaKyQ5B5JrltDN0g8u3+WZ12JtHc981U+OWrjTNAstBQjznw820+nrSA8V1XUHvr+e6lYmSZy5/GqJPcjAqR2GwZIzjjvUDHcBgnHr6Uihsp5GRnFQp0AxnNTudzDnnHrmq+TsIYd+tAiXOScn2xXO10IJJIwpxXPUCYUUUUCCrVrnyzjnJxiqtSJK6DCHA69KANA/3iDkdfQU4fMuABu9Kzzcyn+L9BS/apg2d/J9hQM0+ittxye9df8ACy4Ft43sZFOAQU5HqO1efG7mxjfx16Cp7LVr2yuo7m1nKTRnKttBx+BFAH1Zq8htxFIzfLySGHBz3FT3MzXHh8ISysE3AD2r5pl+IfimYgyaqzEdP3Mf/wATSj4ieKhAYRqzeWc5Hkx/z207iNfxaq/2w5G47gDzxWDj720HB4yKy7vWtQu5fMuLje+MZ2KP5Cq5vrk5zJ16/KKB3PZfh8zf2FKigN2KnsPWuu0m2knmZmkDSBRhcdvWvnzT/E+safC0VneGKNuoEaH+Yq7B478SW5Jh1NlJG04ij6f980XA7P4khXaF0cffZSccnFcCxwBj1I69ah1HxBqmojF5dGUf7ij+QqibqY/xj/vkUmFzQJI3EnjHFOUYw3B9Kyxcy/3/ANBS/aZf7/6ClYLmqf42Awcc88mm4J2kjv0FZn2qbu/6Cl+1z5B38j2FMLjbv/j5f61uWi5tY+P4B/Kufd2dyzHLHrU6XtwiBEkwoGMbRQFzo1BCKV4OMD3pdoyeoII+ma53+0boLjzeP90f4Uo1G7BBEvI6fKP8KB3Ok24Ykr2wfT613vwqif7ZO6/dGM/T8a8fOp3Z6zf+Oj/CtDSfFetaRIX06+MLnv5aN/MGgVz6t1+KIWMKooDSIQT3wK5WWNYXAZQPN5bbnHTivEbj4meLrhds2rlhjH/HvEP5LUEfxB8Tx426oeORmCM/+y07gdv4/CxXKQoSVPzD2rQ+FVmZGurgLgD5d7dga8l1HxHq2ozma8u/MkPVvLQfyFT6Z4v13TIjHY3xiQnJAiQ5/NaAufVGrNF/YtvArycSYUHpj1x9ax7lFeQW0ihlxgnHTHavApPib4uk2eZq5bb0zbw8f+OVA3xB8TuxZtUJYnJPkR//ABNFwPp/wRZxrqEku9fLgXex7DvmvD/iprP9teMLydGzEjlEI5BArmbX4n+L7WCWG31jZHKMOBbQ8j67M1zD6peSFi82Sx3ElRyfyouFzcc8nOMgY4qNt2MKeOvArFN/ckAGXOOnyikF/cgYEv6CkFzYKjJIJBYdB3pmFMfXvkiso31yf+Wn6CkF5OFwH4/3RQFzWxkkbMd6wKtG+uCc+Zz/ALoqrQDCiiigQVr6RZ29xbvJOD8rYzk9MCsiui0AbtLuB6s3GP8AZFA0dRZ/DrVJ40lHhXxK0MihldNLuWDA9CCE5GKtv4BSxEcmr6BrdlA8gjEl3Y3MCZPQb2UAH8a+lPEV9fX2vfDbwmdXvdF0fUtOaeaeym8ia5kjiXbCsg5XrkgcnP0qL4v6fFpPwqSyt9avNYSHWIh595ci4ljOTmNn6nHvzg80AfP0PgbQWDs1vIEUZB81ufbrWjF8P/DZTItJJGx089xj361pRMFB2FypPccV0Xhm3F/e2NscnzJBkAdVHJpiZ1XhD4A+Br3TIJtS0yd5pBuO28kAAP0NbU/7PXw3RCV0i5zgn/j9m/8Aiq9P0eNIoI4l4AAAFLfTZIDMVwTyDQI8gPwB+Howf7Kn57fbJf8A4qoG+AfgEkbNKnwTjP2yX/4qvVXYq55ygPPtUJuEcbUUKx5yTQB5lH8BPh6eulXA7f8AH5L/APFVi+NPgl4G0zRp7iy06ZJVHyk3UjD8t1exNL5WwM+W6nHFc78QHMvhi6EfzDyzhR1NIZ8zf8INoA+U277iQP8AXNjn8aZB4L8Os/7yBxGvBxMxJP510DvJ5rFs71HAA5H+NIrbEB6nIUjoRTGc9L4L0BGcC2kYjsJmOP1qpJ4Q0VVLNaumDwPObn9a6WXyldgVKAA4AI/Ks+8ulSNthVSuFC+tAHG3mgadHK6xxNx0+c/41QfSLQZ/dn/vo1vXRcvxxnqKzXyWwM9fSgdjk7+NIbySOP7injn2q9pGkXOr3MdrpljdX95IMpBaRNLIcDJIVQScAE1T1QEahMD1z3+lev8A7K+P+Fx6GAf+WNxx/wBsWpCOPX4b+Ke/hDxL9P7KuP8A4isq/wDD1zpV21rrGmX1hchQ4huoZIX2nODtYA4ODz7V9Ew+Ida074ean4yi8aaq2vWmsS29vpdxciaC7QThBCISN2SpPKnIx+Nct+1WzN8VoneNkc6XbkpnO0lpOKAR4yun2pTcVPPQbjTl020IOEJP+8alxvVeDv5z6GrUa5HGSehJ4xQMqLpdmQMo3qfmNSjR7PGTGeR/fNW1XBwx6etSLnnNMLFJdGsuMxtj13HGKd/YtgRkRv8A99GtA9Mg4GM4HWmeY2CN3fNAEFnoNhcXSRCJ+f8AaJr0G0+HfhpbMJdQSG6ZdwbzXAHsRmsrwnagzmeVcKD1rqpb0POCwIaQ7Rt68CgTMofDzw6ZgptHVT8uRO5w351Wn8CeG8OqWsqvwV/fOcj1610JlkNtwdhPODyW5qrcz74pWWf94hAAK4GMc4Pb6UwOafwVoa7n+yyeWvBJlbBPtzUNx4S0O3mBNkzx7cjE7cn35zWvLcSRShg3y5wdpzyfarOwsrnBU7uVPBPHWkBzH/CJaMfmNsyrkcCVuP1on8K6IsoSO2Y5BI/evz+tbJy0xy+VBGVHNOuBvIQqCXBCkHnFA0jk7nw7pccZYW7BccMJSefTrXn9erTr5akY46BxXlNAmFFFFIQV1vhGFptOuFTAZnKjP+6K5Ku88BAnSZtoAPnn5j2+VaGNbnutx8VYdc8PWGia78PtL1W1to40U3Gpkjcqhdw/0fKn6HvWd4k8ZJqng+28N6R4S0vQdPhukuP9FvjIAVyT8vkrkn1JrkYI1GOx65zyTVuFMqDglsD2IzQgLC/OsbgHIXB9z716V8INNjlvDdt8yw5QEcjJ9M15mgczRhMtggFe4NfQ3gXTE0vw/bxttEj4dyPU0xHXxv5aZPB5qjcSh+P7xzwOn1pJpQoYcgk4ANZ80vXA/eAnAFAh8lyMON2Mj0xke9RW7pGckdvl98VTllaU7WZQzLhgOPyqOKZt0SyEADoh5NACm4B/1rDLMM5HrWR4ukEvh69TI+6SMdqfczrExQMN/wDs1HcyJPpk8a7Su05HegZ4gJQh8xmAkHfHWq086Pt2FU4+Ygd+1JcS+VJIpUbc49+Diq6TKzsFXBI4J/z1oGOdklLMx3Sd93eqE8O9iMsBxkkZq2QdxBQgep/kKhkGGLOW6j5fWgDD1ONlYIFwM59CBWW4YSEAgknBGK6TVFRQcHryQece1c7MNrdR16460DOR1QYv5hz17/Suz+FHi4+BfGGna+lit+beORTA03k7t6FfvbW6Zz0rjNU/4/5uvUdfpV6DBt4wBg4XJ7DikJHu+m/GzwvZaqNTsfhPo0OoBzILlbxfMVyclgfs+Qc9+tcL8U/GsnxD8WHW301dNxbR2/kC487O0sc7tq/3umO1cdEgznGB6+lWY48gAjB6k0DsATCg8g9etWIwWyCOD0xSqBnOcKRjmpYlZXJGOB0zTAmjhBGQARjGff2qPywzKcDGOTmrCEEA8AEjjNKYkJAHHrgcZoGVX6DA5HpToomlk2x4zjpnrUmB0yDjrxjitnQbVkU3EyDe3yxA9Pr+FAjesrAwWaQAszFc4U4z3/nV5LdmuYwyeXgHkgdcdP6VDYxyO6l2LY6k9z7e1bEds+5XBUEHkH19qYipPEfKMkaiSUDgZ5HNYE7btzqgBx0J6+tddqNuVIaMSZCnPHJrl77abiONGK46nHekBRtliXZJO2A/KKOf/wBVTyO7uUyGkLZGOMCobmPN0uwqABuU44zSoWflisko+b5Ov1oAWOX5ZNkCq+MEcevWnOpQgq3IOVB61NHGszsqh/NHOP7w9ammtwZ5PvgAAEj2FA7mFdoTDjJJ5bPbNeR17DOm+GTYSUH8J7Yrx6hiYUUUUhBXoXw5j36XNn7vnnI9flWvPa9K+GSltHuQOP8ASDyOv3VpMa3OwgXeJFK4HUVcEOfmRgBw23oQemKQRNGxIxzzgNVnTbO5v7yKC2jBklfauWwcUIDpPh/4d/tPxBHezqyQ2vJB6M3pXt0cm1VKjCZx+FY2i6dDoekRWsEfzKMyH1J6nNT206yDYpOeWXHOfWqJL8zIeD0HJ7msu8eQNGqN8u7dyRmprt1I+UhtvfOPwJqhK48qNRxnOJM5oAjunZMyxKGk9SOlVYpJFQPI6tJgsAeD9KLu4aB0LEhQ2OO5NZ10rymOdsbI2+RU6t9aAI7/AM6WOaQluYyFQLj5v64qpotyYisE8jOZeCGIHOKtQsk85lljeMjICnOFJ5rL+zNHqcM1yuHBwm3nv1oGeZeJLU22v3UeVOZGI9M9RWYY2LI2MP3APeu2+I9l5WtJcYLxzJkYAGDXMNGwRHZl+gXIpjKoy0RDghkyck8io4z/AHuQw5PcD6VPujYsCvVckt1zS9VOcZQcAnHH0pAZWpkCNSEbHYVz1w25TzgDtXQ6tlFKk4jGGPeufmQK52kD6d6Bo43U8i/mz1yP5Vq2S7rePg/dA/Ss3V/+QjPk5ORz+ArZsATaRAjA2r/KkJblmIZRcirCrkHIwPSi3i3YGAvPr1q/HBwMAHJIOaYyqqHJxzyMYGcVMqcbmH1PSrKQhcbQvJ7d6mdAVKEHjPvmgCmCMruPykfSnbSBkg8HBA/nUpjKYIC4xnPWljjYkhWGPbkUDEtbYTTKSmFB6HuM11VurOnK7UQYUDtVPT7RvkLDccZwO9b9jGvlhI1ZiTkf7JoJNPTLLa8aNy5G5s9D2xW49sqOI44xuIwMc4IqloEUrz+ZI7OQvzZ4xj2/KuoWJba2M8+7OQVBH5UAcnr+LGF5rgEBuM7+c/TtXnN1qLGUhhgZyEHau18XMLiSczKGHO3Dd64C7iMILBVznBX1oGh0OoSNN5jhVjHrWnboJGyjHJGAemB1/GucYgQvGcbQQ3qatw3TQork5OAVOelAWOy0xEe4CibkcqQOc1oatYTsvmqihHU7wowQexrl7GYiIXUQYrkYYHlT3rsND8WJbX0UF6ivbyfKWI5UUxHAXTFRhiAw3AgCvIK+lPG+gLBLJdWYDW8y+ZkdM/WvmukwYUUUUhBXpnwvAOkz9OLgk5/3VrzOvTvhgCdBueAcXJ5I/wBlaTGjvbeVWlxgsvQk9/WvVfAOipYWq39wmJ5Vyu4cqvb8a888MRJd69brOkXlg5ZT0OORj3r1oXiOCN2NvG3+6O2KAZoCVHY/Nk9eec0+2YIsewjO48jjisi1LrPI7OHjcBR2xV6F8FFBBC8nAqkSyz5TSM2zaPMOACc/jVG9VotkTFRnoff0rbhijhthdTkAHJU+ma43WtZRpgbciVsjnPC80ASMzzXMoYSJEiDB4+Y+uO1V55I3gjXOHQbWxwT2pZGR4lTf5gDGQp7D3qlNeiONWi2gyyBWQrgr+Pp70AXlV3Co+3zYyAQ3p2yfWqot3kUlnLKpLgDqp9K0FM7RqDhiSSwPX604qZJQGOH6AbeM+9AzjvHttJc6JbXCrgwN84JGdp44rzyQDYytyvJxnpXr2tQRvaTRvjBUxsA2APTH415JcQmCdo5WCyKcMMdT6UDKybRISqfPjaC3ep5WypBGG28kc4FVpVVJ+cBsZAHQVbUF7bcv3uA3FAGXqcRdhx1HOT29K5m6wsjHvnmutuQI4sYLA5B5xXK3pCzlVBIzjAPSgaOI1c51GfjHI/kK6DT482luQB9wZP4VgavxqU/1H8hXR6fgWNvjg7F49eKBI0baMrg5yOp46VowJu4AHPbOKqQrhe4J/wAa0IkyCq7SQeeKBimJQwBYA9eD0qIj5yB3644zVlD82wDnbjkc/WgW580YGMjgZ7UCI44vMOAvy9hnFLEsa3KJjaE4Oe596kAKkYznp+NIoBLqFIbsfX1oA6a2hjHlOuclsdeBWraKYUQgNMxOPu/zrl9Jvfs8oWRzs24L/wB012unBoocKu9XPGCcnj0pgatovkbASJBjOTxg+/vWrdzCWKESsdnQgetYqsxQbSDnC4XqMetWkmcbUcAbmyQBjt29KAMLX9KMqER/OSdysOT9a43WNHmjCN5XyMvXuQP5V6TK2UiXmNVOMH3/AMaiurOMvtYAFgAzZ7YpAeRxafI0u2OLdk9R2q1NYlljUpt4JYnofpXoKWtqruXJjwuDheVqreyWrj9zCemBkYDUDucrYW2y1IVQoxyCSM/Spxa5cFDlD1q7cXDOuBCoCHgAdPanp+5iCv8AKytv+bjj0oEdroSpceFp7eVgCoYqp6gY96+Ra+hJPEyWUDxCTcxUqcHgj396+e6GDCiiikIK9N+F5xolxzz9pPAPP3FrzKvSfhmcaPcHGCLg4OOvyrxQxo9A0y7a11C3lUYG7aw65969RsyS8MkkgMTDgAYHrXkgPlyfun2leScZOa3tH8UtZxxW8/721BLEAcg+3pQgZ63AY5QzsF5cHIHbsTVzTh8w2EZ3cg+lcnpWrLeASWbu6qCCB/hW/pl2jETOGTHLKT2pkl/xhdOlslsFAiCbmxxkD0xXnjriRZbaJ44yMEnJJrtPEkqXSOwk2I0ZVs8547V57PfPCRHFvdm+6ynhce1UgNOa5MNzMySjaECH5enfBpLYtLdbplyCcFQOM9vwrKa/aQkInzsTI7EA5HStGxd5dqQBtjRgOcAN7HPtSA6OykZFYBTkgjIbJyauRtuh3LIrdiwHQen1qrZRAiJpcKeCozySPWr8MYSJiQNrgggDgn1xSGY2qQq8wjXK5UnnnjtXn3i7TGguo5tuFkIBPv616jqQXksvzBc56Ee1cl4hPm2G/eGII98/nQB5vMrJIARkHof6VctYHERRV5YZ2tzV2SNDMAVJLdh0PPU1KkTAI6sCF4O7kYoGYF9EEHBIbGNp4wPSuM1LBZsAbv4vr7V6Dq4EqfvRhVGMKcZrgdUVdzMo+8evZeaBo4PVv+QjP9R/IV02lDdZ2+cg7AB78VzOr/8AIRnz6j+VdRpS5s7Y4J+RfrjA6UIEbMMZKhe/WtWwslRdzL5nGNoJHPbmm6PbGVi+zcB1B549a66w0d5xGzjGMkKRj6H3oC5zn2GRJA80LEsM5HpU32SUDcI9pI4B7+9d5HZyR/LKUywwFxxj19qsLYRqMY3jscd/WmI8ykt/Lb7vJGQCcc+1QlWdCyt8ufmz1rttX0xWhZiq4/vAdK5R4wCS3HbGaQFA5aRf3YAI4A6H3ruvCdwJba3jE6CQMQN3JAHpXGeW0cakAbQPmUdQau6TP5d5EWPzZPQ+tAHsMFrGyAoY2YvlsHk4ovNNWRdyI5cd+mSK4e2ZknaaOWVXJ2nLY5x6V0Fhr2pRhVKoVC8h+f1pgU5zJBMFuodsbPtZX5JxyOattqFhCjZXey8nHUelGoaumoQJBd26xN08wetcTdalDa353wMkq8Hcc5xQB151C2uIZGaMklcHd1J+orEllSdT5QVlK4POFUeg96x5vESNC4gh7lRu6nNZ0l1LcyKDJlAB8qn0oA0dZuVswBCFdwMbsZx/9euY1G/uJ2+eUsp6k9RT7yUTTtywA4/3qozkt8pAPbIFIaKkzFlL46jvXnlek7Q6ncDn0HHavNqGJhRRRSEFej/DZC+i3ADYY3BA+u1a84r0f4bkHRp1Ynm5JA7Z2r3oY0d1AqmM/MckkMx/nVSUKuGjDAr1wvc+9WZE2r+/O0HIBU81Vm3OAAwK53DOR/8AW6UkMdDqFxYOtxaySIyjGR0BrtNM8eMU8q/gAcjCzJzn6ivP5jjKK2CSMZGNtVvNKMoHQgnLDAqiWexf2yLyFUSdXjb72OpHpUUdoss4ZduCuGUnBUYrgdLhYCOQPIuRkgGuy0S8KErcPvRh8sjDkHvVCHRWq/aB5RKMo+XA+Vvet+1tHtw0kjkspCFQ3r61HdLBG8biTI4K8bdv1FFtLaRzlDLGxkYliJOv1H4fpSA6KwgTYBImGxndnJ/A1opGhO4ZGOMY6+9c+ms2Nvvje6iT5uMN1PXFadnqdrdozxXcZj4BPcfhSGLfoC4wiljnk9q43xDDLdTpbWFvLdzoNzeSpfao9cCu5d7WYALG0hPG/OCfpWYnhnT2YtamS3klbLt5hOBj070AYOm/DvWNX0cX0MO2QbkFvKxhfPXOCMY59axNQ8N61pVoRqljJZjzApd13J+DDiuxlXxRo1m9pompE2LOZGKovmnOMnJ57DgYrgdZu76aY/2ncXU8qNhjOzMfXPNAzA1pgpBwJGU7Sex+lcBrSgTBCGG3p712uty72O3IAHOTjjr0riNVIMz/ADZAPHWgaOG1fnUZ/r/QV12igvZWyqCT5a8Zx2HIrkdV/wCQhNj17fSuz0Mf6Bb/AHR+7U5PrigSPQPBMalwSBlMrj1r1AaKZID5cm4mIYBPNcT8P7Xy7SOZwH3N0xg5r1+G1V7cIccKAeaAZy6aPcrKGmjYMDwyjcOnSrn9lNF5Zj3soB3DHWurgb7OoBHy9896vQXEJXiJdzDstAjzF7HzJZGaJyB1XrXmt/aNb6hLHMhByWVCOPYV9LNJavuXyo1LdWA5P1rh/Fel20l3l4iN65JAGKBniTgqkhLKJQMqp9PrUEJVjnowwR9a6XxNpC2c5mtf3lucLuYfdPtWBiRXHOwr8vzCmB19gROsPmQtgruwPYdfpW7bxIsoB7AM2eATj0rE8PXSNAsLMFdQQBj7w9u9a6O+cyEOSu047j6UgHahEHgZkXJJDEZ4Fc/4nsTdQRXCRgSRDkg8sPX8K3HuClmQyqqocEZzj/E1j310GcApuRfU/e70wOGm2hXyAh+uM/SoAWVg8RYEDt3q/dkNLI204LNz2X0x7VS3D5doYADcSDSGRyjcWJIyBnaR0qHaWORjJH41KzAZYHPqcdRUcrg/dBJUcn2oGQO4iQ4xgrzk15lXoN1JuZiOD0JPevPqGSwooopCCvTfhfs/sa4Lc/6Q2VH+6teZV6Z8L2ZNIn2D5jcNyOv3VoGjsGkUSbDhuCcjnFUZgWUgKRngEHv9Kuzp5kmVdSMYIcfqais9QutKkE2nXdzazgMi3EEhRvplcHBoQGn4b8Fa74i026vdGtBdrbSbJEWRQ2SOcAkZ/CsfVtI1PSGWLVrC6tGDY2XEJQH6Ejn8K7fw18VvEujabcwC6+3zSkOJr+R5mQY6LluPWua8U+PfEfiFXi1TV7lrZ+sKERxsPQquAe3WmA2yl81AA+3jlc8jPQVp2hG51aXyxuBChuK5JJ2txvVmGQCXX+tW21G5A2gsjY4/HuKroI6123KTJIzbOMA8njj8KxdRaOHBiDK3AJB3Z9RVCTUZtu1pHPY81HHJzh8pu9Dk0gHeY7BnAI5rv/Cln51gzBB54wR7k9q4ywtJbq6RIsKc5Oe/1r17QbJoNPhMwVS5DBl6HtikBf05HjHPTIDZB/IVsQLhsvvYYyABwKrW5yy4AZuMED+VWHfcZI5GA524HHJ9qAImbypOhA756/Qe1cX8S7i0/s0M0QNyGAR+pzjnmuznjnbAYj7w6dh9a86+KpjhmtIVQEoDIzHv2oA8p1q6aWYttUKc4LHpXK3TZaQk5weo5FdLqpVgXG1lZSR/hXLMeuMnnpQUjldU/wCP+bp1/pXcaKoGm2u7vGvOf9muG1P/AI/pvr/Su60QbdOtTgEmNOPXihCPdPAVuH0O0GN24En869ItiqxgISMkDp6da434bgS+HrDDDKA/N0wfSu0t1P3snfn+LjNAie6YKoGOSecHIqAnCkodp4HXtUxXIKsO+c46VFdKqorAAkPtJoAiJDBX5z0BrP1LNwCuNxjHBz2q+yboOVxg5FVpAV8zcvzMMcDpQB5j4zZLexaIj5WIxzkD1NcOZGUxs5x2yR1+tdJ41uml1eWOHPlouD0wD9KxbK2nvHZkYMw4bjj8KYy3bIwdJEO1lGRzjNb1nqFvOiJckRzAHAGQM/WoYtCuWgViyrkcjHANVbzS7iHh1Y7R1XtxSAuX15utWAKgFgQwbOB3xXOX94zOVg+4D1znPrVg20hG0gkAdB1+tVvsrrjLNx/EOCPrQBkyqQuOCCc8CldCxC4UYGcAfzq+yKjkZ/eIc8DqKrycFic/d6MMD60AU3KshQ4yG/hHas6RzsJye42ir0pBzkdB1B6ms6Q7fmBDbvbGKCjOuSehI4FcLXbSkkE8YyeM1xNDJYUUUUhBXpXw0UHRZ2IGRckfhtWvNa9N+GGDol18uSLjOT2+VaBo6i6RkKqXY54wR0/GoncFAnRQcFh0z9KsMT5KlGQoScn0qnIWRQuflc4GRjj/ABoQFeZgYnAXEKjPTqarsiuEL7iwHAPaprpR5Y43Bj0PT0qMZj+V1Xg4OOtUA+BlKdP3hXPI/T60vmeZwpIdRtG7g4pIyBCCoYMe3cUIV55+YcbvegQW7sJHLECP3HJq2M/KuDkDHP6VSVV2NG+RJngk8YrZ06JZroB1AbGWyOnoaAO28A6FJ8t07MC3QHnj1r0SC1ZlCI+TH+AFU/DWnxrplk5JIMeFxkZNdBjylKc8gAFRnmkA238oOo79h0P1p3lMHOGEgdhlhjNO+VHIcYUpkkDNWFhACeWR5ZwemOaAHWNsjmWSRXKqNwz0FeE/EW8W81a6KB2eJjGgLenWvdvE1z/YfhO5uVZRKeFLnrnp/OvmfW5JHaRpXUuSWcjvmgEc5qpDxby5UhRgA8VzExUFgcfjW3q0gYKdzAMOR0rDkwctgEkYHtQUjmtR/wCP2X6/0rvNDUnTbXccfukIwM9hXBaiCL2UHrn+ld7oeP7Ps8HB8tAfyFAkfQvwjlaXwqMqGMTkE98e9d5Mo2BQQe5/wrz74JtHJpF9Eo5WTdt3e1enNADAxbnAwAaBEEKlpdp6MmfoKr3bDeB1U8KP61cT5U8wYB27VNVbld0yFSDjnI4wT7UAJIMRAR7mcjODxVS7ZoLSd8nzNmfm7Vetlk2lurbud3YVS1jCvJDkEGMhjjPOKAPCr+NrzUJfm3vI/IXjrXUaJpaWdsu1SMfNlu9YkMDjW0hdNm6Qg8cE/WvRobN44FEse1Vwc5/KmMpzQN5GEAUk59hUAs9pZmbI7fL1rWjiXylKk7jlcY/nTJIpXYISVH+yOP8A9dIDmtR02AwARbVkOQV7571yF6skEmCgJznGOp/+tXpMluEAVwzKxyCw6VyXiRIRIGICANgA9uPSmByryGQH5Tndzn3qG7YnhVBYjAPrxVy6RUkR1+444K8c+9Zd4wRVOOi9R60AUHYorduAMEdfasm5l3HqFHpirl3cAkqWBDckHgViTSkMc5UYpDIJ5CELHk/yFchXVT4aN84J7c1ytDEwooopCCvSvhiFOkT5BP8ApBzj02rXmtekfDP/AJBU4JIXz2/9BWhjR106gsxUYXpg8fyquwZSN/zJjkGrUnmNlsZJO4kngCoGAZMY+Y9wOn/1qEBU2BmAZlO1flx0pLeB7iUJDE7kjOFXP510PhKG2k1aFLtIVUnEauMrvPTPtXqnkC2jkH2CGJ0H3goGM9qoR5AfD1/LHvEJj7hjxzTW8OamWYCBZWH3iDyB2r1OO282YJHCPOJ3PvONqkVXAhDMptym0/Jg/eP+c0AeSyWs1tdgXMLqyLjDc10fhG0kvLt9hCjcFzV/xvaC3s7bfvE8+Xj3nDADrn2rX+Fdkz20k7MrSFyF2j7p9jQB6po1kttpduCAQgG36Dv+dT3O7cVcEgDgjvWxbqGto43HCAfWq3/LVVxuXliDzSEZ1jGZPk2FkAYk9M1v6fp/mQwh/ujBOeuB6UzTpI1CKqjB9u1ahuGWNdo2qAc8dAKAPIfjxq7NNZ6RaScIvnSgNjp0H868H1CTfE0gIYliSWPOewrqvHOt/wBr+JL6/LlleQpGm37oHAxXE3G/ygAmACcnvmmUYmpNvI5YnHf/ADxWS3Dbs/T3q/flg3K8LyBnrVAt1wB1yaQznr//AI+5Pr6+1d/oQP2CywCcxLnA7YrgdQ4vJfrXoXh9iLGyOScRIPbGKEI9w+Ajn7ZqNsR95FfrwCK9euwyWuMEY7nrXinwHcxeJpUU/JJF+ua9u1RNqlFcjbzz2oEUIcbsA5yCcdahkIEwRzyFznpUlvjzo2H9zJx71HKhkuV568EgZxQBct4xLhVJLEc89vrWJqkoGoSBguxRyT7V0tlGUDEPwF4PvXGa/c/ZY5ZHK72b5VJ5P/1qAOC0yyGoeNokG4xxuZMDpjP8q9L1GIxkqCuFPG4Vyvw2tfP8Q3VxJyQo2nHAGc8Gu31iaNrmYhclR2NAGL5RZyQql8As2f6U77MzAgbt3Uc8CrC8hSDjcOAOtaemWpuJNzkBAOe1AHOX8awWxmncJGnJJ5ryrxHqEV3fmXIaDG0dsV0/xL1eS71M2VqMWts20qDwx7155ckqm4MoeQ4I9aBjby4xbiLqN2Rg4BOKx724Z1AAA46Z5qe5YBfm5JIwPT2rGv32yqRlsjkHjFA0QXcpJY8EgY/CsqaYl8thuOuOKtzszsfmHPcVnOxLH168GgBsrjyjyOORXN1uyMSpGMDHf17VhUhMKKKKBBXovw2JGk3A7Gc8/wB35V5rzqvSPhoD/Y1yVGW884Pf7q0mNHbBiIMqxJAwBgYx9aawURxbiEkGBkc5B9fSlXAi3qA4B5565qSNVQq20GPsGGeP8mhDZVuNxKeXn5G+8nUj1r260YajotjPKcM8QZ/VuK8buk8m1cjb+8HUcYPcV7NoEefCWmg/KfKx8xxziqJMHVJ/s9xIbeMsRHsfHPy57GoLOaXUb6Fdi7Mgkg8A57VoakkaW1vDI5VXJZyODnPrTPCtuJLyOS3DKivjYTk8H+VUI4r4vySN4ihQPgRxAAHkA5PH6V23wXhzoscjqTukJ+Xn2rjfizsXxY6OoIEIzzzXpnwXtWXwpFK2FVnJyDnjNID0JQF+UcAct34qtsWMu5ON42qpqS+Pl22QSDkdu3vWTHcNcyeW4yoYcDtSA09OiCu5Kkt79s1T+IGrDQ/Ct/cFsSCIxx54yzcCty1j58zGSx7ccV5F8fdXytlpgI2k+YxB9OlA0eL3Skn5GCAnHB6//XrF1Fj9nkPmNlnwVByM1p3I8xcuycc4H9axNRZQr4k3d/SmMxLpgZTjlhxz61UcYGcZJ9+M1ZkKk8881VmUhNpKsx5IpMZg3/8Ax+S/Wu60GQCxtwM58tM/kK4S9z9qkz616JoVup06zb5R+6Qkn/dFCEesfBpjB4xiUtlmQ57jseK+hdUTb5oABI7H0r5y+EoCeMLE7scFW47V9IauojbknLYAzQI56cAKdpC5bt/hU1shJHHAGORT5YRnchHJ4A5zVqNVjiQBSRnmgCaTbBZMxBHH6149401Az38sR3lYxxjufavV/EdwttoruW2qBuOa8NAF3rESSMMNJzg54znmgEejfDWyaz06WecL5sp4PTIq1cmSaVxjAOQSK2NKi22EY8tVbHygdKzSmy6Jbn1GMA0AMiUJzuYqOenJreLpYaJcTn5QELHt29ayEDbPl24PGMZqx4zmFv4NuQpA/ckgn+VAHz9qN4kk0kgy29t24dPmJ/Kufu5X3OSSD1z3q/esp8zZ82TnP3Rn6VhzysrsMDOcnnj8KBg8i5KtjA5B96y9SddyMGLHGCPQVK0p6nJyxycVRuJCxYs2Bjk47UDRSuZFUuQSuDz7Vnuw3E/N16irVy6kYLZXPNUXYKTg5I7UgElfAbC4OPwrDrRklZgcgjjGRWdQJhRRRQIK9I+GW8aTcFegnJ4OOdq15vWhp+sahp0ZSxu5IULbiFPU+v6UDTse3oQQCFHTHAzipogREWKFgOFPbmvEx4m1kHI1CbOc9v8ACnjxVrgBA1KfBOccYz+VCC57M6bmWMlSzEDCt3PrXtwt1tdEtoJGIKoqlj618VL4p1tZFkXUZg4IIYYyD+VasnxK8YyACTX7xgOgO3/CncR9Q6lNHFvZ1STjEYY5z9as+HFWK+ieISRJIDuwc5Jr5OHxA8UgN/xOrn5uvC8/pT4viL4thIMeu3akdMbf8KdxHvPxblWTxTKHjYBYlBPTIr2D4URCHwPaBGQhl3AL7mvhq+8ZeIb+4ae81W4mmYYLNjJH5Vq2HxT8bafapbWfiK8hgQYVF24A/KlcZ926urIuR1C4yD+lZmmofOIdf3knORXxU/xa8dvjd4mvjjpyv+FRw/FTxvC5eLxHeqxGMjb/AIUAfoCrCGyaR+DjcTXy78QdYfWPEt9OG3QBjFHzyQODivJZvi348miaOTxPfsjDBGV6flXNv4j1d2Ja/mJPUkigEemzSBYmMi4LHGM59v5Vzeo7Sh8vpnhu1ci+t6k4w93KRUR1O8Yc3DkZzRcdzfdinOAHAxkdqruQzcdM9qxft1z/AM9mpv2uf/nq1AXEvSTdSE9c16Z4fU/2TZHI/wBUnB/3a8udmdizHJPU1oQa3qVvGiQ3ciIoAUDHAHShCPor4XJ/xWemYGfm6tzzivpXU0DAb+Soxk96/O7T/GPiDTruO6stUnhnj+6644/St+T4w+P5Tl/E96x+if8AxNFwPtzy/njTGMHJWrESjyup5OQa+F/+Ft+O85/4SW9z9E/wpV+LvjxVAXxLegDoMJ/hQB9ifEm6EGkCEEYYgcd68tt5F/tG3P3CJBjdxk+1eA6l8SvGGpgC/wBeupwOQGC/4VTTxv4kR1ddXuNwOQeDz+VFwPvhQEsYSp/g6jtWTIgWTzBhlB2nd/hXxl/wtjx1tC/8JJeYAwOE/wAKjPxS8anOfEN5z7L/AIUAfakUY3KQCQvOfSqnxJkWHwpOHbAZNvHHWvjf/hanjcLgeIrzH/Af8Ki1D4m+MtRt/IvfEF3NF/dbbj+VFwPRbwCMlSrbscEc5rGuk4O8gAn8q86fxLrD/ev5ifwqF9c1NxhryU/lRcdzs7j5ST156A1Qlbcx4yRk8Vy51W+PW5eozf3ROTM1Fx3Nyd8Btgxkc+496oXLMpBBwpHIHaqBu5z1lamNNI3VzSFcnYgk5PboBVOnbjjGabQDCiiigQUUUUAFFFFABRRRQAUUUUASQKHmjU9CwB/Ouw8OeB9U8TyXS+HdIu9RNqEM3kDOzdu25577W/KuQtv+PiL/AHh/Ovqn9kRitr4/ZSQRb2hDDjtc80DPIf8AhTnjPP8AyKGq/wDfI/xrj7zSBZXVxa3VtJDc28rQSxOcFHUlWU+4IIr6o/ZlkuL9dMv9Rv4bm5ktZSWk8RTXFw53kfNaN8q8d89ge9fPvxHz/wALH8XYP/MaveP+3iSgEcqbC3Cg7Dz2yaY1lbgHKMD2JarmMe9I0RbHU96BlUWMB2jYcn0J4oSxt2Y/LwOOpq35LswCYGOS1TRxDaMjBUdaAK40y14zGTxzhjTjpdp2jPP+0eKtquVAB4xmpAmOoxgUwM86VbAAGPB6feNNOl224jyj0zkMa11j5VRjnk56UjKzOFjXczMFAUck+goAzIdFjnmihggeaaRgqxoSWYn2r3rwl8DdCtdEFz4siZ7uQbhGLhkCe3ynmui+EXw1g8NacPEPiTH9oSKDHHIP9QD2/wB41ueJdSkvJpl5+zhflUjHNAmeW6t8NfCsN35cGlOkZ5U/a3JP4ZpLb4X+F5AQbGUk9/tD/Ln15rs4YXeYPL8rDPLdRVorGjBbVcswO84/T60wOCn+F3hpLzyYrFnAwD/pEnXH1rqtN+Cfg6SEST6fOwYD/l5kXB/Ou70fSBdW8U6RhGCruI4yRW1fPHbqsKY3Y/X1pCPKrv4N+B4fMb+zZAqHJP2uXgf99V4r460rwxa6k1vodk8UacFnmds/mTXsPxb8XnTbJtPsnH2iVTuIPIB/rXgcrOzu75LNyW60FJFAaZbngpg5/vGse9jWKdlQYA9810Rywzjr6nrXP6j/AMfTdPwpAyrRRRQSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBLbf8AHxF/vj+devfCf4k3/wAOm1c2Gm2l+upJCsi3DMNvl+ZwMevmH8q8htRm5iz/AHx/OuoWPccrjHr60DR7Lpfx2fTboXGmeBPDFlc7SBLBF5b4PUZABryjWr2bVte1PVZ0SKa/u5rt0TlUMjs+AT2G7FV0QYJY446HmplUBOMjHY0DsQxRhgMjnHBqZYuM4yD09akRD97aMduasheAenvjNMZQKbT8oP496V42Y4UAHPfvVkoDlcgc8YFKkWSVK7iOR7UWEVUUkkYHtU4jGACRjHU9akRULE8jOQMjpU8FlNdybUVnY4Cgd6BlNhypGeOnHWvfPgR8NFhCeJvEMOXAD2sLDhP9sj19KwPht8PGutSjuNWjxHGd4Q9zX0Xd4tNNjgiXZheFHYUEtnK+Krpr+RlPyonAXpXKNaossiy7pGVeh6ZPvXXXFu0zB2zwfvCsbUYDLJsA8tgd2PagRiCGXKuu5OQoU4IP1rW8LaK15dyWu0+Uo3FvTJ5FNstJubiRFSJpwT8pzjJ9fpXoltBb+HdNZ5tizuBuOeWPoKAIblrXSbEliqYXCA15r4l8RR6bYz6jcsu4g7BnqfSruuay97JPPI+2NAfvH5QM/wBK8E+IfiL+2NSEMB/0WDgYOdx7k0DSOY1m/n1TUJrqd2Z5HJ/+tWcd27jkYOKnYsrBkJBBzn0qBjyT6859aCiFiQ3AByeo9KwdQ/4+WH8q3m4UcfN1+tYN+CLkgjBxSEytRRRQSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBNZ/8fcH++v8AOuvVQAQO9cjYjN7bj1kX+ddqsZJHb1oGiNAMgDt157VKoBTK5PPNPSPLHbkD2qZYiW9O556UyiFFLFR0z2yan4UrjpU6Q4Kkn8MUrRDjGeDQBEQqy7cYbH5iruk2f2u6aIAl8EgdM+lReXljg59MjpXSeA7eKTxEsU5H7xGEZb+91BoEXtC0KMyCSayEgzkq6kA16V4a8MS3jQyQwR2wHITyxz9DWzp9nPAECBHBUPggEZ6Gur0vUCu1RFGrDg4HemSX9A8Ny2Sr5qc9cds10UunxuDJOxzjkdhTGvGislZjlm4yO1YWo6lK0hV3JAPHHBpASXlvZMxUISOGBHeqx02znkMhc4IwR0xWfc3jFiqyE5PA46U6OdVj3HIAzkk9fagDZgax0i28wckDgGvOvEmty61eMu8Km7aqY+770virW2vWjtYGAX+LB7VyN/qVvotnLe3cvzqCsajkse1AIwvidriaZp66XaMDcsv71gegPavH8/MMsSSOtX9Vupr+/uLm6kMkkr5JJziqUhwT0z+VBRWlHOOw7CmNjqPp1qSQDggnB5NV3K7mIH0OcUDIi+RgjIHcnFYN9/x8N9K3XJJOevv3rBvQRcMDjj0pCZXooooJCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAtaZg6laA9PNT+Yr0OZRuXoAR0xXnWnnF/bH/pqv8AMV36N+74GT0FBSLdvCGHOMD261NtVHO8FeMnuRUELlRjnjnApxfoRyScZFMZYIjCjqCTwCc0zYN3PTGBx2pVYiMbQMg9DUsSbjgPn68/SgVxW3hgpBLEE9P5060aSOVZYCVkRtwPQimSFvMDNkA/Nx3qSIhCwIG0nGCKBHvPgjUv7S0hblmC3aLtkH49a6WOURMGUgMeQRzmvAPDet3WlakssbEwuuyePPDAV6toutWl3AhhuNyHnZuwy0BY9Ki1Ddpsfm5LAkCsi9vkeQMv3cYJPauY1PWiYUitx8inJ3HFZH/CSGC28y5Mcagn5WxyPagR1hcOu9jtAySTXN6xrZvCsVtKUhyQxU/e7flXJav4mfVQFRmtocDjdgtz605JbfT7SR5WG0fxSN8xHtQM1mKQGWaeQR7Blj0PA4/SvJ/F2stq10sMW5bSH/VrnOT6mrviHXp9T/dx5igBxsU84FcrMpZQ7E5yR0xQxlaQHDclVB6etVx1IyR/WrUwA27ieR09KrFipBwBxzkZoGV5Nwyxz71XdTknAqcknPJJ7E1A+QMDqBQBETuRum4+tYN7n7QxNbUgGAdvI/SsS7/17UhMhooooJCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAsaf/wAf9t/11X+Yr0QD7pGAMdh1rzzTjjULU/8ATVf5ivRASeoJHXjtTKQE4HA5xU0LBXAxwTzgUyQMcEYyfQc0qsAVVVwQMUDLYUE7iTjHFWFRYwrMuMYGOtRQjf8AfYBu+3pUyozANGzIc4OelMkaCrO3CnnIXPH0pHLO4ZsMwA4A9DTpgTPn7pIyccYBrX0nRb3UbC5nt0OyIc/3j9KQFG3jKgg5K7uTnirayvE4KFl5xkcY9KrKrKUCA8cEHGafJuCbM8LyBQBqxa5qEUSwNOWJOTv5wfY1nzTtJNulLMxH8Xb2FVWO91ZieMA570r5ydp2njHcUAOuS3mgK57E4HPtUV7cNKpaR95bIwTmmzljnK/KTgZHf3quxZjIqqdvoP50DK82NqDC7j0x6iqUjtuJK8YH41YkG5htB3dxioJCYy7fdwuTigZu+DfCs/ie2194AQ2m6e94gA+8ysvyn6rvx7iufvdH1K1sIr660+6hsJm2RXDwsschxnAJGD+FfSP7J+liPRNe1VkH+k3CW6n2Rdx/9GD8q7j48eHz4i+GGrwxpvubRRew/wC9Hyce5TePxoFc+HZCAo3YBHpVSRuq45zj61PLgdMk8VVkb5g3QdD70mMhkJAyTk5rHuW3TM3rWpMVKsTkADHBrJlOZCaBMZRRRQSFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBZ03nUbUf8ATVf5ivSYgAfmycc5I/nXnGlAtqlmqgsTMgAHU/MK9SSwuWJAtZ9w7BCaaGiqVOehHvSJE4z8vB5BNaKWN2cA28yseBuU80ht7gbcwycjGSpxmmO5HBGE2qyttbsPWrSsFdkVgyAZGBnr/WlUttAVSrAZ+6avaXpV9qlwkFlZyzTO4HyocemSe1AivpdvLqt0lrbKzNIcdORnqa+gPCui2uk6VDARmZVw7ddxp/w/+Hkfh1Bc3wD30g+b0UegrZ1iIqPMhwGTJwO4pCPMfHnhOAzreWAEDlSGXZ8pbPXHavMrmOSJ2jmUbgcc9wK+h1ki1OJoJ1CuR8pJ/WvL/iBpD28TsVCtbtzjowPQ+9AzgjKzeWqAfJxg8/hWxp2iXVxGZGcI5PCgdaj8PQiWUTyxhSn3Bjgt3rsrQoZtjDDdMoP1z3pgYlz4acNHGzbifmBPUEdAawF0WcXrGaGQx7scjp716NJcESI0qqI16MOSQPU1JJqWkSwSB7lRKBn5lx2pAcK2jQWqjauZM/MT0NY9xpkN4t3ImYFjXhmOOR7V0HiK9szsaG9UsfmCFSFx7VxOr6nuVoYm3qx+ZvegZ9C/s0eNNEHhu38LzSfZNZWSSQLKcLclmJ+Q/wB4DA29eMjPOPdZAjRssgUoQQwboR3zX51CR43WSMlXU5VlOCCK9Ju/ipP4k+G194Y8VySyXcarLZagucuUP+rlA65XIDepGe5pCsef+PtMi0Lxhq2m2k0U1vb3LpFJGwcMmcryO+CM+9czI2N+OvfFTyncvynIJzxwKqzMo38846CgorO2AScYOeo5FZ0py5NXnchcZ49aoycuaQmMooopkhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAbXgqVIPGWgyyjMaX8DMPUCRSa+u11+yYL5NpHjJG3dgk9u1fH3hcFvEukqgLMbyEADqTvFfV2heGL+6iIKSWxLBsv8xNNAblrrNpO+JdPRRno3HBrXij02VCfIjPtsyaXSvBixxKLu6kd8544FdTY6Zp9k5bALEZ5Pp04oAy7Dw3Y3x3JZRhcddg6V0VnY2emWzi1jQOw6gd6c2oRKmIlCgdR3FZ11dMODkjrnPagCe4vDMfvMeME9KzbndwWUeWeOOvNMMyMcZOF5weM0OylQflHbOckUAcjcM0E8iq2wo4G71qXV1ttZszBeY6YDJzkepFUr4CO5urgyNt342ADk1Rk1Ly2+QEIGz0GRQBy2o6HcaFFEkqE24YskqDPU/xH6Uy2lfzWlckkjrj+ldrZ6zt3wmbcjnJyuRn0p9xY6ZqEgD2flTg7t6DA+tAzjbm7dfLB2rGcoT6Vi3l7FFcl5gNqEKO4I9/eu31PwlDMqyQX8gUc4K5FcJ4q8NXmlfvpbhLmFwdhVvvH6UAcr4hmR7sBOIwMrxmsKUlnGchVOWwPapLuV2ciVGDZwR61WZizH5SF4HB6UhkYYsPmAxyQKhfGD79hUjtkYPPpUEpPYjNAyq/uRgcCqdx945AFT3D4BI6nAP+FUZXA4ZcZ6fWkBHIRxuz9fSqkvLnPNT5HIzknvVeT755zQJjaKKKZIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHSfDRBJ8RvCqN0bVbQH/AL/LX6DhYYAFGzJ7ivzx8B3Is/HHh25cZWHUbeQj1AlU/wBK+1ovHOkyqrkbBn7rKQc0wOsnuQA+1kPQ898VnzTuBvVQUPHPYetYDeONBZ38yUKxH4H8agPi3RSwDXIVecbj0oA20uHQsMnB5B7mla5BKjA9OuPzrBl8X+HFVQLyNweck4qpN4s0Vt7RXJVRySASKANu5vIdykMeflIUZ/Go4blQQkpY/KdpPPHrXPPr9i+021zG7H5tp44Peq2qap9kspZjsY42gZ3HPrj0oHY53XtcBuruMZLeb+72nOOaw7nVnaTkt/ebPrWVcxS3Mkl0S+HcnPQE59Khun8tGWMbTnByOlAG2dUIVYVYE5yflPf3rTsfE0scUnmMjEjYFJwQc9c1xnzN88kpVRgk5zuqO5uXzEsWWAOBzyBQOx6BceI52YRJcBARk7ADj8a5zxFqhe1VJGDbWJJzmsFLs9nO7+Idvzqhr19g7VPbGPf1oCxlahKr3jFGzz1xVHcRkg47cGk3jdnceOnuahckkjt3x3pDsP5PVcj2qF2K/wAPTvS+Z2BIA/h7E1BI20NuOOOKAK07HPI/M1nXRbdzjB981bun4x36GqBPzkfpSEBONo5B60yQYcipSCCNw+btUL9eaBMbRRRTEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBf0FzHrmnOvVbmNh+DCvcZNRa42iRhlSQCOMZrwewz9tt9r7D5i4b+7z1r2O2v9PupIohctLMygFY0J5A5NNDLzyGTcCW4UHGM8VCksucvgqF54q2slqjMwtj5mAMyEgN+FMt7m3hYebHG6f3gTnP1oAroks2MCMjOT8ucVee3nDkiJQ7AHCvgnj0/Ko/twaWTG+IE5CooA9ufSqz30SyswmmzgjcGzQBMHljIY5eSQYJK8JzyKlE00sibkkA55A4Yfyqg2p28LkhNy4ODjFVxqzQxbVPyj5ueMfjQBuupiPmLkgHO3GazdQuBLI5jijC4KlT1z1qg2oo7DliO/Xg1WbUPL3AshB4Oev1oGiVozkeXlWxjGeFFRNEUO7OTuwB3NV5NZtYG3Fw5xgqOh4rOufExwdkUfyjjj8qLjNmS5WziaaUbQOMEZ57cd65i9vWupPMck44A9qrX2oS3Uoad8jPboKqtNu3tjtkUrgW5HOOuCP0qLzM4Abnp9arNJyOtRGY4+ZOOhOaQFwuP4s4HB4xVS4lCEcEZHrVZpTuYLynJ5qEsCM5JPYigBXkLNk45/SoMkNzz36U4kkc885+tIpJbIzmgQu44yCTjvUT/eJqRh6cEHvUb/e5oExtFFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFnTmVNQtXcBlWVSQehGRXpcevWkSkRQrGWGD5fy15arFWDDqDmrbajMeyfgD/AI0DR3416FShCfMO5OajbxHu4Ea7epz3rgmvpmXB20fbph02/XFA7o7U+IXwAqDg1WfXmYsAmFPSuS+2y9toP0pDeS+w/CgLo6mTWJmUKUB9iarPqszKfm+vtXPfa5MEcc0guXHZaQXRuPqUrceYQOOKrPcs5yXY896yxcSD09aU3MhGDjH0oC5oGZsYfdk9qY7nbtUknGeKo+e/rTTKx64+tAXL3msHTLcZ7dBSLOFdwSuO2ao+Yfak3ewzQFy2bjJz1+tRFsE556DioM0AkUWFcsFuRtOQe2aCOCMgenvUKuVOQBRvOTwOaAuSHBUdMkYJIpp+8Tx16CmmRiADjAoEh9qAuSEnqfzAqKTG846Uu800nJyaAYlFFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) Group A - AP view of a small infant who had a swollen left elbow after a difficult delivery. The displacement medially of the proximal radius and ulna (arrows) helps to make the diagnosis of a displaced total distal humeral physis. Panel B) Normal elbow for comparison. Panel C) Group B - AP view showing the posteromedial displacement of the distal fragment (arrows). The relationship between the ossification center of the lateral condyle and the proximal radius has been maintained. Panel D) Group C - AP view with marked medial displacement of the distal fragment. Panel E) Group C - lateral view of the same patient showing posterior displacement of the distal fragment. There is also a large metaphyseal fragment associated with the distal fragment (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24083=[""].join("\n");
var outline_f23_33_24083=null;
var title_f23_33_24084="Bone marrow biopsy in parvovirus B19 infection";
var content_f23_33_24084=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F83402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F83402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bone marrow biopsy in parvovirus B19 infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High-power micrograph (hematoxylin and eosin stain; original magnification, x100) of a bone marrow specimen from a renal transplant patient with parvovirus B19. The giant pronormoblast (arrow) with prominent nuclear inclusions is characteristic of parvovirus B19 infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Mackowiak P. Persistent anemia in a renal transplant recipient. Clin Infect Dis 2005; 40:1159. By permission of the Infectious Diseases Society of America. Copyright &copy; 2012 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24084=[""].join("\n");
var outline_f23_33_24084=null;
var title_f23_33_24085="Construction of a colostomy - proximal and distal";
var content_f23_33_24085=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 487px\">",
"   <div class=\"ttl\">",
"    Construction of a colostomy - Hartmann's pouch",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 467px; height: 659px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts the proximal limb of the colon brought onto the abdominal wall. The proximal bowel is opened with electrocautery. The distal limb will remain in the abdominal cavity and the suture line inverted with silk sutures, creating a Hartmann's pouch.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24085=[""].join("\n");
var outline_f23_33_24085=null;
var title_f23_33_24086="Paravaginal defect repair";
var content_f23_33_24086=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Transvaginal paravaginal defect repair",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 602px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transvaginal paravaginal repair - After complete sharp dissection of the anterior vaginal mucosa, the endopelvic fascia is sharply incised using Metzenbaum scissors, thereby entering the retropubic space. Medial retraction allows visualization of the pelvic sidewall and the arcus tendineus fascia pelvis (Image A). The lateral vagina is then reattached to the pelvic sidewall with a series of interrupted permanent sutures through the lateral vagina and arcus tendineus fascia pelvis (Image B). The interrupted sutures are not tied until all have been placed (Image C). Tying of the sutures results in closure of the lateral vaginal support defect.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24086=[""].join("\n");
var outline_f23_33_24086=null;
var title_f23_33_24087="Normal pancreas EUS";
var content_f23_33_24087=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53041%7EGAST%2F53097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53041%7EGAST%2F53097&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound image of a normal pancreas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 307px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEzAU0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDutRthM8duv7y1OFlQdj61oQ2btc3BgliVUUx7+7KB0+tYmtarCsSy2EyrMyncR2/CuXu/E6TNBFDfOHlT5o1x94d6pjOrt7FbaGC7kJUFGKeZzk+v1rH1TX9L+xxqoMN3vwXPAJrnde8dqfCtqu4+bYzGPhvvZ715BrV9eT30iPOSWkEic9c+1IR7H4k8b2+p2sKxwRwgDymQsCCw7j1rgLTVPNhMXkcfaiWI5GfWs3TY8wvcTo0yCQEq/BZvbHatXwpo7HUpGdDGTKWCsTtakK5R1+ymee2kyq25cypF3JzzzU1zoUusXsNmCGDMCCP4M9h616rrfh1NR8M+Zp0cUlxENjovDAntnsKfonhZNNET3Q230aKyHflQO+aYzyyLRhoU+q6dK7oI14Y16t8JnEryW8zlopLb12449a4/xw0J8Y3MSjzJZrfdtx1IFT/CjWpF1uzS4Ty4i2wkHgY7Gk9BPQk+IFm6CR1dhGGH7t8kbQeor0T4osLj9n23MfI8pDx7Vz/xY0p59TuIwrLE8fm7EkADemP8K6CFW1z9n+4g24lgjKlc5IxVfaK+0j5S0jBmOe0iN+Rr6v8AhRMi6mpPAaVGyfccV8nacNt5LE2QWUgfUV9F/Dm/M1hbTIcGaDGR/fWoRHU3vj7aO2ux3MSHciIflXJPufSo7YG98MvHH1mtXQDHfFbPxpWebR9K1q1MZSaIQzq3CnvyfXrXMeB9QjnsTDGcmI5APcd6rrctvVM+fPFUbHTNHkwcRxvbH2ZHP+Ncua9j+IPhwW2rXenkhLTUn+1WMrcKs3dCe2eleQXEMkEzxTIySISrKwwQfSkyWiLNJmikNAhc0AFyEUEljgAU2ug8KWQWRtWuUzb2rDyk7zTfwoPXB5NAz2D4WwN/wkmrSY+S2tYbQn/aCirHxOha71OCOB0jljXIbGSD/St/4faM+h+HQ97gXlwxurknsTyBXFai51zxbI7mRrYHyx5R5DHpT6DWiPe/g3M6fCx57ly0haTcxI5OAO1eVfEG6MZsYgJCGdiwjYBvwzXsrWSeHfhra2WTvZVJB6knk14L47vRc66YyigxRE7hk4/D/wCtSWwLY6TwFBs0bV7h4iEeLy184j5ifWvUtYEq+GvD0M5XzBGN6ghRjArzDwhdNd+DUtIbd4w7qJC4YFueuP8ACvVvEjJGbG2ijieSC1BCvzjjryeaaBHFi7gm8W70TFuuN+1t2SOhzR4kvZbjV3cz2wIceSB95vXnpWdDFDdalNKjyw7lwxiXAz7+1UL7cLkRSkeXGciVVAB/CkBQ1ye/WaZY9wMj5SRVwV9RnvUVtHIlzBIFLIg3yPkHOOuPSrks4leMLJ+6ZwN5++B9O1K08CXbRW6SLBGCeCPmPc4oArW0kj3EwgkeWHeZFDgAoD1H096xjfzrbSWsy+aRJiPIwNpPUe1S30rDUXkjiuFgKbQz4HX26ipniRdIiWcb5d2FZhh0/H0oAEvFljeKzhyjD51K/Jkfyq7aXxju1d4hDIUwI0b7v41iXN3HaIu1jtcbTCvUn2rMa/u01YxTsFQxbS23n6GgDt54IPEEHnxsFvgQAR0JHrWB4ktYrKOVYsMAu+UjojUmj30tlAqQROscZILAZPNVdS05pbK4liZpFQ5kGc5b0Ipganwv1rXdL1XTNOtr50sbi7Rp1hAKSbsA5yM9ABXh0FuuoeKre0nZhHc3qQuy9QGkCkj3wa9i8I3ksfiPw6sIDK15FHJtXGPmryLSP+R403/sJQ/+jVpP4WKWkGfVH/DMXgr/AKCPiH/wJi/+NV538W/gv4c8H/2V/Zd5q0n2rzd/2iVGxt2YxhB/eNfXFeKftJf8y7/28/8AtKqirsuCTlZnzh4hl1Swa4SeRvtC/IzbsEY7AVz1vLfQSxyEsH3YBK8819D634Otr7W7y4MwaZJAzgqCue9aUXh7R3tU+22cMyRPuDDnGev0NJks8N0XQbu5tZSA0p37v3g4HuKe3h6/nuEdoEwODjk4r6GmGkWscSaXbxRROQu9xkY75qjd6dGL9RCsXyvuKLjhaAPLbjwpLY6TDeSxP5Nw2wgngAd/atGK1tXsoeTEkUgQkPyM9yfSvSNbsbW50d4pX2ocny1yxWvOZ7PbFdxoX2soACgYPocUAegeDxDPqr2CMS8oDL6cDqata9N9mu0hQx8Zy2M8+lcR4Z1PUNN1OykBZEiG2ZtoyB7VuePPEMN08F5aNGI88leTu9aARy/xH00JqdlqoILA4Zl75rzS1uZNL1a5RHZpLaTzkYAZIJ5FbvjjxDcRWstsXeYTsrxgc7SOtc3r0rwzafqSRBllULJkck+lJgz6I1ryfEPgyz1+2SLzEjCTIw+/x3NS/ByWGe21fQiu2G5jMka5yM+grivghrUbG68O6owa0uwTEhPI9q2popvBvjO0ntokhtopMZLHJU9eKOnoJbeh4H8QNIl8OeMby3KlQkpdMjqM13Xwo1XcZdO34Ynz7c5/MV337SfhFNX0a38TaUiuAoZyndTXzjoeqz6ZewTQuVkhbcuO/qKHvccu6Ptvw6YPE3hK70WfaJdpaLJ4B/8ArH+deCztqPhXxX5MyOpi+WZCMAHPb2rtfBPi2J0tdWs3AVyPNA/gfvn2r0Lxp4csfHmiNeWCRLrEcfHqw9P8DT30Baqxwt/Zab4s0Fre5G+3kG5WX70L/wB4V4/4z8Jz2B2a/DK8Y4h1i1TflewmXv8AXrXTxtq/hG+kikt5kdG/eROc7R/hXaab4nsbweVPIsErD545BlT+BpeoeTPm5/Cl9L82mSWmoxno1tMpb8VOGH5Uz/hD/EA/1mlzxD+9KVRR+JNfRt94L8Lau5ln0q0Mjcl7d/LJ/Kqcfww8IoQ50qQ+0l0SPyzRYVjwmw8N28d0iX1x9uuSflsNOPmux9GcfKo+ma9i8F+B5Yri31LXYYYpIR/oenRf6u3Hq3qfeuutoNB8N25FpDZWKAf8sVG4/jXH+JviAm1rbR0Lbs5l9fxoHY0vG/iEQqul2TLJeTnBwf0q98CvB8t5rNxeXUUkdtA4ZhIv8XXAP1rlfhz4Vv8AxbrySJCzRY3NePyFX0+tfQev6pYeD9Ag0zT2USldigdWPcn3o3F8Whk/EfW4pLoQh/3NuCW54JrwGO6OoazPdGPcGk2gFSMqD69xW54r1qa7eSxjdXupPmmGc7Vq34JsJBLJeTRyNBbYEecgEEY696GN9jsvh/bO2pxMY8+U24f3UHpW/rupGc6ncvtjdUKRuy54Hv0ql4dW4tLG4ZlzPIdobkDcelUvGd1daLpUFuWhlmnf5yOQvv6GmhowPCd/GsVxLcAyCT5VkHOeeQe1Lrt9am7dTbBYoo+STwfqKrlmVhCFK3AXM/zBV9iFrkbq4KSXANzIUbhTsyM/WkI17W9mSYvZ/vBMuVCr8u369qkaCKaVHnm+0yKh2WyDC4PcN3NZaozweRM0kckg2x4XZnI7Adc1d0j7dYSJEkY8ryyhdk3OpPXjsaAKd496sz+UY0yPuckEDpk+tU9RnbUb9CJDHHEoMkaHO4/Wr+o6pe2sVzJOWzjy1eROfrgVSvrgtp9vHBGsN25Decq/eHfNAFJrQROY5pPM3/vFQHkAelP0+0W8W682QsMgtGV5XHTBqDT3V5TNiS5nViPmTHy9wKfo94bfW3dQFtmOWSQH5R/jQI7HTJkWcvJCrQwIqLk/MWPqKp6uzW9zPHZypAr/ADyFR0+nvTm0pkh/tKK4y07ErD6Y9azLrStXkaaedDIGjykan5j7mmMv+HbiBvFPh/ySGuBcxq59RuHOPWvFNK/5HfTv+wlF/wCjVr0/wlbLH490F3jlS5N5HuUqQOteXaX/AMjtp/8A2Eov/RopS+Fil8DP0erxP9pM4/4R3/t5/wDaVe2V4l+0r/zLn/bz/wC0quHxGtL4kKb9dMtrcmKKbzyFkZTn86ozyWVmJmtFaW1lJUgHox74rHecWsaXEZc2JwoOO561QswskctzbyEkTBVGeopEHYQWFlOLKV3dbYIVCovIb3qhpF4tjIZJY5Ad5BVmBLDtV2zuJrm4ubcK0i7A0e0bVDVWCC8eWC4hS0njbaX35Vj7UgNK6uBcwh7ceXvztJHDe2K4+/jRLn7K8/lKVLEom7n0rd0uV7S2WObaJ7d2O8jt9KqRzfatQW4WBfskwIZs4yfagRhWtuUu2iu4yYwm0/Lw3uaytftLRXjkWNh5S5XZkBgT1xXSairfbo7xYZPLUbBzgH6npVLxDo8moGaaJmW32DzVA+ZF9BQBxV9p0OqrazDfF5O7zDsAyKpQ2UF7p01qqApE26EMeCO9bUljNak28QuPKjQAKHwCp74xVLV9Mltb5bsMEhcD7oOR+HSkBk2CPpeoia3j8p0YeWy5zx2r3zRbqz8eeHUdlQ6rbxFJVIBLcdga8U1izWSGGfywVk5z23etWPBeq3+gX63kE+1/M/exqu3A/rxRsLbU9x+Huow3FhN4T8QNGBICIFb/ANBr5l+Lvgu48G+Kbi2dCLeRi8TAcYJ4r6RuRaeMLCPUtMgjj1iHBXDbWz64q1f2Wm/EfRW0HxRGltrsA2wzsMFj6imV5Hyp4K8Sz6NdkL+8gk4lhPRh6j3r3nwj40fTo4bqzlaewJ6ry8Psw9K8X+Inw21nwXeOLqImAN8kq9CPWsTQPEdzpdwHSVon6buqt/vClsTax9rRzeHfiBYPHd+WZ9u3z4WAP5/0NefeLPg/qqzST6W0eoxuQFJYJIg6Z9D+FeYaB4xthMs0czaTeHrNbjdDJ/vDtXqmhfELVLOJWCxalE3zPLaSAHP+6aB3PPp/DXijR7/NxaX0VsqkEshy30xRqOk64RGLLUrlo/4jJGQfyr2+y+LFk6AXMM0L9xLEQf0qxL8T9PYfu1jc/wC0CKAPBrb4feIdYaOFYLy5kLAySMCE2nvntXqnhj4QWtrBDN4gaG2t05+zxkHcfc/4ZrVvPiZK6YgCxn/YTP8AOuG8T/ERVRmvL5YyOdu7fIfoB0oCx6drHiHSvD+mtYaLFFbwAYAhABP0/wAa8Y8XeJnVt8ebm/lBRFByIh6msCfxTLqskZs4XtrN22tcy/fz9Kt+F9Bm1C8ZdNjWYM26V5hzycHn0oC5X8J+HrnVdVZYRPNIeZpm4IPsR2xXsmnWHmNBYw+Y8VvgMdwBkPqTiq9rBbWTNoPh2A7tubq6TjB9Aa30t49L08RWsuLgJlyxJOfQ07AkWdRFvawxeYpWCE4BDEHd71xGoG71rxC0aoi2wyxQE9u+TWx4g1Z7fQ5YXCPeTkDcRuwP7wFYEk1/o2lm4lcTG5iOPKPzY7nHagZy+rzRiebLB5R8pkDbRt9PwrAsbu3EgsRFO6FyC23LK3r9KtWzW11LdPdxM548sKS2PwrN1KeW9n32yTRhRgEYTdjqPypCZoGaVr9l3rK9r80Snlhz69q2LaF31JmtblNw/wBIkZzkgkdBisvw29utrI8gkM7EoGdgSBTLq1kkmlWzmkieQZJXnzPX6UCKN3fXU9xMt1AkgLFY93XcO9VHuLyDTnu7e3BkU+WZWB4Hpirl3ai0jad2eYqnlKGPAPtWbv1kaMsEVtAsSEgM7YJzQMsW+sQz2ZaEtviHz4XBP09aTTYob/U4ZjuTkKUY4B9zVCUvpN3p/nWoeTZ823ncTWo0SPNAJAsZnBkk2fw46CgR1stzHaaxaW+0yRINzOoyBTb7VRp++7V3d7hmyD6dse1Zng2VLG7nS6cmExs4xyFHuazdW1i0uXjCK5s7dv3kuPvc9BTGdZ4CtZ9Y8W6bNEy/6LslmSR1THzds9T7CvAdMBHjbT89tSi/9GivXdKkhn+I/h9NPf8A0ea6ilYdehFeQaZ/yOmn/wDYRi/9GilL4WEvgZ+j9eH/ALTHXw5/28/+0q9wrw79pk/N4c/7ef8A2lV0/iNKXxo8l0nxSLWJrG7cvAXLZ65HbFXfB3iK1vJbnSSNsgckSMvRfWvHonuLa7jhY79pyMnp7V1WkyEXEk0OfOCHKDjPtU3M7nt9prFvp8YV3hkEJwJFPb3NZF7rcEFzKIXjkml+cEnKsfr2rzO2tJfss++4lRSoDxg56n1qvcadfxIiWUvnZyUxyfxoA9Vs/EqyFxd24EpIU7icAn0PpUtu2Fe8t7iOMQybvLL/AHvpXn0UV6JLNrnMAkULLGeVDetUNQu3tNR8lpwIJCcuDlR/hQB7NbzTX0MsNuqtHN85UEEZ+lXLeJI1SxvoFU7Nn3uTn+9XkHhrU7+O6eNFuhv+VZ8ZXJ6Yre1K31szvM07ebAgLJI5AYD1xQB0bQ2S38sPIkHGGI4A6YqG/sRcpGtwscyOd4cdgD0rmbq6luJku45THLsyAuOuOnPQVYsPFk1naIZVAkU7WDkYz7CgDXu9JtZjJDDAXgK5PT5D9a5m60GZLx3ikRpFXdHvOQwHqa6/R/EUHnC4EdoJFXMiEkB1bvirqw27ShoiptJfvIv3VJOeDQBw+jX8mhyJdXN3+/DZlSPIVeemfQV6bBr2l+IvLN2yQXcYHl3kLfMPTNU4tHsC00C2skscpK+eFV1Un19Kw73wl/Zd6IwbloZIyVkwAMj9O1AHrL3lte2TaV4qtkurNlCpc43bgfevHfiN8ClbzNR8NuJ7UjIjj/hqWx1zVtHYC7SX7NJhIgDvRx9e1eh+FvF8MMqQuRbzMu4orbh+VAXPli88F6xp05WFZI2JwFP8X4VSkj1fSp/3sbrMD96FypH1r7Yvbbw54gx/aVtELgf8tk+Uj3rl9V+GGjajHIumajAzqw3Cf6dzSsFj5dtPEPiJyfIutQZYwS2Y9+BU9vreu3Nwlu+r3CSSdB9nAyPavfofhBqljeyS2ksUtvMAGKyBc59vSg/CvWDLFALeMqozvZx8oyeh9c0AeInSdXvxF5+qX0kLjG8HYB7EdqsReEltmhZG33MgAkB+fAPGQa99svhVBGzyaheIkmAHUPnOO4rorfS/D+kQpIkUJMQ/dzP8zFu5xTCx5V4Z+Hjy28T6jLJBZBeVlOS4PcDrXpmj6LbaVaLHZINO08cCaTmWT/61ahlVgksERnkIyLi4XiPPZQKb9lluZWuppVnliG75hlAPpQFhzxpb6bNJH+5tUHzAgCSX3FU0WS3so7qd0liUkIhIRivbce9YuueKZJrcKtm/mLnMqsAgweOO4IrAvNSje6ke8ud5RNxg2/e9KBi3dnDeapPeSyxwJE7FN0pYY+lZmuXsrhBA7yxhPLMmc4HsKg1XV/tVgqwwxwHuQAevasW+lVbYRwzFgF/1Z/i59aQiO9aSKwcRhY4yNyyLkMD7is6Oz+0W0YSS3bfl94JBz9R0NX5bo3MmyBZBFIuDFHyQR1BNRrptrpUMuoQuBZ7f9Wx+cHvigQzattZ/ZlLSSQDc7lgQSe1T2Q1CVokaEhjBuXyzwV9frTvMil0ySe2Z5QVXavX8TVSXUrqKSGF4nlkZCpaMkBR7/wCFAFeaO9iSFY2knlSUgl8Ntz0yKz7gXFvNFb6gPOMzkA7uFP0FX5hdLewLHB5kkoHmeWSAB6gd60306GyuPtl0P3Y+ba+M7qBmPeXFvqt9BbQeZbwwx7fN/vN3xU0du2m6ekk8OSzbY2Zs7h61U/s2bVtfjubOdba0jBdyFyqeufWt/wARWmzTTfxtJcwogWKTGFX3xQBi3Uy2ug3EIIF3K45PAC+lRWdwFtpftUISCNfNAxweKkvoo7e3tftI8ySfB3Ofu/hVnw3af2pPeW9yWZInVncjAKegoAt/CmMy+KtKumCqrzK25jyOeBXj2nf8jnY/9hGL/wBGivedJaxsfGGkLZofImv40RVHC4PevBdPI/4TKx/7CEX/AKNFEvhYS+Bn6P14Z+039/w59Ln/ANpV7nXhP7Tpw/hv6XP/ALSq6fxGlL4j5OnxJIWgZmc8sD2/GtvwzdrJceTeyGKQISHzjNQ3dzZrZGS2TDOcAbao3djI0McysEi2/KR2PoagyOx0nUzpE8kV4wuFdSAT0YU5NQDXtvPp4mimh5EIXhsnvWZYWl3NZRyTsJYXXKOo+YEetdX4cS2t7Nzevm6c4hfp07H0oAotPe6lcX0VxbuxEivsGQVx6VpPai2mSSZI7i1uFJKOmSh966i3ktn36pM/lyLiMwHAz6miebztTjigtVezcDbKxxn2pjMzQLmXTLpHfy0jyFaIr8uO3Jrp9Wu7d7tXcqspTaEzwQf51mz6dDfW9wA6F5RgRuw4we1Zcl8dPa2TZDcSoMAFe3cA0AW7mxn023vgsUVxH99R94qPeq0OknUtP+2XiRQpInyKvJz6itaGxmupjeQCURuo3W5OAQfU+lPhujb2otVtY/s4yQ7kErjqBQBy7abdXMKWk6yWxA/4+fuhgegNJBHqmlRfZrWSWcLkyMBgYx1ya0NWNtdvcXMMM6wBFzIr4Oc9galvkmmgTyi7RtFt/eIeWHTp1pAavhbUI9MuEmS8eS3nAdoRwFK9QRXb2finTNR1NFMzS284+WM4G3AwRj0rywWc00kH2SQQusZEipgEtwenYVfjub6G0K3WnwMsZ4bIVwB1bjtQB6ZeJpVzcSvHJHJCo2rBIPmRvUCqN9odjMy3ccu2WICPzETbu+v51xsMtvcTQXBuJhchd0eRnn39a3LfWL99S8q6nDWjRgvGcLhh7dqYXNJ9B1CG/MsNz51uyZCA5bd6Uy/g1eS6j8gHKJtfPCmnSapdwxqbSNI7lULLIpyuew+tczJ4o1ueTNyYVuYFyyythWJ6cCgDUuZtbYqySzkIwVkhc/KfUitXSrPxNPIHWe+khXILSOc9sfjzmq2h+N7yGycTRWULzRl5pMDntke9VoPGN5ztujbWkOTIxON2O/40gOjk0HV4gx1G9aONvus79R/WtCz/ALLhkCXt5DC6MAAoySMf1rk7nX7LVo1lkumbcMRtu6c9hWVeTWkAMEVnLO06hfNlbk88YpgegXur2f2mc2pmnCMGKrxsI9K5bXfEVzPfBV8zyCpcorYYr9RXMX/yQNaq9zvV8hWfDAf73cVmqlzJEgjKMqgjDEqQeetAGxPq5vCJLKJfsvQySHBIHXIrIvJWuL37XK8ZJO1Ix3x61ZuYpLa322ux5GA5DZHTkD3rOhvfJR0VP9McEeZKwwhPtSAjltGXyrmWMHaQXVScmpIr2DULJVjhZViZgem5/rWbbvcXZe3VriSWEZaQMAj/AEPatDTIAsTQQWEjSn5wY5BnPfNAE6XcunWpSBIAXXeSQRj2NMUWV81tPDsdmB/dIflH1zWbqNzc/wBorbakY3fbjyDwoz6mtu2d4dPa2tILBWePBbYcKPWgBmmywvqMy2tuiIqhSu7CbvrWVPpkkjPI9y9vI7HnPyqPf2q7od3HbbTdWTEl924NmPPrWnfI2p3FubWSGaJVzcHHQZ6UAc/fX8+mwRKZVebaA8y8j8DWNrOrXV/dRs8cnlMCEVVwCfWpfHUzThbewOyF22kKueB6Vn6PDJdXiiIzTtGNnz8KlAHUW1/eR6C8VvbLDE4Ks46sfc1YutYe70qHTz8kUEYZiD8uff1p1/bovh2WO5kEtyzYSNWwBWHpi3UkciLEhsYseYxGFBHYHvQBlam32rVYbmRjKjssaR4/WuiutXht4/s2mR+ZcTSeW7p0Ud6y7K8S51dLsQYQErGmMbiPaq8sxup2Nmnks8hQ+WuAG75NAHUeF9yeKPD0a7WX7em9ienNeM2H/I42X/YQj/8ARor6C8CabpsmtaSbrUrmC7iuU8uKK1DxyYwRl8/Lk5HSvn6zA/4TCzwSf+JhH2/6aiiXwsJfAz9IK8H/AGoDiTw39Ln/ANpV7xXgn7UZxL4a+lz/AO0qun8RpS+I+SYb2XyDbhVKE556j6V1fhB7WXTruO9uAA64UMOFas2Cyh8i3aaMhWcoZB0U+9WLCGKwv54blAF/hB5DVBkdjocsTeTaSSJbTDmLd92T6VHrEckzyyxDySHwUIyob1FYgkttVtkt4FUPESq56j8a7TTIo1s2sr6P7wDLKSeuKYyjoGqJM3lXsv75RtcbMjA75rpZp9NvtOls49RliaMhoc8Yb0zXJwaa6wT3ECCF1JRl353j+8KVGsWgV380TA8q/wAuaAH2errHfRpcNP5kBOXGG/L1qxbas13cyhoRLJGCxJUK20+3ahGtrhJSB5ci9mUcD1zUNrpk8uqxb7VozIu15omxlfXFAHTaFdyWenQFrkxCXp8249ehrQMr+e8cDo4G5mwAzEY9K5nVNFtrW7MNrLNKUQMFXJ2fWoLS1WNmuBftDcNtG88bfZqANeKyN/DG1ztjhGUfaNpb0FadndCwtWDqY0QhPny/0P0rHsdZKXEtjr88VvA5zG20sGPrmvQ/hH5Uetax/pEDbNPldbj76qAyYYg56ZzSA5ebSGkvPtSSiNuXUKQqv61GcXyBHkkiMRBkJAIK+5r1Xw7r+na14q0SztrqDVLqCOY3d3Hb+UjkqdoAwM4H+fTM1CS8vfAepXfiO1SG8ikQWjyQCF5Tn5kwAMjAP+RQB5vEYLnU2jiJ2xJu3xNjmrBu4LXl7XfPKnMjHdvz0/Gs9I0uUElhZLbzFvnRs5YY/lVaNp54oxIfsciZ/dAcj2BpgdNJJbyKiOkol24AV+CPb3qtPbWUt3G7RY4AY5zwB1Nc/bXf2eZHluAIyCrgckYq7Yi2lWSSzu2aMj7nfPfNAGlPptlcui290k/lnayJ2z/hU13p9lFCskvlFF+RmByAR0z+P8qr29naWmJYblhLwzL0x7H1yaqXe65E0RdLWFnLPu6HvQBoSLaxBXgs4mkAJJLdD14FU73UmR42WRymQm2MZAqndy2Gn2YknuVlVBuVFBBaqem6tbSwuP7Oldph8hyQCP8AGkBfW4uWmjyhaJX/AIuo+pq3Z3X753uP3aNwqqm7HvVC2eWWyWBCPLznJ4brzVuOyYwzTW5YSfxCM9B2wDTAg11zDboPO27BjgYHPQmsnT7K/vpIZIpIw5J3l+cityKztnTzLh5rkv8AfSUYBPbP0q7bQrbxoX2Iq5Z9nIUHsKQFSy042Es1vDFFJj+IDGfapDdw6PH5aOj3coJaTgCIdwKbcWXlMLi2uWkgwSwPBb61geVdX8syS24n3n93DHjK++aYF641WGa1aFEKW28eZLKAzyH1HtUqwTZlF1JtWVMQZ6gfSm6dZWbWgf7FLug4kV2yc1ZtYzfTxyTpLMkW4RqgwQMUgM6bTxZLbwvdpPGo3SIpIyT0FWdJgt7OxfzZTBK4Y+XECTt7A0y8hu49sYQLhwOE3Nms7xLPeW+BveOJDlwVAyMe1AGfOoiDXkULRzSPshDdSe+Kv6c2m6TapLPcSG+nJIiHQH1NYlz4jWZY3yiSRjbDDgHDetN1aW+XRwZRFCTy7EDdn60AbF+4mdltjvmZh8/UAd6phZbq++yo8q2UI8wqOPMbtxWB4UnuZ28mJ92Mlm6mtXSrjde3bJOYY4mHmO5/lQIuRaVc6dOJ7jAIB2E+relZ9rYXqpLmdUt42LEj+Jj2qXxLfO9ugFyrlyDEJDkgepqS3vZv7JhiSIzM7ZLgcD1NAzofh681t4h8PtOH86e7RQrtwF3da8fsv+Rus/8Ar/j/APRor2Twz9qu/GugrHCWhhuosDHQbhljXjdnkeLbT/r/AI//AEYKH8LB/Az9Ia8C/am/13hr/duf/aVe+joK8A/am/1/hv8A3bj+cdXT3NKXxHzouqK8UzSwqIpVxLGo/i/vCqN1dG5gDrGzrGRtdTyAPWtCyjjuEaJj5Txkh1H86zZfOtWYKEMTEYA6NUmRt+EY4L6/lXIt51+cEnAcVsa5feXcxx5lAHDbOd49q5q4hlmtItRt1dVT5JFTqtbegaZqywh4YhdxRsHRmbkr3xSAuq1g2lNJb3E67G+7nlG9x6VYvxNdWKsBHIHjG2QAZBqpq17pbySGMPbXeAXDr8r0yW5tP7I8zeyTg7kWP5uPcelMYyytrhNT+1Wl7G8kWFdW+aM+1d/pN3c3WowrNFDEZk2rJGOAfeuE8N3unCWCO/ldlcks8IAwfcV1UiXVlOHsXEsA5Qy9MexpCJ7q5U6ldSX2YZYVMTLH0f3p+kwm/t5fLe3khnX5o2Hzcf1qpNq5M4W4t/Njc5LwYLL65FTTJZylP7PuZVuM8Ioxuz60xjNW8OOuliW2IaUAbreRt3y+g9K5XSNX1bRtauxp941sJE8uSJSVDDup9R7V0sq3FrMz3chzvAV1bt3GKn1Sws9SVPshihukX94zsAHz059aAIfDes6gbxRp2LW6XcryRTGJs+uR2Oa7DULq/wBQiSO/W5upIyPLklnLkN369q4GXw5JY6a7zpHNIzZEiS4YY7e9TaJrcttqMS3F3cxRqVExiQO4HcqDwT9aQHWs/wBqkHk3VvGy/KYwnK47E1ZnlsmtyzWCtIB139T7eldFrmp+GB4P0OZmvftFzbSPbyyWyK8mGIPmAHjn0zxXnC3CLMrQ3EbAn96p6geopsb0L11a2dqpJszH8pZSq5BPoaryQzztJH9nNpHtXYyAYY+lSTavdR232NrWMRNxHJI2dx9qmhuJYIgJYNhcZZlO4j0wPrSEXEspxGUmtkTKYeZyMDHpUMaWJM8dveA6h0K3C5VgPQf1qqdQiSENK0t1KW2AT8BT1zjvUpnt5s3wgWST7shY4I7fLTAqz6Wl/EnmyJLIjbgzjCqfQVGsWoFJHkkhhhjOwbFAIHrirMQa4W4g2l0kYMmzjH1qC+KzIkcyTbFOxd3TI96QEckyuqB7aWSOB9wOdpY+/tU39pfaGC3IkZlH7oxjCHPv7VeutQsbCzjW7tHdmTanljK/iKfayS67BH/ZFm0AjYx7iPkIxzn6UAV7UzSh1lxC0a53hd2F96r2s8P2xVlnZw7YQL3+ta/22w06CW21LazxjaQrgc/WuLuLuW7S6mtrKcxRgeXkcgA9MjvTA39QV57lEhYeVGMkluBz0qDUZbQLEibVlQHEsQ5Y+lV57uxPh8LdmdWdh8kcRGWPqaXTD9peKKGC3SID5uuT9TSAuR6XcvcRJHM1ssiAEF+D6k1LdW1zDOpSfZGcRjnt60lvZX0qzSQFGtV5aXJP4DNQ/aQ3lxFHuLpzx2CAUAM1+6ijnji+aYIwZyj7QtY2rXkN/AiW8XDE7uc59zW3p2iJcPcT3ToQzfOi525HasLW7lrEz7bK2WYnCY4CoOnFMDlbfTnTVGuLOFHlYYVcdD+NWjCzWskeqTG4mZySEPCY7VqadqIg0wrDZk3TYLTFeOfSszVDHPqNvAhYDPzIo/Mk0hFDSb94UuZYIliDZRQOtLeF2gWG3UByMyHGQDWlLPEsf2a3hQkyYyvWq91bR2rGaQsgLfdAyXbtQBjwWk95fxJcIqIqYLk4LD6V3+m2st0kVhZtgJgfKM4rn9Fg87WUN1GfnwuDyx9gK9U0u5tPDUdwk0Y88oZZSBxGvYZ9aAMixuLjS/Hug2Vqo/e3cXnP3xnpXhlof+Kstf8Ar+j/APRgr2TQdVi1Dx1od0kZCyXsaqT1I3da8btT/wAVXa/9fyf+jBRL4WOXws/SCI5jU+1fP/7VDYuvDY/2Lj+cde720v7tfpXgn7U7Zu/Df/XOf+aVpBamlLc+ZhcGS7KzYSUN94cFhVxpo4pPKmybeQfKw6qwrLQfaJDFP+7nUfKG4/WtGxtotQtiiN5V5HyEc/K+PT3qDItWlz9kkmjLSKs6/cX+L8K6rwjqI0W5a1eaR7dgGUS8FDXLpZSvLHNtV2h/1kTH5seoNdJp+qrazMzQpPbAYdpB0B96QFDx0iPrxUBmhkQFdi9c+9ZHhvUBpOsbCkoilBRllXPHtXTNZRzrLebJCobdGrPkEe1Fvqug32ftELx3cIyAV5Prg96bGxsUNrba3/o9kWiuhuSVv1XFbdxJqdiFtrd4wgb5PNHGD2zWDeSrqKJaWdyIwp8yFj8p9xV21kuVea01C5/0jaNiXC5WYezdjQBveFZ1vLx7adfs92oK5YcE1qXNnd2ZEttaRvJIhR3wQFIrHtL+2sUijntJ4JZE/wBfgkbuxFdHoHjK6tLCeF7iO8ikO145ouV9waAMF9gG5bZ5bo/NIgbP1q61rb3apbyJJbr8rCQjkn/Zpl5qUoeS6W1ijuWGFweCKztP1sajNLFfxOjAYV1P3T6igCdLfU9Ov7qOyKy2gwAZ+XB9fpV3w1P4cm8R2sPi+GX7OzZPl42E54L99nXOOelYeuyT2hUx3rShiAZieTjpkVPp8E+poCVmmES7t0SBW49PakBueJ/CumzXMp8Oas01lhvJimb50B6hfb0rkLaOO0f9yUVoseajcs2OwNbF3CLmyleMPbug43HD0zQJbOWR4pkyyAfM4xz9abBle4kZ44riGG4nEv3TMMIp/pV211RPtNtakyRTqMtsGQPoa1LrULGa7gtPODbsfNGfkzSavaxW1yrARLBjGwcn/gNICC5kkuVjS6gjWLzA0RB+YA9/qazpbOGSR1tZ2OHbe0pwqnPT+lWWlsG8tI5jFeIMRqTkkU+/SGKEXJFuVABkjLfNJ7Y9c0wLFtPNHJGlq6iRAFZCOG9we4q0kN5dzx+WnkRu/wA6Mcgn1HpXPJrMAuhDODBBuLqyHJT/AOtUVzr73CeWzfZYZZNqyufmdR0I9KQHeWUl1pN+0aaOL1iu4TSOCg+grmtTvdUv9RFlDL9ijkkPmFV2BWIpvhy91C21ZhBNFNCyHDSv0Ud6tW88t4882otkhsqykbMDvTAxYtGgSK/LQSXxtuN0h/1jDn8RVvSILi5ij+1Qy2i+XuaJG29+la19fWt1Y27QWyQshJLLJ98j1rPh1+3aVxdxhYSMFt27efSgCprdldXxhgtxcxwB8bM9D6k10+kQW9ssMDSb/KxujTqR6k1ylrq9xf6i5utzW5fEccB4Y9ga1IJruPV54ZTFYyOmVHXaKQFjxl4wWzu1tra2eCwhH3FH3j64rNgtlaEak11FBcz8pCrZbZ9O1ZE9ncahqswuHD7TkSHgMPpQ1v5DA3knlwRnJERBZh6UwZcu/Esgg+yiIxkAn5j0965R4tQvL17mXFwZB3HQCtmQ212Zb1LeONsbY4WbLH61f0GW7SJFureKPdwAGHJ7CkBn6Zby3Vltd3jTIClBtOaf4ge0FzbWttNGvlj5yMFmbvmtfUgUl8m0lUXjJlkUblj9yfWuNfRZ8tJGpkcP1QZd2NAE9laWttdtLIc/wKWbHJ74rbvNMkvfsQgBS1QgeaR1NaWheDIoRHda3JHAUXd5eck/WpfEfiC3tIktLUl2BAQD7ooA07UWulCWFLBZNRROHJz1/iJ7Vxet3lxIjfb5FKyttWCNslz7mrUmqJZ6dcs7l9Quj85HO1fSuCvDeXV0hkLDy1LIo6j3pgd18PtRltviDpUU+k2l9HJcRQx+buAtTuHzrgj5vrkV5hbn/iq7Y4A/05P/AEYK634dS3CePNCfzWJkv4VKk9tw5rkLc/8AFU2//X6n/owUn8LE/hZ+hlvL+7X6V4V+1C+668Of9c5/5pXtFvJ+7XntXh/7TT7rrw9/1zn/AJpWkNzWlufPmpC3uWiuJQYnI5YdCRS2cSXDbbdGDMc4zkZ9qpRRtd2+FY4iP3TyAK29HtBbp5yMYmHJKnKmoMi9p9ok1ncJvZpowQUbgj8afoqxNa3MEy4lgXJAbcHX6U631mNrkCVYxdIcB14Ei+9Z51K3sNTkkjXCSH94vcUDOp0e805hHHBciGIjo/IB9KwdbJkvzG2wlG/dtEM5HsajWLTZ1eSwvYkQnPlTDHPpms6zudPecrNI1jdRsQsinchoAs6kyi0QRyzjLYwyfdP1qzC2oNaRCG4e52HPlsMkfQ1f/wCEosrVHt7i1hllAz5q/dcev1qKy1aye4XyN0LZ3IyHg+xpCOv8OX994hs10yU+ReWpDRedgFvbFP1x9U023e0vbaOOObJFwq52n0Ncxqeq2V7eQt9oMN/EQRJjacfUV0c97JqPktdxzsqJhrhJNwYdjimM5+2ubgGMiWW4khPyooyD+dWY9Jutbvp2tE3zHoofaEPpUF3pczSG60zMu07iwbBAqXRZ3sZmnjDQpKMsxPf1pANfQrmKHfOkjSISs8cjcAe1aXhN72xgeO6nlt4pSQhRc7fTmt/TJHOi3MplsrzcclJeGI9j61z51uVbwQi0kigPyllGVUetACXYuYLyWbctwmMsZDjIrb0HX5ljEEWj20iv8waQjn2rCjW0+3M7zG82rgLuwv41rabcWUrrBFYloFOcYwB9DTAlm1ALqTXFvLa2dwcj7M8WV/A0thqUks05uIHu/NwyJjCr/umn31s9rM720cE1tKOVkHzJ9Cahluvstk0UVxLBMBkgKCAD0oAyjbahc3gvo7ZJbdMq6AYZfYVdheOaKGT7PLFdB9hWWPKD0yajsdZu/s7wee079QRHj+Vd94Y8A6xrHhazuLnWobZtQd2jiktSzJhioydw68Hp3pAcdqVvN5jJPBp8W5OHjG7d9azzYajNbxfbba1+xwAleNuT25rt9N8Exq2oXet+I4ltdOuvsbiOBnUvgHqvPf0qj48tYtA1VtIv75EhAVwEBfzFIyDTA5i0W182BZFgnkYE7EbgL2rLe4vF1C4t42iRVbiTqirV231uLZLHZWEKMmVE2OSPYVBPqIvIo7e2spoyvMm4ffP4UgG2t/AyypNZSPucxmSI8N710WjaB9rtnkW2NsVXEZnHzc8cetZGl6vb2sU6f2ePMx8obsfpVmy8VX7wi11O4eFMFkKJnaKYF6LSW8LFbm8hRnByuJB8o9SKwdRvRqmptKl1K3ckjAJ9M+lbGm/2deW8873M1+iHL+Zxn6Vx13LZz3szW0M0OPuxnjaPWgDoLe8+yySNetHIcAJtPBNULl0hkFzNA9xGedoHB9hXOSXdwbwEQ5WP7mBnn1qTVJ7rzIftly8OBnGev4UhHRaRaSatMI0sYLTnczdWxVm8kGp6lb6do4WSKM/vJMHgisTw4+qXDy21hHOVlwpdVyWzXsuheD/7B0+Oe8gWHeN0jE/MBQBlaHoE4M4kjDqV+ZgMfh71c1gWXh/T4ZPspV0PyJxlmPc03X/GenWSRxWrhVXIVQfmZq4DVtcnjuhe3TCUJykbnOT2pjOq8+C/ia81tljVT8kecbvY1wuv3lrcTNJbx+Y+c7wMKvoKh1LxVLrUjJeSRRFV6RjhapadeRtEIlG6EDhQvzOfWkBmTPPOI7eKPbJu3eYOtTKltZ+ckMzS3Mo2mR+w74qYXSWs8k8zCNm+RVHLH2xWZfyTIy5i2ySHbGn8Rz3oEdF8N7Np/iHoaQHekd3FI7KOmG6VwsH/ACNFv/1+p/6MFezfD25tdA1jQrVI/M1C7uog7do1LD9a8ZiP/FTwH/p8X/0YKb+Fjfws+8oJP3a89q8U/aTfddeH/wDrnN/NK9egk+RfpXjP7Rj5udB/65zfzSrhuaU9zwDR5Li3vhcWyq5UfPGejL3q9q94LaXfZZSCXkxN2NZ8KG3eMluM4DAcj2NVr8sJCrMSc9CKgyEuLlZHDqCp7gdvpULzyNKJGbLDuajpKALJuN4+ZVyPbrUZIAJwpVu3pUVFAFu3kkjQnCuuMEMOQKYGdGbyQdp9qg/E5qaGYjCscLQBMbx2CqgPAwc8k11mgeIbODSzA73UFwO6DcCK4x9mNyttJ7UxHKENGSrDuDQB6fYeIY7WArFdCWMnklcdfUVBqkEEZWczSmE/MdhzgH2rhLK7SCRzcwGUOOoOCPeus8O67ZQQSfaojNDxlm+8o9KALuna5BYTqgd7+zJz8owU+tad/d3+p27z2tvIbbHyiI8/Wop7vw/q8f8AokUMOBjfu2kfUUmm6hBpkBt4vMXJ+WRXypoGO8Oo9veWxeHzVuMqyyKRgDv9a0tQlh0+6dbaRy4+dY3OB+FUNW13VdPgiLKTblg27ZkkexqKK8TU5ywmtRIwyEmU7vpQBMdTnES3LTJcRueE3c1qW+2WJrhra4Ryu5BIeGFUbOzntbWRZNNjurlmzGgOAPpWlFLc3lmbZ0SznK7T57ZCj0FAGZFcagYnuLC32tn5vLOQp9CK9I8O/E60n0bQ9Ov9Q8Q2mo6bI7XT2kcawzgvlUYs44C4HT1615qlrqen3H2e2OnKrf8ALx5vU/SqesQXKEpOWLn7xiYeWxpAeuz/ABIttN03Wo9Et4o7++vxcwIsaPDEu1Rzn+LjPA715LrPijWb7XJdS1KC3uLtj+8nccNxgD2wABgVl6PLdWdyrS3sCOWCgMN2wV0OsaqGlWO7ntbi1AwfLQLg+p96AKDajeX5eRktoiB92FBg/jRYa+1hBKdri5I25C5wPWq2pvYPB5mnN5UKjkB8FjVaziuFWFDdhVfMjbhyPagRo2V3LeWckqb7tnYn5U+bHv6VS1GaUxSMZZI1ZcMuc7cVqaHa2QtJ5Y737ON2d6sQW+gqksmmpLNa3YvG/jJbgNTGQ6GlhIu0X8/yDLYbAzVmQ26adKTvZy2DLnJ9sVgST2kcpGm25eYMRtJwp/Cum0nRtbvZLc3caiJj8sSDAH1pCKuguZ90H2mOGIcliuWNd34P+GQ8S3pvDGz2kXJurk7UH+NUb/QtP8O3ENxe3cFw7MGe1hPIHpmofHvxOu9UtI9KsY2trFMbIIX25x/ex1pjseha7rfhzwDam10Yw3+qsMPOrfJGfbHWvKPFfjW7nTcNUuZ5ZBho92VX6Vw2q6o8o3SDynPZTzWJHcsspfkk0Bfsbd7qr+ZBImXkj+YlucGk1LXZr1UCqfNxhmx0+lZbtclPMIKxk/MRUtpC8srSebtiXrIf5CkIv6crxSiR7dmfsG4z7mtGK/aWSXMywj7uyIc1iSak0TbIsqOhkbkn6VSjuPnfDMCeh/xoA25pTYytO2zOPkDcsPepNO1VZboSTx/MTtVVGXNUdNkimOZUMrjjJ5ya045YNJdjHGZbsgkuw4SgDufBaaheeL9EmkspXRL6HakMbMIl3Dl2AwPXmvK4wR4lhyMf6Yv/AKGK7L4W+MtftfGWkadZ6rdwWV5qUTXEMchCyZIByPcAD8K42Ny3iSIsST9sXr/vim/hY38LPtmCT5F+leP/ALQjFrnQsf3Jv5pXqcMvyLz2ryP4+yZuNE5/gl/mtVHcunueJWt+zQfZpYvNI+6cc1m3e8TEOGHpmtq0iLCOa3x5qHa6MORWu9lLdbIryKN8jIZRhx/jUmZw5GD1zSVs6xosti5MZ8yLrx1H1rIIxQA2ilooASlqzpi79StFNubndKg8gHHmfMPlz79Pxr6Z8Y3TeJvC/id/C+s6lo8Gn6e0l34a1TSlihgjVMFY22gI/GRgkk+3QA+XQSDmjOTX1NbHT5dKtvjC8dqWg8PPA8JVcHUlbyQSP9rcR06Yr5bkdpHZ3OWY5JPUmkBPLNM0KRuFCjocdaZ5Y8klXG7uuetQ5z1zx0ozTAfE3luGIyR2PQ1rxXs6wD7OjNAx+aJlyv4GsyJTLkK3bnNaVhq8unKUMKvGwwVLZpAdFoXiBrFjbTeYImHEM3zAf7pqa0mV9cDrEyDrl8YxXPWt5ay3yv5TvG33oyeR9Ku6gsAIlspMJ3SZ/mWmB0XiHWbi0uYBbS7wOcdB+dc5qXiSW7Yq0Yt5B1yc5qG5a4v4EikkYhOgVOD+NJa+GLm7JdFkkX0HJHsaBkOg3kou5pWkty2ODcE4H0rpoWtdTlU3l3HbxrgFuTv+g7Cqul+B7q7uFFzaTW6A89i30rpUtZNKSWxgRLdE4DXMQZzSEEmieD4jvs57+WccliMR5rmdahDyFxLBFk/IinJ+rCr9zp98EbmaeN+oJ2p+Fc5ELqK6aD7KWkJ4dlJ20xmmYPNeBb6ON4l5znbgetbEUGnoklyskcmVwsDE4GO9ZdvpN1cXUSJG80xGDHsOD712Vp8ONWLxXTBbOIcuZhgY9qQip4c1CFIt0VjbtcE/IQM4/CtQ+APFHiieW8gihit1H+sdwiirtpFo3hnEtwzXDryCn3SayPEXxVluYHtoPLSIfwLkLn6imMu2Wi6B4OAfWEGp6gpOwIQIwfr3rlvGPjbVWieC1aG1gc/diX5sfWuNudVd71ZQ7XGMnaScIfaq+pPJNH5pdmJ6k0guB1y7WFo43+99525Y/jWd50gbcW+f1703KBDkEt/KkRHkYBAWY9hQIe37xiQrM3UkmremabcX7N5AIRfvORwKsactnYTCTUw0jAZ8pT1+tWdV8TS3Vsba0ijtLXoI4xgn6mgCK+ezs7YW8chuZuhP8K1jyzO4Ck4UdFHQVGW5zSdaAAn1NGeMYpxQjGeCaaRg4NAGvpWqJZsruo+ToAOvvUd/qz3bvldqN1x1NZlPiKb8yglfQUAdP8NJdvxB8Nqidb+Hn/gYrIj/AORii/6+1/8AQxW78NbqOPx/4c8uNd738IyR0G4Vgr/yMMf/AF9r/wCh0+jD7LPsGGX5B9K8q+Or5uNG/wByX+a16RDL8g+leX/G590+j/7kv81qomkDyqyv5o7kyGIeb/EhGA1bWmeJIjMqzxjYD0P3kNYK7ssd6sCOV/wqh5ypc5lTBB4PepMz1aawttYiMli0TSFfuk4NcZ4i8MTW8PmxxHePvY6Gq1pq8UNxG0UjxOvRh0NdgurShBMWE0L9Q/INAzyl0KsVYYIpmK9XurLwzrUsUF1H/Z11J0njbKH61ieLPhtrGiJ9ohge6sSNyzxjKkUBY4VGaN1dGKupyGBwQfUVu6x4z8Tazp4sdW8Qare2YwfJnundTjoSCefxrEeNkYhgQR1BpmKQi8usamukNpS6hdjS2fzDaee3kl/7xTO3PHXFURjBznNGKSgBKUk4x6UUUwDtQuP4s0UUAX7RLdCjGUs3ZQMV3mjaDpWqWq+ZJJBddcMhIP415xEH8wBOCa9I8H3sltaGM325cY8pxgD8aQG6fDd2tuINNSKRejleCKLKx1DTnMDK0Uq/NlDkH61DZXl/c3jR2MZWRjgDJx9a1pdA8XW0Qubi3haLqZQ2Tj6Uxm/aNeajFbt9pV5lHKRsFI/OsufRFS8lk1/UE8stlIzJukH1xVCOW6vE2WBhlnTh1K7cGpIrNNyyX97Arn70bDLg0AbWkR6NHdFHku54WGFzgD8K3LG30G01VJGtXXPSNiGL++e1Yn2WO2bz5rBvIKjEivkH8Ko6n4i0pIJIoYiLlF9eVoA9Eu/HGmaZE40/w8kTYwJSgZmPt6VwniHxprN5bSf6JLCjHKtctwPwrl9N1XUnnDWMDjPQFslvzqp4x1G9uFMc0EiEdSJQefegDj/EV/qd2rveXe5A2AicLWPBNF9ndWba4GRgdTUuoTzDNuzR9OTnOaz47dmkUOQik/eNIRopqMUVv5UUW6Rup24rLmZmc549hV64t4IosrctLIeyLwPqaoNK5Xbnj0AoAIRHkmUnHtQkzRbvKOM9+9RmrFpbNcvtDBR6mgCuSSck5NJWtdaXDaR7prtC/ZFHNZmM4C9fQUANpVYr0ODU0ls8aAyEBj0XqahwO9ACtu6seTTeSaczFsU2gBKKeNuct+QpGIJPGPagDovht/yULw1/2EYf/QxWav8AyMEf/X0v/oddL8HNHl1b4gaQ0V3YW4s7mK4YXdwITIA4+WPP3n/2RXNkbdfXkf8AH0Oh/wBun0Y+jPqeKT5Bz2rzT4zvmfSf9yT+a130Unyj6V518X2zPpXP8En81qolwPMBaeeHkgO2QcvFnBH0rQs4YZYVW+AkQ8CVeq/Wu0h8MwapdyT3Y8t1/jiHP1xUGoeFEs900Ekdwq/e8s/My+4qSDlL3w9PZSCazxNGfmUr8w/Grmn3YlgeLcLeX+KJhwfcV0Hh3TRa3S3NnqP2dieI5RlGHoQeldqfC2k6mN2oRGwuX5WQfNC/0I6UCPMbaKVN0d1btLD3Kpnj1r0f4fapq2nRm30jUYr21/i0++5BHoCa5XxP4e8UeG599gDcWB+7JF86496l0O/ttRdY7ho4bxeuPkcGkB0/iLwp4X8UXbM1vN4e1U/fiYZiY+xrzvxD8Ltc0fzJPsz3dqOVmt/nGPfFd7qjz26RxXc4uIX4R2GSv1qbw9qes6JPvstXjaBTzF94FfQg0xng1zYSwFg4KleoYYNVCK9/8a3+i+IWjS/sxZzSHm5gjyufcV5v4m8A3umxNd2E0V9YHkSRHkfUdqQWOHxSd6kdGViGGCKZQIByfSnRglvuhh6Gm0gJB4NAGvYLahQXlVHz25xXfW1jZTWEcn2hHQ9STxivN7BJLmeNMrtB6svArqyt9p0Km0eKRSM7FTIpgjpLmazsbffpF1dMQPmx6e1Fpq+qxWrTRazMkbDKwv8AMT7YrmZJZ7hBKsP2eT+Pa+Afwqqyzrk/Nu6jLYoGdBPr+qRSC4aeEsvRYV2k/Ud6da+Jo2v1muTIA/3vNjxg+3rXKQTXEl15rrMAnG4DJ/CtXSvsLKs11eiO552/aeR19KQj0O98X2NzpvkwG26Yzk5ri01WJLiWJbY3UjD74TJ/Os+/El5dLHDLby56eWuFP41bW5u9KmRdOgUTEc/NkUxkyytLgx20q3SDI3Ps2/hWJqVpe3Bd2MMY6k+Zya2NVu7ye1J1BreAkcspG6uLu45LdiY5fOQ87uwpAQSRhJCJSwA7gU24lDuNucD1qJmLHkk02gQ4ux7mm0UUAKa2tFs7iaFnjQ7ezY6UzwzYi8vQWG5U5K4611euanFb2/2UKqR9CkIwfzoA4u+jVZG8xwWHYcmqaMVbKnHv6VcvblCx+yw+VGe7csfxqjQA4uQ2VY59aaTmkNGaACilpKACiirkNhNLGJAp8s98UAbPw1Qt8QvDXHA1GH/0MVln/kPL/wBfI/8AQ67v4fabFF4y8NDd8wvYW2+nzCuEk41wf9fI/wDQ6fRj6M+j45PlH0rz74sPum0z/ck/mtdnHJ8o5rhPii26bTv91/5iqiVA09B1BoEjaFzI6HBA5yK6O+0iz1lfOtx9mvANwKttyfcVyEenyQyLLHCyzofmMR6++K7PTbwXNj5d8VII+SYLtZD6GpJOH1fSrq1my0IbnIOTg+xrU0DUv7LYH7bJDbtxJZ3Xzxn/AHSelbkhuDLtt7gb+8cy5VxVPU5dPlVrPV7Ix5Gd8a5FAF9dVhtGafSrl4iwy9sTvif6Vka1Y2utjzTYmKQjPmIMEH2IqpHpM1nHv0m6int/4Vft7H0onuby1USQ3LwZ/wBZGo3BT6j2oAybqHWrNDbidrqJOQN3zgfSqEepmMP56SpMOkijBH1FdI+rgyob+G2vyV+WeEFJAPf1qtqINwnmWm11I6MuHWkBl6d4lgt51nKrMD8rrIMKa3o7nRtTDxQm7sTJ/FGcp+VcFrRbY5UMuP8AWRyJgfUVP4dvIbaNDcNI8RP8DYIH0oEdjf8AgyxvmFvboplCZLg8n3rzu+8LXttcypt+RTjdXs2gXvhq4WM/a7zzQM7QRn866S7i0G7tv9CunWfoftCDj8aY9z5hOmXDSMkSGQjg4qx/YeowKsj2rBT/AHhxXqOtaW0d4wuIra4IPyyQNsOKxdZZrKyYSrMIG4Ku24UhWOasLSaFGka0AdRklW4xU9vNBcRsy+asgz8u7iqFzqUUcPlQQhRjgqxzWPHMyuSCdx75xQBouJTNkIZRn7mTg10lpeXH2QRtocMkeOuTmuWtre+umIiYZ9NwGatQ2OrxyESCYgDnEnSgDTvJJ5V8uGcwHvHjkVQuvssduEkn3ydzIucmqt3LcwQmNy8ik/fYdPbNZhkIY7MgH15oA34tU+z2+IJokIHRV60un61IglEiJMzHg/dA/GufjG+RRIdqt1bFa7WMHkgxXMrKByCvBoAZqN+ZySWiB/uhc/rWW0rMCCxwe3appdsbFRlB6AcmkmZBFhYVB/vk8n8KAK1JS4z0HPtT40Yg4A49etADKkg8syr5udmecVetXDr5cjRAHqNvNW7mfbGkNrawAD+Mj5jQBej1NDEtrpccVlFj55Dy7VUvLN2LFhK6Y/1jtgGr2iabcACSS2G4878dBT9XUMDBbx+bIfvMx4/CmBylwGUhSQQPSmOUIGxSD3JqwYC8jKxSML1JNQsiBiFbcB3pARUU5FLMFVSxPYCuk0rwfqF7D58y/Z4OoLdT9KAOZHJq1Z2M93OIoY2Zj6CvRNL8BRLbi6upxFCvJLnBarQGnQLKtoqxjGAy8s1AWOb0/wAMxWmJ9R5UdE9a055YNq5QKBxHCg5+ppqq8hPnMyqOjMe1K8cQdVt8kt1c9aYzT8CedP4+0HEQWNLyIls/7Q4rzeX/AJDn/bz/AOzV6j4FMbeONDRMhVvYup6/MK8un/5DR/6+P/ZqOgfZZ7pHJ8orifiU+ZdP/wB1/wCYrqUk4Fcd8Qn3S2P+6/8AMU0OJ223KRy2sbxuB8rDmrEWoTSptuLTa5/jUcN9RXGWF9caWhEU7tGf+WcnOPpW1a6nLcQGSKQLKOw6fjSEaQeSXASQoyHIwOlOvdVmUBZIxIydxjJH0NYMt3fC4jlby1Yddp61JfatDqGFuAsVwvAJ4zQBdttbs5Lj/VmNTwyhetVr23N5cGTT5EYqeAeG+hFZiRQ7siVraQ9z8yH8abPc3FpcK86iU/wvH3pAMvVvopxEiqwByyDgr7ipGllgRWa4IGflLjofStCz1ezvTGb+1ljZT8s0Y/Q1e1HTbO++axcGFhh1H3s+tAHKalfx3OGvLEXCn5WkTjHuazjo9rePmxmVF7oTyK6CbwrdPEU067ZmBxskGDWPe6Le6VFK9xbYl9VypoALDS9VsyRHZySBTw205rZtdbtonCaw17bEcMFTINZPh/xjd6UUjnuruJM/8tV3rW7rviOLVLVWRbS7OP8AWQMFcf8AATQJFyRtP1GFVsdSintzwRJ8jJXM6/GdLVYRNHcQv0G7diuf1CWKQ5LpHJ/tDaf0rDnlljdlWXcD/dOaBkt/tDMCB14NUxJtPAB+ophYk8nNOGGHCnPtQIc07NjACn/Z4zVu2vbhVKx3AjGO5zVNVIkG0c/7VObljvA/4D2oAkllmLENcbvx4qseScnNKwXPyEkfSm0ASReYWXy+ce2cVLPNLn5pm3ei8CoEd0zsZhnrim8596AHbmPJOT705pPlwEQe4HNMB4I4/KkH40wFBI6HFKrOASpPPWmkVJBGshIaQIB60ATWoicnzvMz6g9K04msITG8Yd2zzsBLVlusKnG/cvt1NXbfZCEaOOXc3Qg8ikB039pyzWwgtY3tIu7Ocu1VJYz5ToGPI5djg1WSO/CF7e1bB/ic5Y1qaVo8mpShbh/KA5Yev40wOdltrWOzfgmXPDE1RgSW4kWGMD5uMKK9Hu/C2jWyb5pTNL2jRs1Rkt0tF3WlssI9TyaQzb8I+HdP0xI5LlftN23IjQZx9a6LVL2Dy/3rpEicBFFcNDqlzAnyeYSerniniSS7dS5MmPXhVpgjYu9Tt5IyArv/ALT8/kKzUvbe3jK2doN56ySdvpTZTDEC0synHRR3NVOZMHldx6t6UgJrVxPI5kjaVzwCeAKrTRNHM2/IPbBrQA8uPbEwLfTgVVMTO+QCx7saAOx+FkXh7+3NN/tOXV01QXqeQtskRhbpjeWO7rnOO1eM3O3+2m25/wCPjv8A71en+BGK+NtCAK/8fsQA/wCBCvLrn/kMP/13/wDZqf2Q+yz1tZeBya5Px2+6Sy5/hf8AmK31k4Fcx40fMlp9G/pQhomFx5w+YZUfmKs20qoBsJWQ/ddT19jVVmjMecc+oHIpqfKhZBuxyaBG39ojaIGUP5qHlc9agnvLe6Voym09iwrMnuWldGkPI4DL/WpoRE52h0y38D8Z+lAGjaWkaorR3AY/xROeDUgmSImNojEeowcg1WtYraNlVwUcdAzf1q0LQT7hJHtX+Fg2QaAKZVXd2cuhzyFPBqeHzbZfPsbzd6xvwaI7FnJQKGxxy3NQfZTY3BEuyUddjHB/A0gN+wvJb2dJZLplkAwVJwK3HN28TLcXQEDcZkTcB+NceJVaUCF/syOMEP0Na+nXg08ASSGVTwQTuQ0wM/WPCKtG0sdws3OQU5H5VzVx4ciMZbahcdTGdp/Ku5vL23jBmt7GRQerQycflXOXOLndJbsUY9VK8/nQBytxow8vcJZUXplxkfnWZcaXPANy5ceqiusmSbHls0uD1GOKjmtWjGC5YdipxikI4d0ZT8ysD7im9K7J4FYfOA/1prWtiw/e2vI9DQByBZmPJJpWcsADjit+ays3ciOCRPr0qnPYIJ1WLFAGVkjpRW4NHjPLPz6A4xTZ9HSO3Mqy7gBkAdfxpgYtFaum6Wt5HlpAnvVs6PDEcM7H8KAOfqzBbeZyZY1Hpnmt57KwtoNzIzt6L1qzb21iiq32YkN13CgDlWgYOQgLj1FWIbS6/gjH5V1sy24T93CEUdjUajaB5WDnsBSAxbLRLiTmVkiX1xk1v6VpNrFOMLLOe7A1PGSFHnuNv91etW476THk2kP2dDwWT5nagDdht/MVFChPRB1/GnXemONqlkIbkkHp9abonh9LiQG5F2WbqQTuP+FdFqel6Lp9sschKP6NJuJpjOXisYIEkmS4ikC8bcVkXMqOxGzp3zW7qJtmjAtkVYx07ZrLMMEhwXBJ9O1IDJmdWjYbsEdKNNiujy+ET1c4/SrssttbEraQbmHWSTn8qw7trl7vzmI8n+J3OB9BQI1ZoLYyFhOZJB/dHApg3yP8uWx0z2qCORCgLD5T0A71YDgKdpCL3bpQATO8YAkI+hPFLJcuyBd2R7DArOW3mnvvMUtMo+6D0rQjt5HlAkZS4/gXtQBu+BDt8aaAAF/4/Yuf+BCvLbv/AJC8n/Xc/wDoVeo+CI2Tx1oWeP8ATYuP+BCvLbz/AJCsn/XY/wDoVPoV0PQ1l4Fc94tfc9r9G/pWmJeKw/Er7nt/o39KEJF7IVvvYzTvPKAhcqT19DUbjA6EfqKURnOc7l74oAmUKFy8YYH0qkVjnnLQM/yHlGHSrLfKoMbEj0p8L5bJBz34waQhBMcDJOR6jIrQs9QmhB8ojb3XHSqLKhbMTlT6GnSNJjPyE+oPNAGt/aVncf8AH3BNDIP+WsXT8RURu0lYRSSq6/wswwazVk8xdpOCeuOKSS3EKhncOmO/NMDUurcLGGMsbIvOxufyq9prWLRq4KgDqOuK5CBR5zFJ5fLP8HUCtC2nNu+4BgOhK0gOy1NJDY77ZYJYz12Ng4+lc6lzZ2Z80PcQsfvDG5aqTSLM4a0mIbuualEqpFtu4ZgT/wAtE5FMY6R7e7XzLS/Uv/d6ZqpMG/5aqGPqrU2TZE+6MquejMnWqsgLtu3j32ikIsSxLwdzgCoGRc5ick0wAh+JCR6E07BBzGBmgBxgkxkc+uTwKjNnmQPmN2HYVOJGKngj6Cocvu3Aj69KAF8pyx+VB7d6ZNtjRx8ucc4NOV3ckKisR1NPkMhG0JkDuRQBX05SyFkcKPcVYnRuCZCfwpqKOu9c/wB0DFKMsxBZjjsBQA1oyycyLGPU01I1JAEhkI7g8VLsMnD4b2NOG+FuBGg7KVxQAqRpt+c89gDUkSAkKZNi+rdKhSFnYtxk9+1OYAd2OPyoAmD2sUoMkomwf4RXUWWv6ZaW4Npaw/acYDspODXKwBZJArqW/wBkcCtYXb20Yjgt4VPTJGTTA2oNRvJ4XuG1RUY8eXEuKr253S7nJkY9WftWekbXO1rgysO0cC4/Otm3tYpY/Lisp3453NgCgYl0DdR+VaYZsfMQvH51zlxbPbTcyKzfxYNdHdt9ng8hmS3i/wCecbfMfqayXFlsYCTMnaOPn8zSAyZnRnwq8/XNVtQg+1RLGeSOmTwK0Jlt/JKx8SGqoiKdX59uaBEAtnt41DMWPqBxUyReYgMqFiOinp+NOYkHLknHqelSRO1whSEN7mgBA9wRsifYOnyDgVd00nm3sY2mlJ+aTH9agFqSu0ux9hwPxqc6jDZ2/wBnt8u/cpwKBnS+C7a3tvGuiefL5tybyP5UOQvzd68bvv8AkKS/9dj/AOhV7H8KdT+x+MrAS2FhcfaZo4R9qh8wxZYfOhyNr+/NeOX5zqc3A/1p6fWn0H9k6gSVk66+5ofof6VZEvFZ2rPuaL6GhCR0DZYEMpA9RRsSPBfdg/xLUiyIWwN2PQ0sqsq/LhhQBHlQfmyy/wB4USlVUEMTSmNfL3KTvHVDUMio65BZGHVWFIBwmVRk/qKf9pjUZdfl9cdKYpIj55FRgjkEUCJpJoG+8eOzAVDcEQxb0mO09wNwpvlv1QY+nNPUTLhgg298f4UALacsJGUf70Y4P4VpK6NkMv58Zqn50Y42sPccU6OfnaSX9N4oAaXSKckKKvrKhj+7Ihx65FU2f58FFHtil+0zcxqqlffg0ARTl1RyrMfQnnFR28ziMGd9zeoFMmzyJmIU9hRuKxhVh246P1zQBKZFY5DL+XNMkYjktx7daZG8n8ZUj12806QDGd24+4oAcku7mPfj3FOkyyfdGfWokXfyX2GnZx8rynHqKAHxKY+SvWnhjzkg/wBKi6/cbgd2NGQBhjk+uKAHBVbmR8H6UgAzw2F9e9INg53AmnrcIOsauaAHJKmcfNkd1FBw7ZLlv97mombJ3geUD6UjykgYTI9QKAJ22bDkkH2rOkvUacQlHGP4jVtXY/eUKPQ9TVG7KpcqSqKT3NAGtbNG+0IGHvWis0EMR8xxk9B1NY0fKDdLge3FPh8tX3eYGHpQBeOozxSAw7lWpm1m8dPLaeTH9xaoFs5ORj2qF3Kj90RnvgUATzySH76bc9y2SakimMcBEJVWNUss/Uj3JqOR+yj8qAJyyh8FsuepFKDg4TA9T1NNgCk5l/LFSeY4U+TGuPUjpQA1zkYA+rGnxM4RijnA9OKhEcjnk5P6UwbkfG4/hQBbaS5mjCM2xPbqafGgiGYxkjuelMiQkAs30Hc1buYJYYlMqEK3QUDNPwHvbxxoLOf+X2L/ANCFeX6h/wAhKf8A66n+demeBuPHGgFm/wCX2LAz/tCvMtQ/5CE//XRv50+g+hoebVS/fcU/GmebUNw+SKRJuQXDwkYJZfrV0X6lhvIAPrWzr/w68U6ZqkttBoesXkaBSJ4tNl2tlQxxgHoTjr2rPk8DeK5VBfwvr2R6adN/8TQApkEoBGD+NOLErhxkD2zT4fBfi2PG3wvr5H/YOmH/ALLWjF4W8UKAG8L6+D/2Dpjn/wAdoAym2lcEAj2qvznHSums/BHim9uoYYvDesI8rhA01lLGgJ7liuAPc0kvgjxRG5H/AAjut5BxxYSkf+g0Ac2I5PvRsCR+FP8ANYjEiLn+8K6FvBvigLlvDOtMfUafN/8AE0i+DfE2Mjw1rgPodPm/+JoA587ccpn1BFCpGRwMD0refwZ4mblfDmvKw7f2fNg/+O1d0j4eeJNQkuhNour2ghtpJ1aWxl/eMo4jHA5Pb+VAHKsExgF1oJIXhwwrdHgzxQowfDOt/UWE3/xNRt4Q8WI2B4a1zae/9nSn/wBloAxJJPMXBTbj3pkciopxvwe1b/8AwhnilhlvDetH3GnTA/8AoNJ/whnijOP+Ea13Hvp03/xNAGANhUsof6U/assJXaBn35ro4PAXip7aa4/4R3V1iiZUKmzlDktnBC7ckcckdOPWoZ/BnigD5fDOtt7jT5s/+g0AYKQoI9hJHvmo3iROp3iukj8GeJtvzeGdcB/7B83/AMTTf+EL8Tg8eF9d/wDACb/4mgDnlWIgYJFTqkJGSHb6Vtf8IV4l7+Gte/8ABfN/8TV24+H3iODSrK8j0TWZJbhpA8AsJd8W0gAtx3zkcDpQBzAjjLD+VPeAIu4fK3YYrXHgzxSxz/wjOugjv9gm/wDiacPBnipvveG9dP1sJv8A4mgDm5pxboXlGfbvTra8jmTcufpmtm/8C+KJYGVPDWu5/wCwdN/8TUGmeB/FcEe1/DOtkD/qHTZ/9BoApO7YGxhk9sdKytYhYmORuOerdK7q48DeKrSVFk8N6u4eNZB5VnI+AwyASF4PqOoPBqteeCvEdzGEk8Ma9tH/AFD5v/iaAOb+ZrQCMBsr1HNUtOjKFlfdkHpXWx+D/E0aiOHwrr/1Onzf/E1Th8HeMEvmVvDGuhD3GnTY/PbQBS24A3BuemabJLsAQEMPYV09r4H8Sz3MMUvh/W0EjqhdrCXCAnGT8vQdaNX8A+JLDVLu0t9E1m5SKVo1nj06XbIASAwwp4OM9aAOXMibdoX5qfCjKv8ACPw5rYHhDxZ5wT/hGNbCj+L+zpv/AImrDeC/FBXjw5rp/wC3CYf+y0AYjRsR2Apv7w8K2FHet5fB3igDH/CM639TYTf/ABNWrTwN4rvJxBH4e1VG2s2ZrOSNcAEnkrjPHA7njvQM5oOAMMxxSEqfmAH1rbl8HeJVGW8Na83sunTf/E1Vl8LeK2UpF4V15F99Om/+JoEZpuEjGS4B7U241RXQBg7v/eY1N/whPi7cT/wi+vknu2nzf/E0f8IT4tLZfwvrxA7DTpv/AImgC14CufO8eeHxg4+3w/8AoQrgdR/4/wC4/wCujfzr2H4aeAfEbeJ7TULzR9UsIrC5t5ds1jKvmgyAHBIGMDk+wrx/U0Zb+5yCD5jdven0K6FYsaaWJoIpKRJt/wDCbeLB08U+IP8AwZT/APxVL/wm3iz/AKGnxB/4M5//AIqiigA/4TbxZ/0NXiD/AMGc/wD8VR/wm3izH/I0+IP/AAZz/wDxVFFAAfGvis/8zT4g/wDBlP8A/FUn/Ca+K/8AoafEH/gyn/8AiqKKAD/hNfFf/Q0+IP8AwZT/APxVH/CbeLP+hp8Qf+DKf/4qiigBf+E28Wf9DT4g/wDBlP8A/FUn/Ca+KzjPinX/APwZT/8AxVFFAw/4TbxZ/wBDT4g/8GU//wAVR/wm3iz/AKGnxB/4Mp//AIqiigBf+E28Wf8AQ0+IP/BlP/8AFUn/AAm3iz/oafEH/gyn/wDiqKKAD/hNfFec/wDCU+IP/BlP/wDFUf8ACbeLP+hp8Qf+DKf/AOKoooAP+E28Wf8AQ0+IP/BlP/8AFUv/AAm3iz/oafEH/gyn/wDiqKKAE/4TbxZ/0NPiD/wZT/8AxVA8a+K8/wDI0+IP/BlP/wDFUUUCF/4TbxZ/0NPiD/wZT/8AxVH/AAm3iz/oafEH/gyn/wDiqKKYB/wm3iz/AKGnxB/4Mp//AIqj/hNvFn/Q0+IP/BlP/wDFUUUgEHjXxWOninxB/wCDKf8A+Kpf+E28Wf8AQ0+IP/BlP/8AFUUUAH/CbeLP+hp8Qf8Agyn/APiqP+E28Wf9DT4g/wDBlP8A/FUUUAH/AAmviv8A6GnxB/4Mp/8A4qj/AITXxWP+Zp8Qf+DKf/4qiigBf+E28Wf9DT4g/wDBlP8A/FUf8Jr4r/6GnxB/4Mp//iqKKAE/4TXxX/0NPiD/AMGU/wD8VR/wmvis9fFOv/8Agyn/APiqKKAD/hNvFn/Q0+IP/BlP/wDFUv8Awm3iz/oafEH/AIMp/wD4qiigA/4TbxZ/0NPiD/wZT/8AxVH/AAm3iz/oafEH/gyn/wDiqKKYxG8aeKmGG8Ua+QeMHUpv/iqwnkd2Jd3Yk5JLEk0UUgG5PqaKKKBH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the uniform gray parenchyma of the body of the pancreas (BP) without lobulations. The main pancreatic duct (PD) is uniform in diameter and measures less than 2 mm. The adjacent structure is the splenic vein (SV).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael B Wallace, MD, MPH. SV BP PD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic pancreatitis seen on endoscopic ultrasound",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 333px; height: 306px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chronic pancreatitis seen through endoscopic ultrasound. Note the lobulated parenchyma (Lob), hyperechoic strands (HS), and irregular main pancreatic duct (PD).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Michael B Wallace, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24087=[""].join("\n");
var outline_f23_33_24087=null;
var title_f23_33_24088="ERCP for pancreatic disease in children";
var content_f23_33_24088=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"17\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   ERCP for pancreatic disease in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Moises Guelrud, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24088/contributors\">",
"     George D Ferry, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24088/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/33/24088/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic retrograde cholangiopancreatography (ERCP) has changed the approach to the diagnosis and management of pancreatic disorders in adults. It remains an underutilized technique in children despite accumulating experience since the mid-1980s in the use of ERCP for a variety of indications.",
"   </p>",
"   <p>",
"    The pancreatic disorders that can be evaluated by ERCP are described here. The use of ERCP for biliary disorders in children and the technique, success, and complications of ERCP in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20536?source=see_link\">",
"     \"ERCP for biliary disease in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/45/4822?source=see_link\">",
"     \"ERCP in children: Technique, success and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5495726\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic retrograde cholangiopancreatography (ERCP) should be considered for all patients with pancreatitis for which an anatomical cause is suspected. Potential indications for ERCP in children with pancreatitis are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef72692 \" href=\"UTD.htm?13/38/13931\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prior to considering ERCP, specific non-anatomical causes of pancreatitis should be explored. These include systemic diseases (including inflammatory conditions and cystic fibrosis), drug-induced pancreatitis, and blunt trauma to the pancreas. In recurrent or chronic pancreatitis, hereditary causes should be explored through genetic screens for cationic trypsinogen (PRSS1), SPINK 1, cystic fibrosis transmembrane conductance regulator (CFTR) and chymotrypsinogen C (CTRC) mutations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37288?source=see_link&amp;anchor=H7#H7\">",
"     \"Hereditary pancreatitis\", section on 'Genetic testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42727?source=see_link&amp;anchor=H9#H9\">",
"     \"Causes of chronic pancreatitis in children and adolescents\", section on 'Genetic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Imaging with abdominal computerized tomography (CT) or magnetic resonance cholangiopancreatography (MRCP) is important to establish the extent of the pancreatitis. Some experts suggest MRCP prior to consideration of ERCP for most patients with chronic or recurrent pancreatitis because MRCP is less invasive. Others have suggested endoscopic ultrasound (EUS) which is particularly useful for diagnosing gallbladder sludge, pancreas divisum, congenital biliary anomalies, duodenal duplication cyst, and chronic pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/2\">",
"     2",
"    </a>",
"    ]. On the other hand, ERCP has the advantage of offering therapeutic interventions, such as sphincterotomy and stent placement. Therefore, ERCP is appropriate for patients in whom a treatable anatomic anomaly has been identified or is strongly suspected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link&amp;anchor=H23#H23\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in children\", section on 'Pancreatography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical manifestations and diagnosis of chronic pancreatitis in children\", section on 'Ultrasonography (US)'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Special expertise in performing ERCP in infants and children is not widely available. In centers in which this expertise is available, ERCP is often appropriate for evaluating patients with anatomic pancreatic disorders (",
"    <a class=\"graphic graphic_table graphicRef66925 \" href=\"UTD.htm?30/3/30779\">",
"     table 2",
"    </a>",
"    ). However, the risks and benefits of ERCP depend on individual patient characteristics including age, associated medical comorbidities, and whether an anatomic abnormality identified on noninvasive testing is likely to be treatable with therapeutic ERCP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Unexplained acute or recurrent pancreatitis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Recurrent pancreatitis &ndash; Approximately 10 percent of children with acute pancreatitis will have recurrences [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/3\">",
"       3",
"      </a>",
"      ]. If noninvasive testing (computerized tomography [CT] or magnetic resonance cholangiopancreatography [MRCP]) and genetic testing for hereditary pancreatitis (PRSS1) is unrevealing, we suggest proceeding to ERCP. ERCP can identify an underlying anatomic abnormality in up to 75 percent of children with recurrent pancreatitis in whom non-anatomical causes have been excluded [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/4-14\">",
"       4-14",
"      </a>",
"      ], and in up to 25 percent of those with normal MRCP findings [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/15\">",
"       15",
"      </a>",
"      ]. Various anatomic conditions have been associated with recurrent pancreatitis, which can be categorized as congenital or acquired (",
"      <a class=\"graphic graphic_table graphicRef66925 \" href=\"UTD.htm?30/3/30779\">",
"       table 2",
"      </a>",
"      ). The major diagnoses within these categories will be reviewed below. &nbsp;",
"     </li>",
"     <li>",
"      First attack of pancreatitis &ndash; After a first attack of pancreatitis, the first step is noninvasive testing (typically ultrasound, followed by MRCP or CT). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In children in whom noninvasive testing reveals a cause that is potentially treatable via ERCP, it is appropriate to proceed to therapeutic ERCP.",
"     </li>",
"     <li>",
"      In children in whom the noninvasive test is unrevealing, expert opinion varies about whether to perform an ERCP after an initial attack of pancreatitis. In our practice, we generally perform an ERCP in such patients, because ERCP may reveal an anatomic cause that can be treated, and we believe that the risk of morbidity associated with recurrence probably outweighs the risk of ERCP. Other experts do not generally perform an ERCP in such patients, reasoning that the likelihood of finding an endoscopically treatable abnormality is low when noninvasive imaging is normal. Reliable statistics for estimating the risks and benefits of each of these approaches are not available. The relative merits of ERCP versus MRCP for evaluating common bile duct stones in adults are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link&amp;anchor=H9#H9\">",
"       \"Magnetic resonance cholangiopancreatography\", section on 'Common duct stones'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12294874\">",
"    <span class=\"h1\">",
"     ERCP FINDINGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Congenital anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several congenital biliary and pancreatic anomalies have been associated with pancreatitis in children, some of which are potentially amenable to therapeutic intervention during ERCP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Biliary cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary cysts are cystic dilatations that may occur singly or in multiples throughout the bile ducts. They originally were termed choledochal cysts (involving the extrahepatic bile duct), but the clinical classification was revised in 1977 to include intrahepatic cysts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/47/9977?source=see_link\">",
"     \"Biliary cysts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20536?source=see_link\">",
"     \"ERCP for biliary disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A biliary cyst is identified in 6 to 18 percent of cases of acute pancreatitis in children [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/4-7,9,10,13,14,16\">",
"       4-7,9,10,13,14,16",
"      </a>",
"      ]. Most children with biliary cysts and pancreatitis have an anomalous pancreaticobiliary junction (APBJ, also known as an anomalous pancreaticobiliary union, ABPU) in which the pancreaticobiliary union is located outside the duodenal wall (",
"      <a class=\"graphic graphic_figure graphicRef51092 graphicRef62147 \" href=\"UTD.htm?14/9/14488\">",
"       figure 1A-B",
"      </a>",
"      ). This anomaly has been associated with sphincter of Oddi dysfunction. The predisposition of patients with APBJ to pancreatitis might be explained by the sphincter of Oddi dysfunction, or might be caused by retrograde flow of bile into the pancreatic duct [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/17-21\">",
"       17-21",
"      </a>",
"      ]. (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sphincter of Oddi dysfunction\"",
"      </a>",
"      ). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Therapeutic ERCP is helpful for most patients with biliary cysts and pancreatitis. As an example, in a study of nine children with recurrent pancreatitis and APBJ with a long common channel, sphincter of Oddi dysfunction was suggested by the observation of high basal sphincter pressures. Endoscopic sphincterotomy was successful in preventing further recurrences in 89 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/18\">",
"     18",
"    </a>",
"    ]. Children with a choledochocele (in which the cyst is located within the duodenal wall) may also benefit from sphincterotomy (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77426 \" href=\"UTD.htm?6/54/7008\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/14,22-25\">",
"     14,22-25",
"    </a>",
"    ]. In other patients with biliary cysts, pancreatitis may be due to pancreatic stones or plugs, which can be removed endoscopically (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63089 \" href=\"UTD.htm?19/30/19938\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Pancreas divisum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreas divisum is the most common congenital anomaly of the pancreas and is caused by failure of fusion of the dorsal and ventral endodermal buds. As a result, each duct drains via its own orifice. The major papilla of Vater drains the ventral duct of Wirsung, while the minor accessory papilla drains the dorsal duct of Santorini (",
"    <a class=\"graphic graphic_figure graphicRef78995 \" href=\"UTD.htm?18/24/18822\">",
"     figure 2",
"    </a>",
"    ). Pancreas divisum occurs in approximately 7 percent of individuals in autopsy series [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=see_link\">",
"     \"Anatomy and clinical significance of pancreas divisum\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The association between pancreas divisum and pancreatitis is controversial, since many patients with pancreas divisum (identified during ERCP for indications other than pancreatitis or in autopsy studies) do not have a history of pancreatitis. Indeed, only about 5 percent of individuals with pancreas divisum develop pancreatic symptoms (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=see_link&amp;anchor=H4#H4\">",
"     \"Anatomy and clinical significance of pancreas divisum\", section on 'Clinical manifestations'",
"    </a>",
"    ). However, the rate of pancreas divisum is somewhat higher among patients with recurrent pancreatitis than in the general population. As an example, pancreas divisum has been found in approximately 11 percent of 296 children with recurrent pancreatitis reported in the published literature [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/4,5,7-10,13,14,27,28\">",
"     4,5,7-10,13,14,27,28",
"    </a>",
"    ]. In our own experience with 272 consecutive successful ERCPs performed for a variety of indications, pancreas divisum was found in nine (3.3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/29\">",
"     29",
"    </a>",
"    ]. The prevalence was considerably higher (12 percent) among the 50 children older than one year who had recurrent pancreatitis. These observations suggest but do not prove that pancreas divisum is associated with recurrent pancreatitis in children, but also confirm that most patients with pancreas divisum do not develop pancreatic disease. &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Endoscopic treatment of pancreas divisum is generally reserved for patients whose symptoms are recurrent and disabling. The treatment typically consists of sphincterotomy of the minor papilla, with or without placement of a stent. Clinical improvement with such treatment has been observed in up to 75 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/9,14,30\">",
"     9,14,30",
"    </a>",
"    ]. The results are less favorable in children with evidence of chronic pancreatitis in the dorsal pancreas. Individuals with pancreas divisum but no dilation of the dorsal duct (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51844 \" href=\"UTD.htm?12/33/12817\">",
"     image 3",
"    </a>",
"    ) are more likely to respond to endoscopic therapy than those with pancreas divisum and a dilated dorsal duct (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72695 \" href=\"UTD.htm?33/57/34705\">",
"     image 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15271?source=see_link\">",
"     \"Treatment of pancreas divisum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Other pancreatic congenital anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports have described an association between annular pancreas (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60402 \" href=\"UTD.htm?40/28/41423\">",
"     image 5",
"    </a>",
"    ) and recurrent pancreatitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/14,31,32\">",
"     14,31,32",
"    </a>",
"    ]. However, whether there is a causal relationship remains uncertain, since many of the reported cases of annular pancreas (in adults and children) had coexistent pancreas divisum [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/31\">",
"     31",
"    </a>",
"    ]. Several other anomalies have been described in association with pancreatitis including \"short pancreas\" (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82484 \" href=\"UTD.htm?25/54/26479\">",
"     image 6",
"    </a>",
"    ), cystic dilation of the pancreatic duct, and pancreatocele (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef60893 \" href=\"UTD.htm?11/15/11504\">",
"     image 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/14,33\">",
"     14,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Duodenal duplication cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports have described pancreatitis in association with a duodenal duplication cyst, presumably due to intermittent obstruction of the pancreatic duct [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. ERCP can be helpful for establishing the diagnosis and for definitive treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/34\">",
"     34",
"    </a>",
"    ]. If the cyst is bulging into the intestinal lumen, a wide cystoduodenostomy can be endoscopically performed with excellent results [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/36\">",
"     36",
"    </a>",
"    ]. The appearance of a duplication on endoscopic ultrasound is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1242?source=see_link\">",
"     \"Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acquired diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main acquired diseases associated with acute pancreatitis in children are parasitic infections, biliary pancreatitis, certain medications, systemic inflammatory conditions, and possibly sphincter of Oddi dysfunction. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Parasitic infestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis is occasionally seen as a complication of infestation with Ascaris lumbricoides (",
"    <a class=\"graphic graphic_picture graphicRef74270 \" href=\"UTD.htm?13/62/14305\">",
"     picture 1",
"    </a>",
"    ) or other parasites among children living in endemic areas. In most cases, the pancreatitis is caused by migration of the worm into the bile duct, causing transient obstruction of the papilla of Vater. Less commonly, the worm migrates into the main pancreatic duct, causing recurrent pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/37\">",
"     37",
"    </a>",
"    ], or rarely causing necrotizing pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/38\">",
"     38",
"    </a>",
"    ]. Worms can sometimes be removed endoscopically [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/6/42087?source=see_link\">",
"     \"Endoscopic diagnosis and management of biliary parasitosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Sphincter of Oddi dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the cause of sphincter of Oddi dysfunction is not known precisely, it is generally considered to be an acquired disorder. It was found in 12 percent of children (17 of 139) with recurrent pancreatitis described in a series of published reports [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/9,14,16,30\">",
"     9,14,16,30",
"    </a>",
"    ]. In children with recurrent pancreatitis and no other identifiable cause, we explore the possibility of sphincter of Oddi dysfunction during ERCP by performing sphincter of Oddi manometry (SOM). No pediatric-specific standards have been developed for SOM, so results are evaluated using adult standards, in which basal pressures &gt;40 mmHg are considered abnormal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/40\">",
"     40",
"    </a>",
"    ]. Because of the lack of pediatric-specific standards for SOM and the risk of triggering acute pancreatitis, some experts do not perform this test in children. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical manifestations and diagnosis of sphincter of Oddi dysfunction\", section on 'Sphincter of Oddi manometry'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An association between SOD and recurrent pancreatitis in children has not been fully established, and limited information is available about outcomes of sphincterotomy in these patients. If SOM reveals an elevated sphincter pressure in a child with recurrent pancreatitis, sphincterotomy leads to clinical improvement in a majority of patients. Biliary sphincterotomy alone may not be sufficient to treat such patients, presumably because the pancreatic sphincter is not transected [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/30,41\">",
"     30,41",
"    </a>",
"    ]. Thus, dual sphincterotomy may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/14,42\">",
"     14,42",
"    </a>",
"    ]. However, the safety and efficacy of this approach has not been well studied. Either manometry or sphincterotomy can trigger an episode of acute pancreatitis; the risk is probably higher after pancreatic than biliary sphincterotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/30,43\">",
"     30,43",
"    </a>",
"    ]. In one series, 20 to 30 percent of children developed pancreatitis after endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29126?source=see_link\">",
"     \"Treatment of sphincter of Oddi dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatitis is a recognized complication of human immunodeficiency virus (HIV) infection in children and adults. Most cases are associated with use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/38/14952?source=see_link\">",
"     didanosine",
"    </a>",
"    or other medications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. Opportunistic infections may involve the pancreas [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/45\">",
"     45",
"    </a>",
"    ]. The most common are Cytomegalovirus and Cryptosporidium, followed by Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium. ERCP may permit ductal decompression in children who have developed stricturing due to infections [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/3/63?source=see_link&amp;anchor=H10#H10\">",
"     \"Evaluation of abdominal pain in the HIV-infected patient\", section on 'Pancreatitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CHRONIC PANCREATITIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956054\">",
"    <span class=\"h2\">",
"     Diagnostic ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic retrograde cholangiopancreatography (ERCP) can be helpful for identifying chronic pancreatitis in children with recurrent attacks of pancreatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/4,8,14,30,49\">",
"     4,8,14,30,49",
"    </a>",
"    ]. Two major morphological patterns of chronic pancreatitis can be demonstrated (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42727?source=see_link&amp;anchor=H4#H4\">",
"     \"Causes of chronic pancreatitis in children and adolescents\", section on 'Phenotypic'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic calcifying pancreatitis (most often due to hereditary pancreatitis, fibrosing pancreatitis, autoimmune pancreatitis, or juvenile tropical pancreatitis).",
"     </li>",
"     <li>",
"      Chronic obstructive pancreatitis, which is associated with congenital or acquired lesions of the pancreatic duct, or biliary tree similar to those etiological factors found in recurrent pancreatitis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64898 \" href=\"UTD.htm?9/33/9759\">",
"       image 8",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some of the specific causes of chronic pancreatitis can be identified with laboratory evaluation, genetic tests, and noninvasive imaging including magnetic resonance cholangiopancreatography (MRCP). ERCP is an alternative to MRCP for patients in whom a treatable anatomic anomaly is known or strongly suspected, as discussed above. (See",
"    <a class=\"local\" href=\"#H5495726\">",
"     'Initial evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H956039\">",
"    <span class=\"h2\">",
"     Therapeutic ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic pancreatitis, abdominal pain, and a dilated main pancreatic duct are candidates for a decompression procedure. Decompression can be accomplished by therapeutic ERCP or by a variety of surgical procedures.",
"   </p>",
"   <p>",
"    A role of endoscopic therapy in treatment of chronic pancreatitis is evolving. The only established indication for therapeutic ERCP in children with chronic pancreatitis is for treating abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/1\">",
"     1",
"    </a>",
"    ]. ERCP may be used to remove intraductal stones, dilate strictures, and for pancreatic sphincterotomy, maneuvers which can improve drainage of the pancreatic duct and improve the pain (",
"    <a class=\"graphic graphic_picture graphicRef61617 \" href=\"UTD.htm?5/5/5202\">",
"     picture 2",
"    </a>",
"    ). A few reports in children have suggested that these approaches can be performed safely in expert hands and may relieve symptoms, at least in the short term [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/1,11,14,16,22,30,44\">",
"     1,11,14,16,22,30,44",
"    </a>",
"    ]. At present, endoscopic therapy should only be performed in specialized centers, preferably in the context of a clinical study. &nbsp;",
"   </p>",
"   <p>",
"    The role of endoscopic versus surgical intervention has not been well established in either adults or children. In a series of 37 children with chronic pancreatitis, those managed by surgical therapy had a lower rate of recurrent pancreatitis and hospitalization as compared with those managed by endoscopic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/50\">",
"     50",
"    </a>",
"    ]. Some of the patients in this series responded to surgical therapy after failing therapeutic ERCP. Most experience in surgical procedures for chronic pancreatitis is in adult patients, as described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31369?source=see_link&amp;anchor=H15#H15\">",
"     \"Treatment of chronic pancreatitis\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PANCREATIC PSEUDOCYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic pseudocysts are common consequences of acute and chronic pancreatitis. While most small cysts resolve spontaneously, symptomatic, large (&gt;4 cm) pseudocysts are unlikely to resolve and may be associated with complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/51\">",
"     51",
"    </a>",
"    ]. Such cysts have traditionally been drained surgically or percutaneously.",
"   </p>",
"   <p>",
"    Endoscopic methods have developed as an alternative to surgical and percutaneous drainage. These methods include cystgastrostomy, cystoduodenostomy, and transpapillary drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/1\">",
"     1",
"    </a>",
"    ]. In adults, successful pseudocyst resolution has been reported in approximately 80 percent of cases (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef53245 \" href=\"UTD.htm?12/58/13216\">",
"     image 9",
"    </a>",
"    ). Results have been similar in children, although experience is limited to a few case reports and case series [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/52-55\">",
"     52-55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/53/39766?source=see_link\">",
"     \"Endoscopic management of pseudocysts of the pancreas: Efficacy and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PANCREATIC TRAUMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic retrograde cholangiopancreatography (ERCP) can be safely performed in patients with nonresolving traumatic pancreatitis and may be helpful in identifying the need for surgery or permitting endoscopic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/56-58\">",
"     56-58",
"    </a>",
"    ]. Early ERCP can identify the presence and location of duct leakage. Patients with normal ductograms can be treated conservatively while those with duct disruption can be treated with an intrapancreatic stent, thereby reserving surgery for those in whom stenting is unsuccessful [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24088/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5493583\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic retrograde cholangiopancreatography (ERCP) should be considered for all patients with pancreatitis for which an anatomical cause is suspected that might be treated endoscopically; potential indications for ERCP in children with suspected pancreatic disease are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef72692 \" href=\"UTD.htm?13/38/13931\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5495726\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prior to considering ERCP, specific non-anatomical causes of pancreatitis should be excluded. These include systemic diseases (including inflammatory conditions and cystic fibrosis), drug-induced pancreatitis, and blunt trauma. In recurrent or chronic pancreatitis, hereditary causes should be explored. Imaging with abdominal computerized tomography (CT), magnetic resonance cholangiopancreatography (MRCP), or endoscopic ultrasound (EUS) is important to establish the extent of the pancreatitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=see_link\">",
"       \"Clinical manifestations and diagnosis of chronic pancreatitis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Expert opinion varies about whether to perform an ERCP after an initial attack of pancreatitis in children in whom the noninvasive test is unrevealing. In some centers, ERCP is performed in such patients. In other centers, ERCP is performed only if the pancreatitis is recurrent. &nbsp;(See",
"      <a class=\"local\" href=\"#H2\">",
"       'Unexplained acute or recurrent pancreatitis'",
"      </a>",
"      above.) &nbsp; &nbsp;",
"     </li>",
"     <li>",
"      In 6 to 18 percent of cases of acute pancreatitis in children, a biliary cyst is responsible. Most such children have an anomalous pancreaticobiliary junction (APBJ) in which the pancreaticobiliary union is located outside the duodenal wall (",
"      <a class=\"graphic graphic_figure graphicRef51092 graphicRef62147 \" href=\"UTD.htm?14/9/14488\">",
"       figure 1A-B",
"      </a>",
"      ). This anomaly is associated with sphincter of Oddi dysfunction. Therapeutic ERCP is helpful for most of these patients. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Biliary cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pancreas divisum occurs in approximately 7 percent of individuals. It is more common among children with recurrent pancreatitis. However, most patients with pancreas divisum do not develop pancreatic disease. Endoscopic treatment of pancreas divisum is generally reserved for patients whose symptoms are recurrent and disabling. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pancreas divisum'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other congenital anomalies that may be associated with pancreatitis include annular pancreas, \"short pancreas\", cystic dilation of the pancreatic duct, pancreatocele, and duodenal duplication cysts. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Other pancreatic congenital anomalies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Duodenal duplication cysts'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sphincter of Oddi dysfunction is found in approximately 10 percent of children with recurrent pancreatitis, but a causal association has not been established. The diagnosis is established by performing manometry during ERCP. Sphincterotomy of both the biliary and pancreatic sphincters improves symptoms in some but not all patients with abnormal manometry results. However, sphincterotomy performed for this purpose also frequently triggers an episode of acute pancreatitis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Sphincter of Oddi dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children with chronic pancreatitis, the only indication for therapeutic ERCP is abdominal pain. ERCP may be used to remove intraductal stones, dilate strictures, and for pancreatic sphincterotomy, maneuvers which can help decompress the pancreatic duct and improve the abdominal pain. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Chronic pancreatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endoscopic treatment of large pancreatic pseudocysts or pancreatic trauma is based on experience in adults. These disorders also are amenable to endoscopic treatment in children. Appropriate patient selection and a high level of expertise in therapeutic ERCP are essential. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Pancreatic pseudocysts'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Pancreatic trauma'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/1\">",
"      Fox VL, Werlin SL, Heyman MB. Endoscopic retrograde cholangiopancreatography in children. Subcommittee on Endoscopy and Procedures of the Patient Care Committee of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2000; 30:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/2\">",
"      Varadarajulu S, Wilcox CM, Eloubeidi MA. Impact of EUS in the evaluation of pancreaticobiliary disorders in children. Gastrointest Endosc 2005; 62:239.",
"     </a>",
"    </li>",
"    <li>",
"     Whitcomb D. Hereditary and childhood disorders of the pancreas, including cystic fibrosis. In: Gastrointestinal and Liver Disease, 7th ed, Feldman M, Friedman LS, Sleisenger MH (Eds), Saunders, Philadelphia 2002. p.881.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/4\">",
"      Brown KO, Goldschmiedt M. Endoscopic therapy of biliary and pancreatic disorders in children. Endoscopy 1994; 26:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/5\">",
"      Buckley A, Connon JJ. The role of ERCP in children and adolescents. Gastrointest Endosc 1990; 36:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/6\">",
"      Cotton PB, Laage NJ. Endoscopic retrograde cholangiopancreatography in children. Arch Dis Child 1982; 57:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/7\">",
"      D&iacute;t&egrave; P, Vacek E, Stefan H, et al. Endoscopic retrograde cholangiopancreatography in childhood. Hepatogastroenterology 1992; 39:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/8\">",
"      Graham KS, Ingram JD, Steinberg SE, Narkewicz MR. ERCP in the management of pediatric pancreatitis. Gastrointest Endosc 1998; 47:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/9\">",
"      Lemmel HR, Sherman S, Lehman G. Endoscopic evaluation and therapy of recurrent pancreatitis and pancreaticobiliary pain in the pediatric population (abstract). Gastrointest Endosc 1994; 40:A54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/10\">",
"      Putnam PE, Kocoshis SA, Orenstein SR, Schade RR. Pediatric endoscopic retrograde cholangiopancreatography. Am J Gastroenterol 1991; 86:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/11\">",
"      Poddar U, Thapa BR, Bhasin DK, et al. Endoscopic retrograde cholangiopancreatography in the management of pancreaticobiliary disorders in children. J Gastroenterol Hepatol 2001; 16:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/12\">",
"      Blustein PK, Gaskin K, Filler R, et al. Endoscopic retrograde cholangiopancreatography in pancreatitis in children and adolescents. Pediatrics 1981; 68:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/13\">",
"      Forbes A, Leung JW, Cotton PB. Relapsing acute and chronic pancreatitis. Arch Dis Child 1984; 59:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/14\">",
"      Guelrud M, Mujica C, Jaen D, et al. The role of ERCP in the diagnosis and treatment of idiopathic recurrent pancreatitis in children and adolescents. Gastrointest Endosc 1994; 40:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/15\">",
"      Lucidi V, Alghisi F, Dall'Oglio L, et al. The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians. Pancreas 2011; 40:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/16\">",
"      Brown CW, Werlin SL, Geenen JE, Schmalz M. The diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in children. J Pediatr Gastroenterol Nutr 1993; 17:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/17\">",
"      Mori K, Nagakawa T, Ohta T, et al. Pancreatitis and anomalous union of the pancreaticobiliary ductal system in childhood. J Pediatr Surg 1993; 28:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/18\">",
"      Guelrud M, Morera C, Rodriguez M, et al. Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept. Gastrointest Endosc 1999; 50:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/19\">",
"      Misra SP, Dwivedi M. Pancreaticobiliary ductal union. Gut 1990; 31:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/20\">",
"      Sugiyama M, Haradome H, Takahara T, et al. Biliopancreatic reflux via anomalous pancreaticobiliary junction. Surgery 2004; 135:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/21\">",
"      Sugiyama M, Atomi Y, Kuroda A. Pancreatic disorders associated with anomalous pancreaticobiliary junction. Surgery 1999; 126:492.",
"     </a>",
"    </li>",
"    <li>",
"     Guelrud M, C-LD, Fox VL. ERCP in pediatric practice: Diagnosis and treatment, Isis Medical Media Ltd, Oxford, UK 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/23\">",
"      Greene FL, Brown JJ, Rubinstein P, Anderson MC. Choledochocele and recurrent pancreatitis. Diagnosis and surgical management. Am J Surg 1985; 149:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/24\">",
"      Weisser M, Bennek J, H&ouml;rmann D. Choledochocele--a rare cause of necrotising pancreatitis in childhood. Eur J Pediatr Surg 2000; 10:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/25\">",
"      Siegel JH, Harding GT, Chateau F. Endoscopic incision of choledochal cysts (choledochocele). Endoscopy 1981; 13:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/26\">",
"      Stimec B, Bulaji M, Korneti V, et al. Ductal morphometry of ventral pancreas in pancreas divisum. Comparison between clinical and anatomical results. Ital J Gastroenterol 1996; 28:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/27\">",
"      Portwood MA, Jowell PS, et al. Diagnostic and therapeutic ERCP in children: safe with a high success rate in experienced hands (abstract). Gastrointest Endosc 1995; 41:A342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/28\">",
"      Manegold BC, Pescatore P. Diagnostic and therapeutic ERCP in children under 14 years (abstract). Gastrointest Endosc 1996; 43:A328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/29\">",
"      Guelrud M. The incidence of pancreas divisum in children. Gastrointest Endosc 1996; 43:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/30\">",
"      Hsu RK, Draganov P, Leung JW, et al. Therapeutic ERCP in the management of pancreatitis in children. Gastrointest Endosc 2000; 51:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/31\">",
"      Lehman GA, O'Connor KW. Coexistence of annular pancreas and pancreas divisum--ERCP diagnosis. Gastrointest Endosc 1985; 31:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/32\">",
"      Yogi Y, Shibue T, Hashimoto S. Annular pancreas detected in adults, diagnosed by endoscopic retrograde cholangiopancreatography: report of four cases. Gastroenterol Jpn 1987; 22:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/33\">",
"      Rosenstock E, Achkar E. A \"short pancreas\". Gastrointest Endosc 1986; 32:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/34\">",
"      Holstege A, Barner S, Brambs HJ, et al. Relapsing pancreatitis associated with duodenal wall cysts. Diagnostic approach and treatment. Gastroenterology 1985; 88:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/35\">",
"      Lavine JE, Harrison M, Heyman MB. Gastrointestinal duplications causing relapsing pancreatitis in children. Gastroenterology 1989; 97:1556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/36\">",
"      Johanson JF, Geenen JE, Hogan WJ, Huibregtse K. Endoscopic therapy of a duodenal duplication cyst. Gastrointest Endosc 1992; 38:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/37\">",
"      Krige JE, Lewis G, Bornman PC. Recurrent pancreatitis caused by a calcified ascaris in the duct of Wirsung. Am J Gastroenterol 1987; 82:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/38\">",
"      Maddern GJ, Dennison AR, Blumgart LH. Fatal ascaris pancreatitis: an uncommon problem in the west. Gut 1992; 33:402.",
"     </a>",
"    </li>",
"    <li>",
"     Guelrud M. Endoscopic retrograde cholangiopancreatography in the infant. In: Advanced therapeutic endoscopy, Barkin J (Ed), Raven Press, New York 1990. p.335.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/40\">",
"      Guelrud M, Mendoza S, Rossiter G, Villegas MI. Sphincter of Oddi manometry in healthy volunteers. Dig Dis Sci 1990; 35:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/41\">",
"      Guelrud M, Siegel JH. Hypertensive pancreatic duct sphincter as a cause of pancreatitis. Successful treatment with hydrostatic balloon dilatation. Dig Dis Sci 1984; 29:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/42\">",
"      Varadarajulu S, Wilcox CM. Endoscopic management of sphincter of Oddi dysfunction in children. J Pediatr Gastroenterol Nutr 2006; 42:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/43\">",
"      Jang JY, Yoon CH, Kim KM. Endoscopic retrograde cholangiopancreatography in pancreatic and biliary tract disease in Korean children. World J Gastroenterol 2010; 16:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/44\">",
"      Cheng CL, Fogel EL, Sherman S, et al. Diagnostic and therapeutic endoscopic retrograde cholangiopancreatography in children: a large series report. J Pediatr Gastroenterol Nutr 2005; 41:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/45\">",
"      Miller TL, Winter HS, Luginbuhl LM, et al. Pancreatitis in pediatric human immunodeficiency virus infection. J Pediatr 1992; 120:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/46\">",
"      Butler KM, Venzon D, Henry N, et al. Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine. Pediatrics 1993; 91:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/47\">",
"      Van Dyke RB, Wang L, Williams PL, Pediatric AIDS Clinical Trials Group 219C Team. Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in HIV-infected children. J Infect Dis 2008; 198:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/48\">",
"      Yabut B, Werlin SL, Havens P, et al. Endoscopic retrograde cholangiopancreatography in children with HIV infection. J Pediatr Gastroenterol Nutr 1996; 23:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/49\">",
"      G&uuml;itr&oacute;n A, Adalid R, Barinagarrementer&iacute;a R, et al. [Endoscopic cholangiopancreatography (ERCP) in pediatric patients]. Rev Gastroenterol Mex 1998; 63:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/50\">",
"      Iqbal CW, Moir CR, Ishitani MB. Management of chronic pancreatitis in the pediatric patient: endoscopic retrograde cholangiopancreatography vs operative therapy. J Pediatr Surg 2009; 44:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/51\">",
"      Beebe DS, Bubrick MP, Onstad GR, Hitchcock CR. Management of pancreatic pseudocysts. Surg Gynecol Obstet 1984; 159:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/52\">",
"      Kozarek RA, Christie D, Barclay G. Endoscopic therapy of pancreatitis in the pediatric population. Gastrointest Endosc 1993; 39:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/53\">",
"      Sharma SS, Maharshi S. Endoscopic management of pancreatic pseudocyst in children-a long-term follow-up. J Pediatr Surg 2008; 43:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/54\">",
"      Haluszka O, Campbell A, Horvath K. Endoscopic management of pancreatic pseudocyst in children. Gastrointest Endosc 2002; 55:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/55\">",
"      Theodoros D, Nikolaides P, Petousis G. Ultrasound-guided endoscopic transgastric drainage of a post-traumatic pancreatic pseudocyst in a child. Afr J Paediatr Surg 2010; 7:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/56\">",
"      Hall RI, Lavelle MI, Venables CW. Use of ERCP to identify the site of traumatic injuries of the main pancreatic duct in children. Br J Surg 1986; 73:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/57\">",
"      Rescorla FJ, Plumley DA, Sherman S, et al. The efficacy of early ERCP in pediatric pancreatic trauma. J Pediatr Surg 1995; 30:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24088/abstract/58\">",
"      Canty TG Sr, Weinman D. Treatment of pancreatic duct disruption in children by an endoscopically placed stent. J Pediatr Surg 2001; 36:345.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5868 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-30319E2B35-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24088=[""].join("\n");
var outline_f23_33_24088=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5493583\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5495726\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Unexplained acute or recurrent pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12294874\">",
"      ERCP FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Congenital anomalies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Biliary cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Pancreas divisum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Other pancreatic congenital anomalies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Duodenal duplication cysts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acquired diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Parasitic infestation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CHRONIC PANCREATITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956054\">",
"      Diagnostic ERCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H956039\">",
"      Therapeutic ERCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PANCREATIC PSEUDOCYSTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PANCREATIC TRAUMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5493583\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5868\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5868|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/54/7008\" title=\"diagnostic image 1\">",
"      Choledochocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?19/30/19938\" title=\"diagnostic image 2\">",
"      APBU with stone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/33/12817\" title=\"diagnostic image 3\">",
"      Panc divisum normal duct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/57/34705\" title=\"diagnostic image 4\">",
"      Pancreas divisum with dilation of the dorsal duct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/28/41423\" title=\"diagnostic image 5\">",
"      Annular pancreas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?25/54/26479\" title=\"diagnostic image 6\">",
"      Short pancreas ERCP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/15/11504\" title=\"diagnostic image 7\">",
"      Pancreatocele",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/33/9759\" title=\"diagnostic image 8\">",
"      Chronic pancreatitis ERCP child",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/58/13216\" title=\"diagnostic image 9\">",
"      Pancreatic pseudocyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5868|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/24/37249\" title=\"figure 1A\">",
"      Normal versus anomalous pancreaticobiliary junction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/16/23812\" title=\"figure 1B\">",
"      Types of APBJ",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/24/18822\" title=\"figure 2\">",
"      Anatomy embryology pancreas div",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5868|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/62/14305\" title=\"picture 1\">",
"      ERCP ascaris infestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/5/5202\" title=\"picture 2\">",
"      Decompression of the pancreatic duct",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5868|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/38/13931\" title=\"table 1\">",
"      ERCP for pancreatic disorders in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/3/30779\" title=\"table 2\">",
"      Anatomic causes pancreatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/22/3431?source=related_link\">",
"      Anatomy and clinical significance of pancreas divisum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/47/9977?source=related_link\">",
"      Biliary cysts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42727?source=related_link\">",
"      Causes of chronic pancreatitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/60/28616?source=related_link\">",
"      Clinical manifestations and diagnosis of chronic pancreatitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=related_link\">",
"      Clinical manifestations and diagnosis of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20536?source=related_link\">",
"      ERCP for biliary disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/45/4822?source=related_link\">",
"      ERCP in children: Technique, success and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/6/42087?source=related_link\">",
"      Endoscopic diagnosis and management of biliary parasitosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/53/39766?source=related_link\">",
"      Endoscopic management of pseudocysts of the pancreas: Efficacy and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/13/1242?source=related_link\">",
"      Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/3/63?source=related_link\">",
"      Evaluation of abdominal pain in the HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/26/37288?source=related_link\">",
"      Hereditary pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31369?source=related_link\">",
"      Treatment of chronic pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/58/15271?source=related_link\">",
"      Treatment of pancreas divisum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/28/29126?source=related_link\">",
"      Treatment of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_33_24089="Epidemiology of nontuberculous mycobacterial infections";
var content_f23_33_24089=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology of nontuberculous mycobacterial infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24089/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24089/contributors\">",
"     David E Griffith, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24089/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24089/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24089/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24089/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/33/24089/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycobacteria other than M. tuberculosis and M. leprae are generally free-living organisms that are ubiquitous in the environment (",
"    <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"     table 1",
"    </a>",
"    ). They have been recovered from surface water, tap water, soil, domestic and wild animals, milk, and food products [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. These organisms can also inhabit body surfaces or secretions without causing disease. Thus, occasional isolates of nontuberculous mycobacteria (NTM) were largely considered contaminants or colonizers until the second half of this century. However, as tuberculosis declined and modern microbiological methods were developed, the importance of NTM in human disease became increasingly evident.",
"   </p>",
"   <p>",
"    In broad terms, NTM cause four distinct clinical syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressive pulmonary disease especially in older persons caused primarily by M. avium complex (MAC) and M. kansasii",
"     </li>",
"     <li>",
"      Superficial lymphadenitis, especially cervical lymphadenitis, in children caused mostly by MAC, M. scrofulaceum, and, in northern Europe, M. malmoense and M. haemophilum; the most common cause in adults, however, is M. tuberculosis",
"     </li>",
"     <li>",
"      Disseminated disease in severely immunocompromised patients",
"     </li>",
"     <li>",
"      Skin and soft tissue infection usually as a consequence of direct inoculation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The epidemiology of NTM will be reviewed here. An overview of NTM in HIV-negative and HIV-positive patients, as well as the pathogenesis, microbiology, diagnosis, and treatment of NTM infections are presented separately. Rapidly growing NTM infections in HIV-negative patients, Mycobacterium avium complex infections in HIV-infected patients, and NTM infections in solid organ transplant candidates and recipients are also discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link\">",
"     \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=see_link\">",
"     \"Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=see_link\">",
"     \"Pathogenesis of nontuberculous mycobacterial infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=see_link\">",
"     \"Microbiology of nontuberculous mycobacteria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=see_link\">",
"     \"Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2441?source=see_link\">",
"     \"Treatment of nontuberculous mycobacterial infections of the lung in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=see_link\">",
"     \"Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FREQUENCY OF DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common nontuberculous species causing human disease in the United States are the slowly growing species of the M. avium complex (MAC) and M. kansasii. Less common human pathogens include the slowly growing species M. marinum, M. xenopi, M. simiae, M. malmoense, and M. ulcerans, and the rapidly growing species M. abscessus, M. fortuitum, and M. chelonae.",
"   </p>",
"   <p>",
"    The precise frequency of disease due to the different species of NTM is unknown. Determining the incidence and prevalence of NTM lung disease is difficult because disease reporting is not mandatory in the United States or in many other countries, and there must be an assessment of the clinical significance of individual NTM isolates. \"Isolation prevalence\" for NTM isolates has been used as a surrogate for disease prevalence, although the clinical significance of a specific NTM isolate may be uncertain.",
"   </p>",
"   <p>",
"    A nationwide survey of 32,000 mycobacterial isolates (not patients) reported to the US Centers for Disease Control and Prevention (CDC) in 1979 to 1980 revealed that approximately one-third were NTM [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/6\">",
"     6",
"    </a>",
"    ]. The most commonly recognized species were MAC (61 percent), M. fortuitum complex (19 percent), and M. kansasii (10 percent). Most of the reported isolates were from respiratory specimens. A second study, covering the period 1981 to 1983, revealed a similar distribution [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/7\">",
"     7",
"    </a>",
"    ]. The prevalence of NTM disease in North America during the 1980s was",
"    <span class=\"nowrap\">",
"     1.8/100,000",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By the early 1990s, laboratories in the United States informally reported that approximately two-thirds of recovered mycobacterial species were NTM and only one-third were M. tuberculosis. Some of this increase relates to the high incidence of disseminated MAC disease in patients with AIDS. Disseminated NTM disease occurred in 5.5 percent of AIDS cases reported to the CDC from 1981 to 1987, 96 percent of which were due to MAC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There appears to be a general trend towards increased isolation of NTM in several geographic areas and other patient populations as well, as illustrated by the epidemiologic data below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The CDC published the results of NTM isolates voluntarily reported by state public health laboratories to the Public Health Laboratory System database from 1993 to 1996 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/5\">",
"       5",
"      </a>",
"      ]. The source of these isolates included sputum (75 percent), blood (5 percent), skin and soft tissue (two percent) and lymph nodes (0.4 percent). The most frequently reported potentially pathogenic NTM were MAC, M. fortuitum and M. kansasii. Regionally, NTM species were reported most often from the southeast United States. These results must be interpreted with caution, as there was no verification of clinical significance of the reported isolates.",
"     </li>",
"     <li>",
"      A study reported the \"isolation prevalence\" of pulmonary NTM isolates from Ontario, Canada between 1997 and 2003 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/9\">",
"       9",
"      </a>",
"      ]. The isolation prevalence of all NTM species (excluding M. gordonae) was 9.1 per 100,000 in 1997 and rose to 14.1 per 100,000 in 2003, with an average annual increase of 8.4 percent. Again, the association between NTM isolates and disease was not demonstrated, but the study concluded that isolation prevalence of pulmonary NTM had significantly and rapidly increased in Ontario and that a sizable proportion of patients likely had disease.",
"     </li>",
"     <li>",
"      An editorial suggested that determining the number of patients who experience clinical illness and undergo therapy for NTM lung disease in any given time frame (ie, prevalence) may be the most accurate way to assess the burden of NTM infections on the community and health system [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/10\">",
"       10",
"      </a>",
"      ]. While the estimated incidence of NTM lung disease in the US and Canada may be less than the much better documented incidence of tuberculosis, patients with NTM disease usually suffer longer periods of clinical illness prior to diagnosis and respond less well to therapy than tuberculosis patients due to the need for much longer treatment courses and lower treatment success rates. The authors suggested that the symptomatic disease duration for pulmonary NTM disease may be an order of magnitude higher than for tuberculosis. Thus, the contemporary prevalence of pulmonary NTM disease in regions such as the US and Canada may be as much as 10 times greater than the prevalence of tuberculosis.",
"     </li>",
"     <li>",
"      Using mycobacterial culture data from electronic laboratory databases from four health care delivery systems in the US (southern California, Seattle, Denver, and Pennsylvania) and US census data, the prevalence of NTM pulmonary disease was calculated [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/11\">",
"       11",
"      </a>",
"      ]. The average annual site-specific prevalence between 2004 and 2006 was 1.4 to 6.6 per 100,000. Prevalence was 1.1- to 1.6-fold higher in women. In the two sites where trends were evaluated, a significant increase in prevalence was observed; the prevalence rose by 2.6 percent per year in women and by 2.9 percent per year in men. Among individuals &ge;60 years of age, annual prevalence rose from 19.6 per 100,000 during 1994-1996 to 26.7 per 100,000 during 2004-2006.",
"     </li>",
"     <li>",
"      In a preliminary laboratory-based epidemiologic study that included 933 patients from Oregon with cultures positive for NTM in 2005-2006, the prevalence of pulmonary NTM cases was 5.6 cases per 100,000 population (6.4 cases per 100,000 women and 4.7 cases per 100,000 men) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a subsequent clinical study of Oregon residents between 2005 and 2006 who had at least one respiratory NTM isolate, 407 individuals from the Portland metropolitan area were identified, 283 (70 percent) of whom had evaluable clinical records [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/13\">",
"       13",
"      </a>",
"      ]. Among those with records, 134 (47 percent) met the criteria outlined by the American Thoracic Society and the Infectious Diseases Society of America",
"      <span class=\"nowrap\">",
"       (ATS/IDSA)",
"      </span>",
"      for pulmonary NTM disease. The minimum estimate of 2-year period prevalence was 8.6 per 100,000 in the general population and 20.4 per 100,000 for individuals &ge;50 years of age. The median age was 66 years, and 59 percent of individuals were female. M. avium complex was responsible for 88 percent of cases. Eighty-six percent of patients who met the",
"      <span class=\"nowrap\">",
"       ATS/IDSA",
"      </span>",
"      microbiologic criteria also met the full",
"      <span class=\"nowrap\">",
"       ATS/IDSA",
"      </span>",
"      disease criteria, suggesting that laboratory-based surveillance using microbiologic criteria is a relatively sensitive method for detecting clinical cases of NTM disease in epidemiologic studies [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/14\">",
"       14",
"      </a>",
"      ]. This study is particularly significant since the authors correlated clinical data with microbiologic data from individual patients; this methodology was feasible due to the limited study population size and the relatively well controlled laboratory referral patterns in the population. This type of study provides the best available data for estimating NTM disease prevalence.",
"     </li>",
"     <li>",
"      In a study of pulmonary NTM cases in Queensland, Australia (where NTM disease is a notifiable condition), the incidence of cases rose from 2.2 per 100,000 population in 1999 to 3.2 per 100,000 in 2005 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a population-based study including patients who received treatment for NTM respiratory isolates between 1990 and 2006 in British Columbia, Canada, episodic increases in the number of NTM isolates and incidence rates of subjects colonized with MAC were attributed to an artifact due to implementation of new laboratory techniques. The incidence rates of NTM decreased over time during the study period [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of NTM lymphadenitis conducted among children in the Cleveland, Ohio area, the number of cases of disease increased steadily from 1958 to 1990 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/17\">",
"       17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=see_link&amp;anchor=H2272512904#H2272512904\">",
"       \"Overview of nontuberculous mycobacterial lymphadenitis in children\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon the available data, it appears likely that the burden of NTM disease has been underestimated and has been increasing in the United States and other developed countries as the prevalence of TB disease has been decreasing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to adults, the predominant NTM disease in children is cervical lymphadenitis due to MAC and M. scrofulaceum and cutaneous disease due to M. marinum and M. ulcerans [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/18\">",
"     18",
"    </a>",
"    ]. Rare cases of disseminated disease have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    NTM strains are commonly isolated from sputum in patients with cystic fibrosis and may be clinically significant. In a study from 21 cystic fibrosis centers in the US, NTM were isolated from the sputum of 13 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=see_link\">",
"     \"Cystic fibrosis: Antibiotic therapy for lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22990476\">",
"    <span class=\"h1\">",
"     HOST SUSCEPTIBILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many risk factors for nontuberculous mycobacterial (NTM) diseases are specific to the clinical syndrome or the species. However, a number of inherited and acquired defects in the host immune response, particularly those that affect the Th1 cell and macrophage pathway, have been associated with increased susceptibility to NTM infections in general. Many of these host immune defects are associated especially with disseminated infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis of nontuberculous mycobacterial infections\", section on 'Host response to MAC infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These defects are discussed in further detail elsewhere and include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Interferon gamma receptor deficiencies (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link&amp;anchor=H3#H3\">",
"       \"Mendelian susceptibility to mycobacterial diseases (MSMD)\", section on 'Interferon gamma receptor deficiencies'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Signal transducer and activator of transcription 1 (STAT1) deficiency (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link&amp;anchor=H9#H9\">",
"       \"Mendelian susceptibility to mycobacterial diseases (MSMD)\", section on 'STAT1 deficiency'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Auto-antibodies to interferon gamma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=see_link&amp;anchor=H673461#H673461\">",
"       \"Mendelian susceptibility to mycobacterial diseases (MSMD)\", section on 'Differential diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      CD4 lymphopenia due to HIV or other causes (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"       \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=see_link\">",
"       \"Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/19/30009?source=see_link&amp;anchor=H15#H15\">",
"       \"Idiopathic CD4+ lymphocytopenia\", section on 'Mycobacteria'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Use of TNF-alpha inhibitors, particularly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39303?source=see_link\">",
"       adalimumab",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24169?source=see_link&amp;anchor=H20#H20\">",
"       \"Tumor necrosis factor-alpha inhibitors and mycobacterial infections\", section on 'Risk of nontuberculous mycobacterial infections'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MYCOBACTERIUM AVIUM COMPLEX",
"    </span>",
"    &nbsp;&mdash;&nbsp;The members of the Mycobacterium avium complex (MAC) are ubiquitous, free-living organisms readily recovered from natural reservoirs including soil and water, domestic and wild animals, and foodstuffs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/22\">",
"     22",
"    </a>",
"    ]. Environmental MAC isolates and clinical isolates belong to different serovars [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/23\">",
"     23",
"    </a>",
"    ]. However, mycobacteria can become aerosolized from aqueous sources, and the more easily aerosolized strains are often phenotypically the same as those that cause pulmonary infections [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Isolates similar or identical to clinical isolates have also been recovered from naturally occurring surface water, hot tubs, and piped hot water systems [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/23,26-28\">",
"     23,26-28",
"    </a>",
"    ]. Prolonged exposure to soil has also been identified as a risk factor for MAC infection in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/29\">",
"     29",
"    </a>",
"    ]. A study demonstrated that rRNA gene sequences from NTM were enriched to high levels in many showerhead biofilms, supporting previous theories that showers may represent another potential source of MAC infection in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike M. tuberculosis, there are no convincing data demonstrating human-to-human transmission of infection. Thus, the concept prevails that these organisms are acquired from the environment. Furthermore, environmental exposure to these organisms must be common because data from several countries showed that a substantial fraction of children have delayed cutaneous hypersensitivity responses to MAC antigens, a fraction that increases with age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/31-33\">",
"     31-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A smaller survey of skin test reactivity to M. intracellulare antigen was reported from the National Health and Nutrition Examination Surveys (NHANES) comparing results from 1971 to 1972 with 1999 to 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/34\">",
"     34",
"    </a>",
"    ]. Between these two time periods, the prevalence of M. intracellulare sensitization increased from 11.2 to 16.6 percent. The authors concluded that from 1999 to 2000, an estimated one in six persons in the US demonstrated M. intracellulare sensitization, up from one in nine persons from 1971 to 1972. They felt that the observed rising prevalence of sensitization was consistent with observed increases in rates of pulmonary NTM isolates in the US [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Frequency of disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The geographic distribution of skin test reactivity to MAC is not uniform. A survey of skin test reactivity to a MAC antigen among 275,000 naval recruits who had lived their entire lives in a single county showed skin test reactivity to be most frequent among recruits from the southeastern and gulf coast states (",
"    <a class=\"graphic graphic_figure graphicRef56050 \" href=\"UTD.htm?18/30/18922\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/35\">",
"     35",
"    </a>",
"    ]. In these areas, more than 70 percent of individuals had been exposed to or infected with MAC or an antigenically similar organism.",
"   </p>",
"   <p>",
"    More recent dual skin test studies have been conducted among healthy individuals in the United States using M. avium sensitin, a reagent that has been shown to be both sensitive and specific in distinguishing past disease due to M. avium from past disease due to M. tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/36\">",
"     36",
"    </a>",
"    ]. Among 784 subjects from the northern and southern United States, 40 percent of US-born subjects had M. avium-dominant reactions consistent with prior infection with M. avium or other NTM; M. avium-dominant reactions were found in 46 percent of subjects from southern sites and 33 percent from northern sites. Cross reactions due to NTM were found to be responsible for the majority of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    reactions in the 5 to 14 mm range [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since MAC is not a reportable disease, precise prevalence and incidence data are not available. Data on the frequency of isolating these organisms from clinical specimens were presented above [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/6,7,38\">",
"     6,7,38",
"    </a>",
"    ]. One survey estimated that 3000 cases of MAC pulmonary disease occurred annually in the United States in the early 1980s; similar rates of pulmonary MAC disease have been reported from Switzerland and Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although rigorous data are lacking, there is widespread impression that the frequency of MAC lung disease may be increasing, as discussed above.",
"   </p>",
"   <p>",
"    Two major clinical syndromes of MAC lung disease are recognized:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Disease in those with known underlying lung disease, primarily white, middle-aged or elderly men, often alcoholics",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      smokers with underlying chronic obstructive pulmonary disease. MAC lung disease has also been described in adolescents or adults with cystic fibrosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Disease in those without known underlying lung disease predominantly in nonsmoking women over age 50 who have interstitial patterns on chest radiography. For reasons that are unclear, this is the form of MAC lung disease most likely encountered by clinicians in the US and Canada. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two other less common forms of MAC lung disease have been described:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A hypersensitivity pneumonitis syndrome most frequently reported in association with hot tub use (\"hot tub lung\"). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      One report noted an unexpectedly high frequency (78 of 244 patients) of MAC pulmonary infections presenting as solitary pulmonary nodules, which resembled lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/40\">",
"       40",
"      </a>",
"      ]. Another smaller study showed similar findings [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/41\">",
"       41",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=see_link&amp;anchor=H3#H3\">",
"       \"Overview of nontuberculous mycobacterial infections in HIV-negative patients\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Disseminated disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disseminated NTM (particularly MAC) disease primarily occurs in severely immunocompromised patients, such as those with AIDS. It is thought to arise from infection of a mucosal surface (gut or lung), followed by local multiplication and entry into the bloodstream with seeding of other organs and tissues. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=see_link\">",
"     \"Pathogenesis of nontuberculous mycobacterial infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to the widespread use of highly active antiretroviral therapy and mycobacterial antibiotic prophylaxis, disseminated MAC was very common among patients with advanced AIDS in developed countries but rare to non-existent among patients with advanced AIDS in developing countries where tuberculosis was endemic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/42\">",
"     42",
"    </a>",
"    ]. This was observed despite studies showing that isolation rates of MAC from the environment and rates of skin test reactivity to MAC in healthy persons were comparable in developed and developing countries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. This led to the hypothesis that patients in developing countries had relative immunologic protection against MAC conferred by prior BCG",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    latent infection with M. tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of disseminated MAC has decreased dramatically since the introduction of highly active antiretroviral therapy and effective MAC prophylaxis. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"     \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MYCOBACTERIUM KANSASII",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because large scale testing of skin test reactivity to M. kansasii antigens has not been performed, the geography of M. kansasii is less well known than that of MAC. Based upon reports of clinical disease, the organism seems to predominate along the southeastern and southern coastal states and the central plains states [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/45\">",
"     45",
"    </a>",
"    ]. The CDC surveys noted previously found that M. kansasii was the second most common respiratory NTM isolate in state laboratories in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike other NTM, M. kansasii has never been found in soil or natural water supplies, but has been recovered consistently from tap water in cities where M. kansasii is endemic. Studies in Texas show that M. kansasii disease is concentrated in urban areas, supporting a possible association between clinical disease and potable water supplies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of M. kansasii infection was studied in a population-based laboratory survey from 1992 to 1996 in three counties of northern California and was surprisingly, found to be 2.4 cases per 100,000 adults annually [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/47\">",
"     47",
"    </a>",
"    ]. Of the 270 cases identified, 187 were HIV positive, 33 HIV negative, and 50 with HIV status unknown. HIV negative patients tended to be older (median age 61 versus 39) and Caucasian (62 versus 49 percent); 40 percent of these patients did not have an identifiable underlying condition. Isolation of M. kansasii from respiratory specimens was associated with symptomatic illness in both HIV positive and negative patients. Homelessness and lower socioeconomic status were also important associated findings. The increased frequency reported appeared to track with HIV status (0.75 per 100,000 for HIV negative individuals compared to 115 per 100,000 for HIV positive and 647 per 100,000 for patients with AIDS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. kansasii causes pulmonary disease resembling tuberculosis. The major predisposing factor to lung infection is COPD, which is present in over two-thirds of cases; other underlying conditions may include malignancy, immunosuppressive drugs, alcohol abuse, pneumoconiosis, and HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. Affected patients tend to be in their fifth decade or older, with an approximate 3:1 male predominance. Certain occupational groups are at increased risk, including miners, welders, sandblasters, and painters [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/48\">",
"     48",
"    </a>",
"    ]. Some patients, however, have no risk factor other than their geographic area of residence.",
"   </p>",
"   <p>",
"    A survey of 56 adults with M. kansasii pulmonary infection in Israel diagnosed in the time period 1999 to 2004 noted the following findings [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mean age 58 &plusmn; 18 years",
"     </li>",
"     <li>",
"      64 percent of cases occurred in men",
"     </li>",
"     <li>",
"      59 percent had underlying lung disease",
"     </li>",
"     <li>",
"      15 percent were receiving immunosuppressive medications",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     HIV-related",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to causing pulmonary disease resembling tuberculosis, M. kansasii also causes disseminated disease, particularly in HIV-infected individuals. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients\", section on 'Mycobacterium kansasii'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RAPIDLY GROWING MYCOBACTERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapidly growing mycobacteria include three clinically relevant species M. abscessus, M. chelonae, and M. fortuitum (",
"    <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"     table 1",
"    </a>",
"    ). The most common of this group of organisms encountered in clinical practice or in the clinical microbiology laboratory is M. fortuitum, however, the most important human pathogen is M abscessus. M. fortuitum is rarely a significant respiratory pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These, and other rapidly growing mycobacterial species, are hardy environmental saprophytes widely distributed in nature and able to withstand extremes of temperature and nutritionally spartan environments. They have been isolated from soil, dust, water, terrestrial and aquatic animals, hospital environments, and contaminated reagents and pharmaceuticals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/22,45\">",
"     22,45",
"    </a>",
"    ]. An example of nosocomial transmission of a rapidly growing mycobacterial pathogen involves an outbreak of surgical wound infections caused by Mycobacterium jacuzzii, involving 15 women after insertion of breast implants at a single medical center [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/54\">",
"     54",
"    </a>",
"    ]. A single surgeon who performed all the surgical operations was identified as the source for the organism.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, and management of disease caused by rapidly growing mycobacteria are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"     \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     OTHER NONTUBERCULOUS MYCOBACTERIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Mycobacterium marinum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although infection with M. marinum is uncommon, the epidemiology of M. marinum disease is distinctive from the species described above. The natural habitat of M. marinum is aquatic, as the name suggests. It is found in fresh and salt water, including marine organisms, swimming pools, and fish tanks.",
"   </p>",
"   <p>",
"    M. marinum causes cutaneous disease as a consequence of exposure to water, usually in the context of a minor abrasion, laceration, puncture wound, or bite wound. Skin infections can occur from putting one's hand into a contaminated fish tank, resulting in the condition called fish tank granuloma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/55\">",
"     55",
"    </a>",
"    ]. In a series of 63 cases from France, 84 percent were linked to fish tank exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/56\">",
"     56",
"    </a>",
"    ]. A similar epidemiologic pattern has been found in the United States, along with the recognition that M. marinum may cause a positive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 50-year epidemic of chronic progressive skin disease among residents of Satowan, in the Federated States of Micronesia, began after World War II [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/58\">",
"     58",
"    </a>",
"    ]. In a case-control study, risk factors for disease were taro farming, which is done in standing water that reaches ankle height, and contact with water-filled World War II-era bomb craters. Histopathology of nine skin lesions demonstrated suppurative granulomatous inflammation and nontuberculous mycobacteria DNA was detected by polymerase chain reaction in 7 of 9 specimens. The two samples that were able to be sequenced had 95 and 87 percent identity to M. marinum.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Mycobacterium xenopi",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. xenopi is a slow-growing nontuberculous mycobacterium that is an opportunistic and nosocomial pathogen. It is an uncommon pathogen that most frequently causes pulmonary infection.",
"   </p>",
"   <p>",
"    Its survival in water systems and resistance to common disinfectants enable M. xenopi to contaminate laboratory samples and medical devices such as bronchoscopes, thus causing healthcare-acquired pseudoinfections and laboratory contamination. In a retrospective review of 136 cases of M. xenopi infection seen over a 20 year period in France, three types of pulmonary disease were observed that varied with the host: acute infiltrates in immunocompromised hosts, solitary nodular disease in immunocompetent hosts, and cavitary disease in patients with preexisting lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/59\">",
"     59",
"    </a>",
"    ]. A report from the Netherlands suggests a predominance of M. xenopi infections in men with preexisting lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/60\">",
"     60",
"    </a>",
"    ]. A study from Great Britain suggests an unusually high mortality rate in such patients for unclear reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common extrapulmonary sites are bone and joints. Fifty-eight cases of nosocomial spinal infection occurred in healthy patients following percutaneous nucleotomy for lower back pain or sciatica [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. The outbreak stemmed from the practice of rinsing the surgical instruments with tap water. There were also seven cases of M. xenopi arthritis following invasive surgical procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H376675059\">",
"    <span class=\"h2\">",
"     Mycobacterium haemophilum",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. haemophilum is slow-growing nontuberculous mycobacterium that is thought to live in water [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/65\">",
"     65",
"    </a>",
"    ]. It has a predilection for causing skin and soft tissue infections, particularly in immunocompromised hosts because it grows at 30&deg;C [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/66\">",
"     66",
"    </a>",
"    ]. It is the second most common cause of cervical lymphadenitis in children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/67\">",
"     67",
"    </a>",
"    ], and has been reported rarely to cause lymphadenitis in immunocompetent adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    M. haemophilum was identified as the cause of an outbreak of skin and soft tissue infection and cervical lymphadenitis in 12 immunocompetent individuals, which occurred in the setting of application of permanent makeup to the eyebrows performed by a single makeup artist in Switzerland [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    M. haemophilum is difficult to isolate because it requires special media and conditions (incubation at 30&deg;C) for growth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=see_link&amp;anchor=H11#H11\">",
"     \"Microbiology of nontuberculous mycobacteria\", section on 'Infrequent or difficult to culture NTM'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Mycobacterium simiae",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. simiae has been isolated in the southwestern United States and in other areas of the world such as Israel, Cuba, and western Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/5,70\">",
"     5,70",
"    </a>",
"    ]. Only a minority of M. simiae isolates obtained from immune competent hosts are clinically relevant, making interpretation of the clinical significance of M. simiae isolates difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Mycobacterium szulgai",
"    </span>",
"    &nbsp;&mdash;&nbsp;M. szulgai has been recovered from environmental sources and isolation is usually associated with preexisting pulmonary conditions such as chronic obstructive lung disease or healed tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24089/abstract/71\">",
"     71",
"    </a>",
"    ]. The isolation of M. szulgai is also usually associated with significant disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H213738097\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mycobacteria other than M. tuberculosis and M. leprae are generally free-living organisms that are ubiquitous in the environment (",
"      <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"       table 1",
"      </a>",
"      ). They have been recovered from surface water, tap water, soil, domestic and wild animals, milk, and food products. These organisms can also inhabit body surfaces or secretions without causing disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nontuberculous mycobacteria (NTM) cause four distinct clinical syndromes:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Progressive pulmonary disease (especially in older persons) caused primarily by M. avium complex (MAC) and M. kansasii.",
"     </li>",
"     <li>",
"      Superficial lymphadenitis, especially cervical lymphadenitis, in children caused mostly by MAC, M. scrofulaceum, and, in northern Europe, M. malmoense and M. haemophilum; the most common cause in adults, however, is M. tuberculosis.",
"     </li>",
"     <li>",
"      Disseminated disease in severely immunocompromised patients (eg, disseminated MAC in patients with AIDS). (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Disseminated disease'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Skin and soft tissue infection usually as a consequence of direct inoculation. (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common nontuberculous species causing human disease in the United States are the slowly growing species, MAC and M. kansasii. Less common human pathogens include the slowly growing species M. marinum, M. xenopi, M. simiae, M. malmoense, and M. ulcerans, and the rapidly growing species M. abscessus, M. fortuitum, and M. chelonae. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Frequency of disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unlike other NTM, M. kansasii has never been found in soil or natural water supplies, but has been recovered consistently from tap water in cities where M. kansasii is endemic. M. kansasii causes pulmonary disease resembling tuberculosis. The major predisposing factor to lung infection is COPD, which is present in over two-thirds of cases; other underlying conditions may include malignancy, immunosuppressive drugs, alcohol abuse, pneumoconiosis, and HIV infection. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Mycobacterium kansasii'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rapidly growing mycobacteria include three clinically relevant species M. abscessus, M. chelonae, and M. fortuitum (",
"      <a class=\"graphic graphic_table graphicRef61936 \" href=\"UTD.htm?3/0/3085\">",
"       table 1",
"      </a>",
"      ). Among these, the most important human pathogen is M abscessus. Rapidly growing mycobacterial species are hardy environmental saprophytes widely distributed in nature and able to withstand extremes of temperature and nutritionally spartan environments. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Rapidly growing mycobacteria'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=see_link\">",
"       \"Rapidly growing mycobacterial infections in HIV-negative patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A number of other NTM species cause disease in humans, including M. marinum, M. xenopi, M. haemophilum, M. simiae, and M. szulgai. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Other nontuberculous mycobacteria'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/1\">",
"      Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/2\">",
"      Chapman JS. The ecology of the atypicalmycobacteria. Arch Environ Health 1971; 22:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/3\">",
"      Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/4\">",
"      Gruft H, Falkinham JO 3rd, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981; 3:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/5\">",
"      Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/6\">",
"      Good RC, Snider DE Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982; 146:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/7\">",
"      O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987; 135:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/8\">",
"      Horsburgh CR Jr, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/9\">",
"      Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007; 62:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/10\">",
"      Iseman MD, Marras TK. The importance of nontuberculous mycobacterial lung disease. Am J Respir Crit Care Med 2008; 178:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/11\">",
"      Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/12\">",
"      Cassidy PM, Hedberg K, Saulson A, et al. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009; 49:e124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/13\">",
"      Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/14\">",
"      Griffith DE, Stout JE. It is better to light a candle ... than to repeat the opinions of experts. Am J Respir Crit Care Med 2010; 182:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/15\">",
"      Thomson RM, NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/16\">",
"      Hern&aacute;ndez-Gardu&ntilde;o E, Rodrigues M, Elwood RK. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis 2009; 13:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/17\">",
"      Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/18\">",
"      Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis 1972; 105:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/19\">",
"      Vesterhus P, Holland SM, Abrahamsen TG, Bjerknes R. Familial disseminated infection due to atypical mycobacteria with childhood onset. Clin Infect Dis 1998; 27:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/20\">",
"      Herlin T, Thelle T, Kragballe K, et al. Sustained depression of monocyte cytotoxicity in a boy with disseminated nontuberculous mycobacteriosis. J Pediatr 1981; 99:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/21\">",
"      Olivier KN, Weber DJ, Wallace RJ Jr, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/22\">",
"      Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107.",
"     </a>",
"    </li>",
"    <li>",
"     Horsburgh RC Jr. Epidemiology of Mycobacterium avium complex. In: Mycobacterium Avium Complex Infection, Korvick JA, Benson CA (Eds), Marcel Dekker, Inc, New York 1996. p.1.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/24\">",
"      Meissner G, Anz W. Sources of Mycobacterium avium complex infection resulting in human diseases. Am Rev Respir Dis 1977; 116:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/25\">",
"      Meissner PS, Falkinham JO 3rd. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis 1986; 153:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/26\">",
"      von Reyn CF, Maslow JN, Barber TW, et al. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994; 343:1137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/27\">",
"      du Moulin GC, Stottmeier KD, Pelletier PA, et al. Concentration of Mycobacterium avium by hospital hot water systems. JAMA 1988; 260:1599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/28\">",
"      Marras TK, Wallace RJ Jr, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005; 127:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/29\">",
"      Reed C, von Reyn CF, Chamblee S, et al. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006; 164:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/30\">",
"      Feazel LM, Baumgartner LK, Peterson KL, et al. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A 2009; 106:16393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/31\">",
"      Edwards LB. Community-wide tuberculin testing study in Pamlico county, North Carolina. Am Rev Respir Dis 1965; 92:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/32\">",
"      Lind A, Larsson LO, Bentzon MW, et al. Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area. Tubercle 1991; 72:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/33\">",
"      Osman AA, Hakim JG, L&uuml;neborg-Nielsen M, et al. Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia. Tuber Lung Dis 1994; 75:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/34\">",
"      Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007; 176:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/35\">",
"      Edwards LB, Acquaviva FA, Livesay VT, et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99:Suppl:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/36\">",
"      von Reyn CF, Williams DE, Horsburgh CR Jr, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/37\">",
"      von Reyn CF, Horsburgh CR, Olivier KN, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/38\">",
"      Debrunner M, Salfinger M, Br&auml;ndli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992; 15:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/39\">",
"      Tsukamura M, Kita N, Shimoide H, et al. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137:1280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/40\">",
"      Teirstein AS, Damsker B, Kirschner PA, et al. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment. Mt Sinai J Med 1990; 57:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/41\">",
"      Lim J, Lyu J, Choi CM, et al. Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules. Int J Tuberc Lung Dis 2010; 14:1635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/42\">",
"      Fordham von Reyn C, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS 1996; 10:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/43\">",
"      von Reyn CF, Waddell RD, Eaton T, et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol 1993; 31:3227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/44\">",
"      von Reyn CF, Barber TW, Arbeit RD, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993; 168:1553.",
"     </a>",
"    </li>",
"    <li>",
"     Chapman J. The Atypical Mycobacteria, Plenum Publishing, New York 1977.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/46\">",
"      Steadham JE. High-catalase strains of Mycobacterium kansasii isolated from water in Texas. J Clin Microbiol 1980; 11:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/47\">",
"      Bloch KC, Zwerling L, Pletcher MJ, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/48\">",
"      Marks J. \"Opportunist\" mycobacteria in England and Wales. Tubercle 1969; 50:Suppl:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/49\">",
"      Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 1969; 99:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/50\">",
"      Lillo M, Orengo S, Cernoch P, Harris RL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990; 12:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/51\">",
"      Bamberger DM, Driks MR, Gupta MR, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium. Clin Infect Dis 1994; 18:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/52\">",
"      Shitrit D, Baum GL, Priess R, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest 2006; 129:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/53\">",
"      Park S, Suh GY, Chung MP, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008; 102:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/54\">",
"      Rahav G, Pitlik S, Amitai Z, et al. An outbreak of Mycobacterium jacuzzii infection following insertion of breast implants. Clin Infect Dis 2006; 43:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/55\">",
"      Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/56\">",
"      Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/57\">",
"      Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/58\">",
"      Lillis JV, Ansdell VE, Ruben K, et al. Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders. Clin Infect Dis 2009; 48:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/59\">",
"      Andr&eacute;jak C, Lescure FX, Pukenyte E, et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009; 64:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/60\">",
"      van Ingen J, Boeree MJ, de Lange WC, et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008; 14:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/61\">",
"      Jenkins PA, Campbell IA, Research Committee of The British Thoracic Society. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 2003; 97:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/62\">",
"      Astagneau P, Desplaces N, Vincent V, et al. Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak. Lancet 2001; 358:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/63\">",
"      Ziza JM. [Lessons in medicine: apropos of a modern epidemic of Mycobacterium xenopi spondylodiscitis]. Rev Med Interne 1997; 18:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/64\">",
"      Salliot C, Desplaces N, Boisrenoult P, et al. Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in France. Clin Infect Dis 2006; 43:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/65\">",
"      Falkinham JO 3rd, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 2001; 67:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/66\">",
"      Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996; 9:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/67\">",
"      Cohen YH, Amir J, Ashkenazi S, et al. Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel. Emerg Infect Dis 2008; 14:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/68\">",
"      Minani TJ, Saubolle MA, Yu E, Sussland Z. Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol 2010; 48:2636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/69\">",
"      Giulieri S, Morisod B, Edney T, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis 2011; 52:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/70\">",
"      van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur Respir J 2008; 31:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24089/abstract/71\">",
"      van Ingen J, Boeree MJ, de Lange WC, et al. Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis 2008; 46:1200.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5344 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.234.146.186-8AB89F2CF9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24089=[""].join("\n");
var outline_f23_33_24089=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H213738097\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FREQUENCY OF DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22990476\">",
"      HOST SUSCEPTIBILITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MYCOBACTERIUM AVIUM COMPLEX",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Disseminated disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MYCOBACTERIUM KANSASII",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HIV-related",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RAPIDLY GROWING MYCOBACTERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      OTHER NONTUBERCULOUS MYCOBACTERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Mycobacterium marinum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Mycobacterium xenopi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H376675059\">",
"      Mycobacterium haemophilum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mycobacterium simiae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Mycobacterium szulgai",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H213738097\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5344\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5344|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/30/18922\" title=\"figure 1\">",
"      Geography PPD reactors USA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5344|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/0/3085\" title=\"table 1\">",
"      Mycobacteria classification",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=related_link\">",
"      Cystic fibrosis: Antibiotic therapy for lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/50/11045?source=related_link\">",
"      Diagnosis of nontuberculous mycobacterial infections of the lungs in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/19/30009?source=related_link\">",
"      Idiopathic CD4+ lymphocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4297?source=related_link\">",
"      Mendelian susceptibility to mycobacterial diseases (MSMD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5687?source=related_link\">",
"      Microbiology of nontuberculous mycobacteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31207?source=related_link\">",
"      Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15512?source=related_link\">",
"      Overview of nontuberculous mycobacteria (excluding MAC) in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/11/24759?source=related_link\">",
"      Overview of nontuberculous mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/42/13994?source=related_link\">",
"      Overview of nontuberculous mycobacterial lymphadenitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25288?source=related_link\">",
"      Pathogenesis of nontuberculous mycobacterial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5530?source=related_link\">",
"      Rapidly growing mycobacterial infections in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/24/2441?source=related_link\">",
"      Treatment of nontuberculous mycobacterial infections of the lung in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/38/24169?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors and mycobacterial infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_33_24090="Radiation-induced lung injury";
var content_f23_33_24090=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiation-induced lung injury",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24090/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24090/contributors\">",
"     William W Merrill, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24090/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24090/contributors\">",
"     Brian Kavanagh, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/33/24090/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/33/24090/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/33/24090/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation-induced lung injury was first described in 1898, soon after the development of roentgenograms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/1\">",
"     1",
"    </a>",
"    ]. The distinction between two separate types of radiation-induced lung injury, radiation pneumonitis and radiation fibrosis, was made in 1925 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/2\">",
"     2",
"    </a>",
"    ]. Both types of lung injury are observed today in patients who have undergone thoracic irradiation for the treatment of lung, breast, or hematologic malignancies. Radiation-induced damage to normal lung parenchyma remains the dose-limiting factor in chest radiotherapy, and can involve other structures within the thorax in addition to the lungs (",
"    <a class=\"graphic graphic_table graphicRef79716 \" href=\"UTD.htm?6/8/6283\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A large body of literature describes the histopathologic, biochemical, kinetic, physiologic, and molecular responses of lung cells to ionizing radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. However, the clinical diagnosis of radiation-induced lung injury is often complicated by the presence of other conditions, including malignancy, infection, and cardiogenic pulmonary edema [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/8\">",
"     8",
"    </a>",
"    ]. Radiation-induced lung injury will be reviewed here. The cardiac effects of therapeutic radiation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/21/34137?source=see_link\">",
"     \"Cardiotoxicity of radiation therapy for malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ionizing radiation causes the localized release of sufficient energy to break strong chemical bonds and generate highly reactive free radical species. Cellular molecules including peptides, lipids, and DNA can be affected directly or indirectly via the interaction of the ionizing radiation with tissue water.",
"   </p>",
"   <p>",
"    Overexpression of a transgene for manganese superoxide dismutase protects against the late fibrotic response in a murine model of radiation pneumonitis, and confirms the role of oxygen radicals in the pathogenesis of radiation-induced fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/9\">",
"     9",
"    </a>",
"    ]. There have been preclinical studies of gene therapy combined with chest irradiation to increase tissue expression of manganese superoxide dismutase and limit radiation-induced pulmonary damage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiation-induced lung injury results from the combination of direct cytotoxicity upon normal lung tissue and, perhaps more importantly, the development of fibrosis triggered by radiation-induced cellular signal transduction. The cytotoxic effect is largely a consequence of DNA damage that causes clonogenic death in normal lung epithelial cells, though apoptotic pathways are also induced by radiation. The development of fibrosis that can compromise lung function is mediated by a number of different cytokines, as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetic background",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal and human studies suggest that there is a significant role for genetic susceptibility to irradiation injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Contemporary studies of patients receiving irradiation for breast cancer have shown suggestive associations between genetic factors associated with cutaneous telangiectasia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/13\">",
"     13",
"    </a>",
"    ]",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. Among 137 patients receiving irradiation for non-small cell or small cell lung cancer, presence of a single nucleotide polymorphism in the methylene tetrahydrofolate reductase gene (MTHFR; rs1801133) was associated with an increased risk of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/16\">",
"     16",
"    </a>",
"    ]. In separate studies of lung cancer patients, polymorphisms of the ataxia telangiectasia mutated (ATM) gene were associated with an increased risk of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Role of cytokines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several cytokines are upregulated following lung irradiation and together are thought to mediate the pathologic changes described above.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinically, the most extensively studied radiation-induced cytokine is transforming growth factor beta 1 (TGF-beta), which can induce fibroblast collagen deposition. The plasma TGF-beta level at the end of a clinical course of radiotherapy has been observed to be a predictor of the risk of pneumonitis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/19\">",
"       19",
"      </a>",
"      ]. This knowledge has been applied in a prospective trial in which patients with normal TGF-beta levels at the completion of a specified course of treatment were given additional boost treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/20\">",
"       20",
"      </a>",
"      ]. Subsequent trials have shown no predictable pattern of TGF-beta change in those with and without radiation lung injury [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The proinflammatory cytokines, tumor necrosis factor-alpha (TNFa) and interleukin 1-alpha (IL-1a), are upregulated immediately following irradiation.",
"     </li>",
"     <li>",
"      IL-6 concentrations rise following irradiation, and elevated pretreatment plasma IL-6 concentrations correlate with an increased risk of developing radiation-induced lung injury [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/22,23\">",
"       22,23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Platelet-derived growth factor (PDGF) and basic fibroblast growth factor (bFGF), which are potent fibroblast mitogens are upregulated in animal models of lung irradiation injury prior to the development of histologically recognizable fibrosis along with TGF-beta 1 [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/24\">",
"       24",
"      </a>",
"      ]. Investigators have been able to reduce radiation-induced lung injury and apoptosis in mice by the intravenous administration of bFGF [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/25\">",
"       25",
"      </a>",
"      ]. Basic fibroblast growth factor is thought to inhibit radiation-induced apoptosis in endothelial cells via activation of protein kinase C.",
"     </li>",
"     <li>",
"      Interferon-gamma has been shown to reduce the number of neutrophils and the protein concentration in bronchoalveolar lavage (BAL) fluid following irradiation in a rat model [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/26\">",
"       26",
"      </a>",
"      ]. It has the potential to reduce radiation-induced lung injury via inhibition of both neutrophil accumulation and fibroblast collagen synthesis.",
"     </li>",
"     <li>",
"      CD40 is displayed by antigen-presenting cells including B lymphocytes, macrophages, and dendritic cells. These cells are activated in the presence of CD40 ligand-bearing cells, such as T lymphocytes, mast cells, and eosinophils. The role of inflammation in the pathogenesis of radiation-induced lung injury is supported by the observation that anti-CD40 ligand antibodies significantly reduce the influx of inflammatory cells, collagen deposition, and septal thickening in a murine model of radiation-induced lung injury [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hypersensitivity reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;A less common and unpredictable lung injury has also been described that may involve areas of the lung",
"    <strong>",
"     outside",
"    </strong>",
"    the radiation port. Investigators have described a CD4+ lymphocytic alveolitis and increased gallium uptake in both irradiated and nonirradiated lung, consistent with a hypersensitivity pneumonitis-like reaction. The early development of a bilateral hypersensitivity reaction (as assessed by bronchoalveolar lavage) appears to be a common phenomenon following unilateral chest radiotherapy, but does not predict progression to clinically significant radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/49/19222?source=see_link\">",
"     \"Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     REACTION TO RADIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many factors affect the development of radiation-induced lung disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Method of irradiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation oncologists continue to work to improve the targeting of radiation, increasing the dose given to diseased tissue while sparing normal tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This general approach of shaping the distribution of therapeutic radiation dose within the patient to match as well as possible to the intended target volume, while minimizing the dose to other tissues, is often referred to as conformal radiation therapy. More specialized techniques of conformal radiation therapy include intensity modulated radiation therapy and stereotactic body radiation therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32630?source=see_link\">",
"     \"Intensity-modulated radiation therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=see_link\">",
"     \"Stereotactic body radiation therapy: Rationale and clinical experience\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Volume of lung irradiated",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of radiation-induced injury is directly related to the volume of irradiated lung [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. In patients with breast cancer, for example, the risk of transient lung inflammation following adjuvant chest wall irradiation is approximately 5 percent. The risk is higher with increasing lung volume in the tangential fields, treatment to the regional lymph nodes (supraclavicular, axillary apex, and internal mammary regions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/34\">",
"     34",
"    </a>",
"    ]), and the use of concurrent compared to sequential chemotherapy (8.8 versus 1.3 percent in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/35\">",
"     35",
"    </a>",
"    ]. In one report, when tangential beam irradiation was utilized following breast-conserving surgery, pneumonitis was observed only when &gt;10 percent of the lung was irradiated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=see_link&amp;anchor=H26#H26\">",
"     \"Radiation techniques for locally advanced breast cancer\", section on 'Late complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30359?source=see_link&amp;anchor=H949706082#H949706082\">",
"     \"Complications of breast and chest wall irradiation for early stage breast cancer\", section on 'Pneumonitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Dosage of radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dose of radiation delivered to the lung is a critical factor in determining if injury will occur [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/32,37-40\">",
"     32,37-40",
"    </a>",
"    ]. As noted above, mean dose can be a predictor of the risk of radiation pneumonitis, as can the V20, defined as the volume of normal lung (total lung volume minus planning target volume for radiotherapy) that receives more than 20 Gy.",
"   </p>",
"   <p>",
"    One group analyzed the dose-volume histogram (DVH) and other clinical information in a series of 99 patients treated definitively for inoperable non-small cell lung cancer (NSCLC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/41\">",
"     41",
"    </a>",
"    ]. On multivariate analysis the V20 was the single independent predictor of the development of Grade 2 or higher pneumonitis, meaning the need for steroids, diuretics, or oxygen. For V20 &lt;22 percent, no pneumonitis was observed. For V20 from 22 to 31 percent, there was an 8 percent rate of grade 2 toxicity. Higher rates were observed with higher V20, including several instances of grade 5 (fatal) pneumonitis in patients with V20 &gt;35 percent. For this reason, both the Radiation Therapy Oncology Group (RTOG) and Southwest Oncology Group (SWOG) have specified upper limits of V20 in the range of 30 to 35 percent for patients treated on recent group protocols.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Time-dose factor",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a systematic review, the use of twice daily fractionation appeared to reduce the risk of radiation lung injury compared with administration of the same total daily dose as a single fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/42\">",
"     42",
"    </a>",
"    ]. However, in a study of 37 patients receiving radiation for non-small cell lung cancer, 14 developed radiation pneumonitis, suggesting no benefit to the twice daily fractionation regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/43\">",
"     43",
"    </a>",
"    ]. Due to lack of clear benefit and the increase in logistical difficulties, twice daily dose fractionation is rarely used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Concurrent chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several chemotherapeutic agents are known sensitizers to radiotherapy, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    , taxanes,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/21/14679?source=see_link\">",
"     dactinomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/29/1498?source=see_link\">",
"     vincristine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    , recombinant interferon-alpha, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5,44-47\">",
"     5,44-47",
"    </a>",
"    ]. Patients receiving these drugs are at a higher risk of developing radiation-induced lung injury (RILI). In addition, several of the drugs themselves are associated with lung injury. By contrast, other drugs may sensitize tumor cells to the effects of radiation without an increase in lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"     \"Bleomycin-induced lung injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21990?source=see_link\">",
"     \"Cyclophosphamide pulmonary toxicity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38344?source=see_link\">",
"     \"Taxane-induced pulmonary toxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Concurrent rather than sequential chemotherapy appears to increase the risk, especially in women undergoing anthracycline-based adjuvant chemotherapy plus radiotherapy for breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/35,45\">",
"     35,45",
"    </a>",
"    ]. In one report, the risk of pneumonitis in women treated with a supraclavicular field and concurrent versus sequential chemotherapy was 9 versus 1.3 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/35\">",
"     35",
"    </a>",
"    ]. Because of this risk, concurrent anthracycline-based chemotherapy and radiation are generally avoided in the treatment of breast cancer.",
"   </p>",
"   <p>",
"    It is likely that sequential administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    and RT diminishes the risk of radiation pneumonitis as compared to concurrent treatment. However, women who receive taxanes as a component of their adjuvant therapy for breast cancer may also need to have a smaller volume of lung included in the radiation field. This topic is addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38344?source=see_link&amp;anchor=H7#H7\">",
"     \"Taxane-induced pulmonary toxicity\", section on 'Concomitant radiotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=see_link&amp;anchor=H1404371166#H1404371166\">",
"     \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\", section on 'Sequencing chemotherapy and radiation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     Gemcitabine",
"    </a>",
"    is included in many lung cancer treatment protocols and is a potent radiation sensitizer. When given as concurrent therapy at standard doses, pulmonary toxicity is prohibitive [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/49\">",
"     49",
"    </a>",
"    ]. Toxicity is prominent, even with reduced doses. In a series of 19 patients with non-small cell lung cancer, induction chemotherapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    and gemcitabine (800",
"    <span class=\"nowrap\">",
"     mg/m)",
"    </span>",
"    followed by weekly gemcitabine (200",
"    <span class=\"nowrap\">",
"     mg/m)",
"    </span>",
"    concurrent with radiation was associated with grade 3 to 5 (fatal) radiation pneumonitis in 32 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/50\">",
"     50",
"    </a>",
"    ]. However, radiation treatment planning in this report used a two-dimensional technique and the fields were large (including the primary lesion, grossly involved nodal sites, plus ipsilateral hilum, and mediastinum with a margin of 2 cm). Details about the dose to normal lung were not described. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=see_link&amp;anchor=H32#H32\">",
"     \"Management of stage III non-small cell lung cancer\", section on 'Concurrent chemoradiotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The literature suggests that toxicity is less with conformal (three-dimensional) treatment planning [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/51\">",
"     51",
"    </a>",
"    ]. Toxicity is greater with regimens that include induction chemotherapy prior to chemoradiotherapy, combinations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    with a taxane as opposed to a platinum-type drug, and more frequent dosing of gemcitabine (eg, 30",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    twice weekly) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/51-54\">",
"     51-54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Induction chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of induction chemotherapy prior to chemoradiotherapy may increase the risk of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/45,52,55\">",
"     45,52,55",
"    </a>",
"    ]. In a retrospective review of 96 patients treated for esophageal cancer, the incidence of moderate to severe pneumonitis at one year was higher among those who received induction chemotherapy prior to chemoradiotherapy, compared to those who did not (49 versus 14 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=see_link\">",
"     \"Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior thoracic irradiation, volume loss due to lung collapse, younger age, smoking history, poor pretreatment performance status, poor pretreatment lung function, chronic obstructive pulmonary disease, female sex, endocrine therapy for breast cancer, and glucocorticoid withdrawal during radiotherapy have all been reported to influence the risk of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5,44,56,57\">",
"     5,44,56,57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smoking has been reported as a risk-modifying factor in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. A small retrospective study compared the incidence of clinical radiation pneumonitis in active smokers and nonsmokers, among 405 women who underwent radiotherapy for treatment of breast or esophageal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/58\">",
"     58",
"    </a>",
"    ]. The authors found that none of the subjects who were active cigarette smokers developed clinical pneumonitis following irradiation. In a retrospective study, patients with more severe COPD were found to have less symptomatic radiation pneumonitis than those with more normal lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/59\">",
"     59",
"    </a>",
"    ]. While this could be confounded by the lack of randomization and difficulties with scoring of radiation pneumonitis due to the similarity of symptoms of COPD exacerbation and radiation pneumonitis, it is possible that the less diseased lungs tolerate radiation less well that those afflicted by COPD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings are intriguing because other inflammatory lung diseases with a predominance of lymphocytes, such as hypersensitivity pneumonitis, are also uncommon in smokers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)\", section on 'Effect of cigarette smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies suggest that concurrent, but not sequential use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    increases the rate of pulmonary fibrosis in women treated for breast cancer; however, this has not been a consistent finding, and in general, higher rates of symptomatic pneumonitis have not been seen [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/61\">",
"     61",
"    </a>",
"    ]. In contrast, the frequency of radiation-induced organizing pneumonia may be increased by concurrent endocrine therapy. In a retrospective series of 702 women with breast cancer who received breast conserving therapy, organizing pneumonia was associated with concurrent radiation and endocrine therapy (OR 3.05; 95% CI 1.09-8.54) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The exact interaction of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    with irradiation is not known, although it appears to have both radiosensitizing and radiation recall effects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/63-65\">",
"     63-65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Predicting radiation lung injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from studies based upon these RT parameters has been used to predict the likelihood of radiation-induced lung injury (RILI) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]. Although these efforts have yielded statistically significant results, the clinical prediction has been modest. Similarly, polymorphisms of the transforming growth factor(TGF)-beta 1 gene and serum levels of TGF-beta 1 obtained four weeks after the start of radiotherapy also are predictive of subsequent RILI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. However, to date none of these methods is sufficiently reliable to be clinically useful, either in guiding dose modification or in suggesting the use of agents that might modify RILI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Radiation recall",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation recall pneumonitis can occur when certain antineoplastic agents (eg, Adriamycin,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/27/36279?source=see_link\">",
"     pemetrexed",
"    </a>",
"    ) are administered to a patient who has received prior radiation therapy to the lung [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/63,70-74\">",
"     63,70-74",
"    </a>",
"    ]. Patients typically develop symptoms such as cough and dyspnea, and also radiographic opacities that conform to the prior radiation field.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathologic and clinical changes in the lung following irradiation may be divided into five phases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The immediate phase begins within hours to days following radiation exposure, and is generally asymptomatic. It is characterized by hyperemic, congested mucosa with leukocytic infiltration and increased capillary permeability, resulting in pulmonary edema. An exudative alveolitis follows, accompanied by tracheal bronchial hypersecretion and degenerative changes in the alveolar epithelium and endothelium. Type I alveolar epithelial cells (pneumocytes) are sloughed, and alveolar surfactant levels are increased [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      During the next phase (the latent phase), thick secretions accumulate due to an increase in the number of goblet cells combined with ciliary dysfunction.",
"     </li>",
"     <li>",
"      The third phase (acute exudative phase) is clinically referred to as radiation pneumonitis. It occurs three to twelve weeks following exposure and consists of sloughing of endothelial and epithelial cells, with narrowing of the pulmonary capillaries and microvascular thrombosis. Hyaline membranes form as a result of alveolar pneumocyte desquamation and leakage of a fibrin-rich exudate into the alveoli. Giant cells may be seen along the endothelium, and type II pneumocytes become hyperplastic with marked atypia.",
"     </li>",
"     <li>",
"      In the fourth phase (intermediate phase), there may be resolution of the alveolar exudate and dissolution of the hyaline membranes, or there may be collagen deposition by fibroblasts, which results in thickening of the interstitium. Fibroblasts, probably of bone marrow origin, migrate into and proliferate within the alveolar walls and spaces [",
"      <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/75,76\">",
"       75,76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A final phase consists of fibrosis. It may be evident as early as six months following irradiation, and can progress over years. There is an increase in the number of myofibroblasts within the interstitium and alveolar spaces, along with an increase in collagen. The anatomic narrowing of alveolar spaces results in diminishing lung volume; vascular subintimal fibrosis and distortion cause a loss of capillaries. Traction bronchiectasis, complicated by chronic infection, can develop. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12458?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bronchiectasis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A late histopathologic appearance consistent with organizing pneumonia has also been reported, particularly when injury is seen in the contralateral lung [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/62,77-79\">",
"     62,77-79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19402?source=see_link\">",
"     \"Cryptogenic organizing pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of radiation pneumonitis varies depending upon the particular regimen used and upon the radiation field. In addition, there is a discrepancy between the frequency of clinically apparent pneumonitis and radiographic evidence of lung disease. One review, for example, noted the following frequencies of radiation-induced lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with breast cancer, clinical pneumonitis occurred in 0 to 10 percent, while radiographic abnormalities were present in 27 to 40 percent.",
"     </li>",
"     <li>",
"      In patients with lung cancer, clinical pneumonitis occurred in 5 to 15 percent of patients, while radiographic abnormalities were present in 66 percent. It is unclear to what extent the latter were due to irradiation versus tumor.",
"     </li>",
"     <li>",
"      In patients with mediastinal lymphoma, clinical pneumonitis did not occur, although radiographic abnormalities were present in 60 to 92 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The incidence of radiation pneumonitis may differ when protocols employing non-external beam radiation are used. As an example, in a study of 46 patients who received high dose endobronchial brachytherapy for malignant airway obstruction, radiation pneumonitis was only detected in those subjects who also received external beam therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/80\">",
"     80",
"    </a>",
"    ]. A second study of 80 patients with inoperable hepatic tumors who underwent 90-Yttrium microsphere irradiation found that 5 developed radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/81\">",
"     81",
"    </a>",
"    ]. The occurrence of pneumonitis correlated with the degree of pulmonary shunting of the microspheres: pneumonitis occurred in five of nine patients with at least a 13 percent shunt to the pulmonary circulation (as assessed by 99m technetium-labeled macroaggregated albumin), compared to no patients with a shunt below 13 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28234?source=see_link&amp;anchor=H21#H21\">",
"     \"Nonsurgical local treatment strategies for colorectal cancer liver metastases\", section on 'Radioembolization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms caused by acute radiation pneumonitis usually develop approximately four to twelve weeks following irradiation, whereas symptoms of late or fibrotic radiation pneumonitis develop after six to twelve months. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Pathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The symptoms and signs of the two phases are similar, although fever is less likely to occur in the fibrotic phase. The following symptoms have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/82,83\">",
"     82,83",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A nonproductive cough, which may occur during therapy as a manifestation of bronchial mucosal injury or later as a manifestation of fibrosis.",
"     </li>",
"     <li>",
"      Dyspnea may only occur with exertion, or may be described as an inability to take a deep breath.",
"     </li>",
"     <li>",
"      Fever is usually low grade, but can be more pronounced in severe cases.",
"     </li>",
"     <li>",
"      Chest pain may be pleuritic or substernal and can represent pleuritis, esophageal pathology, or rib fracture.",
"     </li>",
"     <li>",
"      Malaise and weight loss may be observed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Physical signs include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Crackles or a pleural rub may be heard; in some cases auscultation is normal.",
"     </li>",
"     <li>",
"      Dullness to percussion may be detected as a result of a small pleural effusion; this occurs in about 10 percent of patients. Effusions often cause no symptoms and may spontaneously remit. In contrast to malignant effusions, radiation-induced effusions do not increase in size after a period of observed stability. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=see_link\">",
"       \"Diagnostic evaluation of a pleural effusion in adults: Initial testing\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin erythema may outline the radiation port but is not predictive of the occurrence or the severity of radiation pneumonitis.",
"     </li>",
"     <li>",
"      Tachypnea, cyanosis, or signs of pulmonary hypertension may be seen in more advanced cases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=see_link\">",
"       \"Overview of pulmonary hypertension in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of radiation pneumonitis is based on the correlation between the onset of symptoms and signs with the timing of irradiation and the correspondence of the radiographic changes with the radiation therapy portal, and exclusion of other possible causes of the findings, such as infection, thromboembolic disease, drug-induced pneumonitis, pericarditis, esophagitis, or tracheoesophageal fistula [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;No commonly employed laboratory test predicts the development of radiation pneumonitis. A low-grade polymorphonuclear leukocytosis is often present, and the sedimentation rate, serum LDH, and C-reactive protein may be modestly elevated, but these findings are nonspecific.",
"   </p>",
"   <p>",
"    Serum KL-6, a sialylated carbohydrate epitope that is highly expressed in bronchial epithelial cells and type II pneumocytes, has been associated with interstitial lung disease and irradiation-induced lung injury for over 20 years. In a study of 117 patients undergoing radiation therapy for lung cancer, raised serum levels of KL-6 and surfactant protein-D (SP-D) prior to therapy identified patients with evidence of interstitial lung disease on preradiation-therapy chest computed tomography (CT) and a high risk of severe worsening of this disease after radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/84\">",
"     84",
"    </a>",
"    ]. However, measurement of serum KL-6 and SP-D seemed to add little to detection of these high-risk patients compared to chest CT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographic abnormalities following thoracic irradiation need to be distinguished from other pulmonary diseases, such as infection, lymphangitic or direct extension of tumor, drug-induced pneumonitis, thromboembolism, hemorrhage, and cardiogenic edema [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180831\">",
"    <span class=\"h3\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiographs may be normal in symptomatic subjects during the subacute phase of radiation pneumonitis, or may show evolving radiographic patterns depending on the phase of lung injury (eg, acute exudative, organizing, and fibrotic).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perivascular haziness is an early radiation-induced abnormality on chest radiograph, often progressing to patchy alveolar filling densities.",
"     </li>",
"     <li>",
"      Radiographs taken during the chronic phase of radiation pneumonitis may show volume loss with coarse reticular or dense opacities.",
"     </li>",
"     <li>",
"      A",
"      <strong>",
"       straight line",
"      </strong>",
"      effect, which does not conform to anatomical units but rather to the confines of the radiation port, is often seen and is virtually diagnostic of radiation-induced lung injury. However, conformal and stereotactic treatment strategies, such as three-dimensional conformal radiation therapy (3D-CRT), stereotactic body radiation therapy (SBRT), Tomotherapy, and Gamma Knife, do not cause this &ldquo;straight line&rdquo; radiographic finding due to the complex distribution of the radiation therapy. With these techniques, a focal area of opacity with ill-defined margins is seen in the irradiated region. Better delineation of the radiation fields is possible with chest computed tomography as described below. (See",
"      <a class=\"local\" href=\"#H180885\">",
"       'Chest computed tomography'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32630?source=see_link\">",
"       \"Intensity-modulated radiation therapy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=see_link\">",
"       \"Stereotactic body radiation therapy: Rationale and clinical experience\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32855?source=see_link&amp;anchor=H16#H16\">",
"       \"Stereotactic cranial radiosurgery\", section on 'Gamma Knife'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Small pleural effusions and rib fractures may be seen, but lymphadenopathy does not occur.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A few cases have been reported of radiographic abnormalities attributed to radiation pneumonitis outside of the irradiation port, and even in the contralateral lung [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/57,77\">",
"     57,77",
"    </a>",
"    ]. This may be due to radiation scatter, lymphatic obstruction, or immunologic (hypersensitivity-like) mechanisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180885\">",
"    <span class=\"h3\">",
"     Chest computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is more sensitive than the chest radiograph in detecting subtle lung injury following radiation treatment and is often obtained in the evaluation of a patient with increased dyspnea or cough following radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/85\">",
"     85",
"    </a>",
"    ]. However, a chest CT scan is not required to make the diagnosis of irradiation-induced lung injury. The CT scan may take the form of a CT pulmonary angiogram (CTPA) to exclude pulmonary thromboembolism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similar to the plain chest radiograph, the CT scan appearance of radiation pneumonitis correlates with the phase of lung injury, although a given patient may present at any one of the phases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The initial phase, which occurs 3-5 months after completion of radiation therapy, typically shows ground-glass attenuation within the area of irradiated lung.",
"     </li>",
"     <li>",
"      The organizing phase is typically associated with patchy areas of consolidation that coalesce to form a relatively sharp edge that conforms to the radiation therapy portals rather than anatomic structures. These patchy areas sometimes appear nodular.",
"     </li>",
"     <li>",
"      The opacities associated with the organizing phase may resolve with minimal scarring or may evolve into a fibrotic phase, characterized on CT by linear opacities (scarring) or an area of dense consolidation and volume loss. The area of consolidation typically corresponds closely to the radiation port, yielding a nonanatomic straight edge effect similar to that described for the plan chest radiograph above.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lung involvement in CT images of radiation pneumonitis typically aligns closely with the irradiated area. However, comparisons between pre and posttreatment images may be difficult due to tumor growth or shrinkage, changes in depth of respiration, and the complexity of the radiation port. Specialized software appears to improve identification of radiation-induced tissue damage by comparing pretreatment CT images, containing irradiation dosimetric information, with diagnostic CT images obtained at the time of presentation with possible radiation tissue injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/88\">",
"     88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The exact radiographic pattern of lung involvement is influenced by the specific radiation therapy technique used, such as limited tangential beams (eg, for breast cancer treatment), conformal therapy (eg, for bronchogenic cancer), and complex portal arrangements (eg, margins around primary bronchogenic carcinoma and around regional lymph nodes) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Reaction to radiation'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32630?source=see_link\">",
"     \"Intensity-modulated radiation therapy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=see_link\">",
"     \"Stereotactic body radiation therapy: Rationale and clinical experience\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/46/39657?source=see_link\">",
"     \"Techniques of breast and chest wall irradiation for early stage breast cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=see_link\">",
"     \"Radiation techniques for locally advanced breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Nuclear medicine studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard nuclear medicine scans add little to the diagnosis of radiation pneumonitis. However there is growing interest in single photon emission tomography (SPECT), functional magnetic resonance (MR) spectroscopy, and positron emission tomography (PET) scanning to better define and perhaps predict outcome. These interesting concepts are under active investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function testing generally demonstrates a reduction in lung volumes (TLC, FVC, RV), diffusing capacity, and lung compliance in patients with radiation-induced lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. Tidal volumes are also decreased, and the respiratory rate may be elevated. Airway resistance is usually normal or slightly elevated. As with other causes of fibrotic lung disease, there is a normal or low arterial partial pressure of oxygen and carbon dioxide at rest, with an increased alveolar-arterial oxygen gradient. In early or mild cases, abnormal oxygenation may only be manifest when arterial blood gases are drawn during exercise. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diffusing capacity for carbon monoxide (DLCO or transfer factor) is usually depressed in patients with radiation-induced lung damage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/92\">",
"     92",
"    </a>",
"    ], but this finding is nonspecific. One trial suggested that failure of the DLCO to increase from the nadir value following myeloablative chemotherapy was more closely associated with the risk of progressive pulmonary dysfunction during subsequent irradiation than other parameters of lung function [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/93\">",
"     93",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main role for flexible fiberoptic bronchoscopy is to evaluate for infection, drug hypersensitivity, or spread of the underlying malignancy. Bronchoscopy with bronchoalveolar lavage is performed in the majority of patients. Transbronchial biopsy specimens may be useful for assessment of infection or lymphangitic spread of tumor in cases that are clinically atypical for radiation-induced lung injury, but the size of the specimens is usually too small to establish a diagnosis of radiation pneumonitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=see_link\">",
"     \"Basic principles and technique of bronchoalveolar lavage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=see_link\">",
"     \"Role of bronchoalveolar lavage in diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bronchoalveolar lavage fluid (BALF) findings in radiation pneumonitis are not specific, usually showing an increased number of leukocytes (predominantly lymphocytes). The majority of BAL lymphocytes post-irradiation are CD4+. Lymphocyte numbers are increased in both the irradiated and nonirradiated lung [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/30\">",
"     30",
"    </a>",
"    ]. The number of neutrophils, eosinophils, and macrophages may also be increased. In addition, there are more activated lymphocytes in the BALF of patients after irradiation than in controls. Finally, there is an increase in BALF total cell count, percentage of lymphocytes, and ICAM-1 positive T-cells in irradiated subjects with abnormal chest radiographs compared to those with normal chest films [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Tissue specimens are only occasionally required in the evaluation of patients suspected to have radiation pneumonitis. Transbronchial and transthoracic needle biopsy specimens are too small to establish a diagnosis, but may be useful for ruling out infection or lymphangitic spread of tumor in cases that are clinically atypical for radiation-induced lung injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=see_link\">",
"     \"Approach to the adult with interstitial lung disease: Diagnostic testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No prospective controlled studies have evaluated the efficacy of therapies for radiation pneumonitis in humans. Nevertheless, many experts recommend the use of glucocorticoids for symptomatic patients with a subacute onset of radiation lung injury [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5,56,95\">",
"     5,56,95",
"    </a>",
"    ]. Patients who have established fibrosis due to prior irradiation are unlikely to benefit from glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/83\">",
"     83",
"    </a>",
"    ]. It is unknown whether drugs that inhibit collagen synthesis and deposition will slow further fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/60/34762?source=see_link\">",
"     \"Treatment of idiopathic pulmonary fibrosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who are asymptomatic or have minimal symptoms may experience a spontaneous resolution, so we do not initiate treatment unless symptoms become bothersome or pulmonary function declines by more than 10 percent. We continue to monitor these patients at regular intervals (eg, four to six weeks) with assessment of symptoms, chest radiography, and pulmonary function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     Prednisone",
"    </a>",
"    (at least 60",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    is generally given for two weeks, with a gradual taper over three to twelve weeks, although the guidelines for tapering are poorly defined. Glucocorticoids may be effective in the treatment of radiation-associated organizing pneumonia; however, symptoms and radiographic abnormalities tend to recur with discontinuation of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/62,77\">",
"     62,77",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19402?source=see_link\">",
"     \"Cryptogenic organizing pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The recommendation for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    use is based upon clinical experience and data derived from murine models of radiation pneumonitis that demonstrated a protective effect of glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/96\">",
"     96",
"    </a>",
"    ]. Glucocorticoids may reduce radiation pneumonitis via reduction in inflammation, inhibition of TNF-induced nitric oxide-mediated endothelial cell cytotoxicity, or a lymphotoxic mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/95\">",
"     95",
"    </a>",
"    ]. The prophylactic administration of glucocorticoids, antibiotics, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    has",
"    <strong>",
"     not",
"    </strong>",
"    been beneficial in reducing the incidence of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/5,56,78,95\">",
"     5,56,78,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181490\">",
"    <span class=\"h2\">",
"     Other immunosuppressive agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     Azathioprine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    were both effective in treating the symptoms of radiation pneumonitis in single case reports; these agents may be considered in patients who do not tolerate glucocorticoids or who have disease refractory to glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/96,97\">",
"     96,97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181511\">",
"    <span class=\"h2\">",
"     Experimental agents",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Pentoxifylline",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"     Pentoxifylline",
"    </a>",
"    is a xanthine derivative that inhibits platelet aggregation and enhances microvascular blood flow; it also has immunomodulating and antiinflammatory properties that are probably mediated by inhibition of tumor necrosis factor (TNF) and interleukin 1. Pentoxifylline may have a role for the treatment of radiation-induced fibrosis involving the skin and subcutaneous tissues, and also inhibits experimental",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/15/39159?source=see_link\">",
"     bleomycin",
"    </a>",
"    -induced pulmonary fibrosis in rats, possibly via its anti-TNFa effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17129?source=see_link\">",
"     \"Clinical manifestations and treatment of radiation-induced fibrosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=see_link\">",
"     \"Bleomycin-induced lung injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A modest benefit for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/28/13765?source=see_link\">",
"     pentoxifylline",
"    </a>",
"    in the prevention of radiation-induced lung toxicity was suggested in a trial in which 40 patients undergoing RT for breast or lung cancer were randomly assigned to pentoxifylline (400 mg three times daily) or placebo during treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/97\">",
"     97",
"    </a>",
"    ]. During six months of follow-up, the number of patients with grade 2 or 3 pulmonary toxicity was significantly less in the pentoxifylline group (20 versus 50 percent). Four patients in the placebo group (30 percent) with grade 3 lung impairment required steroids and oxygen, while only one patient who received pentoxifylline (5 percent) had clinical impairment from grade 2 pulmonary toxicity. The pentoxifylline group had a significantly better diffusing capacity for carbon monoxide at both three and six months following therapy (73 versus 58, and 72 versus 57 percent at three and six months, respectively), but there were no significant differences in spirometry between the two groups. Although intriguing, these results require independent confirmation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Inhibition of collagen synthesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since excess collagen deposition is a key histopathologic feature of radiation fibrosis, drugs that inhibit collagen synthesis, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/13/32983?source=see_link\">",
"     colchicine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"     penicillamine",
"    </a>",
"    , interferon-gamma, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/26/31141?source=see_link\">",
"     pirfenidone",
"    </a>",
"    , may have the potential to modify the progression of fibrosis. However, there are no controlled studies with these agents in humans with radiation-induced lung injury.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     Azathioprine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    were both effective in treating the symptoms of radiation pneumonitis in single case reports; these agents may be considered in patients who do not tolerate glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/98,99\">",
"     98,99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Amifostine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/42/678?source=see_link\">",
"     Amifostine",
"    </a>",
"    is a cytoprotective agent that appears to shield normal tissues from the toxic effects of chemotherapy and radiotherapy. It is a prodrug that is dephosphorylated by alkaline phosphatase in tissues to a pharmacologically-active free thiol metabolite, which can act as a scavenger of free radicals generated in tissues exposed to radiation. It is approved as therapy for xerostomia in patients following neck irradiation and has been investigated as an agent that might reduce the incidence and severity of radiation pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early reports suggested that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/42/678?source=see_link\">",
"     amifostine",
"    </a>",
"    might decrease radiation-induced pulmonary injury without diminishing the therapeutic effect of radiation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/102,103\">",
"     102,103",
"    </a>",
"    ]. This was supported by a randomized controlled trial of radiation plus amifostine compared to radiation alone in 146 patients with locally advanced lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/100\">",
"     100",
"    </a>",
"    ]. A significant decrease in pneumonitis (9 versus 43 percent) and also grade 3 esophagitis were noted with amifostine pretreatment. However, these results have not been replicated and current guidelines do not advise the use of amifostine for prevention of esophagitis or irradiation-induced pneumonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/104,105\">",
"     104,105",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Captopril",
"    </span>",
"    &nbsp;&mdash;&nbsp;The angiotensin converting enzyme inhibitor (ACEI)",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     captopril",
"    </a>",
"    has been shown to reduce radiation-induced lung fibrosis in rats [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/106\">",
"     106",
"    </a>",
"    ]. In a retrospective study of patients who underwent radiation therapy for lung cancer, those taking an ACEI demonstrated less clinically significant RILI, than those not on an ACEI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/107\">",
"     107",
"    </a>",
"    ]. This area awaits a controlled trial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Significant improvements in the perfusion and ventilation of radiation-injured lung tissue may be noted from 3 to 18 months after radiation therapy. After 18 months, however, further significant improvement appears unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?23/33/24090/abstract/108,109\">",
"     108,109",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H181566\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who undergo thoracic or neck irradiation for the treatment of malignancy (eg, breast, laryngeal, lung, hematologic) are at risk for radiation pneumonitis and radiation fibrosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many factors affect the risk for radiation pneumonitis including the method of irradiation, the volume of irradiated lung, the total dosage and frequency of irradiation, associated chemotherapy, and possibly the genetic background of the patient. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Reaction to radiation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms caused by subacute radiation pneumonitis usually develop approximately four to twelve weeks following irradiation, whereas symptoms of late or fibrotic radiation pneumonitis develop after six to twelve months. Typical symptoms for both types of lung injury include dyspnea, cough, chest pain, fever, and malaise. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physical examination of the lung may reveal crackles, a pleural rub, dullness to percussion, or may be normal. Skin erythema may outline the radiation port but is not predictive of the occurrence or the severity of radiation pneumonitis. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In subacute radiation pneumonitis, the chest radiograph may show perivascular haziness and chest computed tomography may show patchy alveolar ground glass or consolidative opacities. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiographs taken during the chronic phase of radiation pneumonitis may show volume loss with coarse reticular or dense opacities. A straight line effect, which does not conform to anatomical units but rather to the confines of the radiation port, is virtually diagnostic of radiation-induced lung injury. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Imaging studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of radiation pneumonitis is based on the correlation between the onset of symptoms and signs with the timing of irradiation and between the pattern of radiographic changes and the radiation therapy portal. Careful exclusion of other possible diagnoses, such as infection, thromboembolic disease, drug-induced pneumonitis, pericarditis, esophagitis, or tracheoesophageal fistula, is key. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal treatment for radiation-induced lung injury is not known. For symptomatic patients, the typical treatment is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (at least 60",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      for two weeks, followed by a gradual taper over the next three to twelve weeks, although the guidelines for tapering are poorly defined. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who are asymptomatic or have minimal symptoms, we re-evaluate symptoms, chest radiography, and pulmonary function at regular intervals (eg, four to six weeks), but do not initiate treatment unless symptoms become bothersome or pulmonary function declines by more than 10 percent. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who have established fibrosis due to prior irradiation are unlikely to benefit from glucocorticoid therapy. It is unknown whether drugs that inhibit collagen synthesis and deposition will slow further fibrosis. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/60/34762?source=see_link\">",
"       \"Treatment of idiopathic pulmonary fibrosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/1\">",
"      Bergonie, J, Teissier, J. Rapport sur l'action des rayons X sur la tuberculose. Arch Electr Med 1898; 6:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/2\">",
"      Evans, WA, Leucutia, T. Intrathoracic changes induced by heavy irradiation. AJR 1925; 13:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/3\">",
"      Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/4\">",
"      Coggle JE, Lambert BE, Moores SR. Radiation effects in the lung. Environ Health Perspect 1986; 70:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/5\">",
"      McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995; 31:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/6\">",
"      Molls M, Herrmann Th, Steinberg F, Feldmann HJ. Radiopathology of the lung: experimental and clinical observations. Recent Results Cancer Res 1993; 130:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/7\">",
"      Movsas B, Raffin TA, Epstein AH, Link CJ Jr. Pulmonary radiation injury. Chest 1997; 111:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/8\">",
"      Kocak Z, Evans ES, Zhou SM, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 2005; 62:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/9\">",
"      Epperly M, Bray J, Kraeger S, et al. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 1998; 5:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/10\">",
"      Greenberger JS, Epperly MW, Gretton J, et al. Radioprotective gene therapy. Curr Gene Ther 2003; 3:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/11\">",
"      Haston CK, Begin M, Dorion G, Cory SM. Distinct loci influence radiation-induced alveolitis from fibrosing alveolitis in the mouse. Cancer Res 2007; 67:10796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/12\">",
"      Kelsey CR, Rosenstein BS, Marks LB. Predicting toxicity from radiation therapy--it's genetic, right? Cancer 2012; 118:3450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/13\">",
"      Kuptsova N, Chang-Claude J, Kropp S, et al. Genetic predictors of long-term toxicities after radiation therapy for breast cancer. Int J Cancer 2008; 122:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/14\">",
"      Suga T, Ishikawa A, Kohda M, et al. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007; 69:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/15\">",
"      Giotopoulos G, Symonds RP, Foweraker K, et al. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 2007; 96:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/16\">",
"      Mak RH, Alexander BM, Asomaning K, et al. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer 2012; 118:3654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/17\">",
"      Zhang L, Yang M, Bi N, et al. ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 2010; 77:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/18\">",
"      Xiong H, Liao Z, Liu Z, et al. ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 2013; 85:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/19\">",
"      Anscher MS, Kong FM, Andrews K, et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 1998; 41:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/20\">",
"      Anscher MS, Marks LB, Shafman TD, et al. Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/21\">",
"      Mazeron R, Etienne-Mastroianni B, P&eacute;rol D, et al. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2010; 77:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/22\">",
"      Chen Y, Williams J, Ding I, et al. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 2002; 12:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/23\">",
"      Chen Y, Rubin P, Williams J, et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2001; 49:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/24\">",
"      Rubin P, Johnston CJ, Williams JP, et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995; 33:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/25\">",
"      Fuks Z, Persaud RS, Alfieri A, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994; 54:2582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/26\">",
"      Rosiello RA, Merrill WW, Rockwell S, et al. Radiation pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine. Am Rev Respir Dis 1993; 148:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/27\">",
"      Adawi A, Zhang Y, Baggs R, et al. Blockade of CD40-CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. Clin Immunol Immunopathol 1998; 89:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/28\">",
"      Mart&iacute;n C, Romero S, S&aacute;nchez-Pay&aacute; J, et al. Bilateral lymphocytic alveolitis: a common reaction after unilateral thoracic irradiation. Eur Respir J 1999; 13:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/29\">",
"      Bradley JD, Hope A, El Naqa I, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007; 69:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/30\">",
"      Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995; 31:361.",
"     </a>",
"    </li>",
"    <li>",
"     Respiratory system. In: Clinical Radiation Pathology, Rubin P, Casseratt GW (Eds), WB Saunders, Philadelphia 1968. p.423.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/32\">",
"      Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010; 76:S70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/33\">",
"      Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010; 76:S10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/34\">",
"      Lind PA, Marks LB, Hardenbergh PH, et al. Technical factors associated with radiation pneumonitis after local +/- regional radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys 2002; 52:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/35\">",
"      Lingos TI, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1991; 21:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/36\">",
"      Kimsey FC, Mendenhall NP, Ewald LM, et al. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer 1994; 73:2549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/37\">",
"      Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005; 235:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/38\">",
"      Carruthers SA, Wallington MM. Total body irradiation and pneumonitis risk: a review of outcomes. Br J Cancer 2004; 90:2080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/39\">",
"      Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/40\">",
"      Fay M, Tan A, Fisher R, et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61:1355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/41\">",
"      Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/42\">",
"      Roach M 3rd, Gandara DR, Yuo HS, et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995; 13:2606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/43\">",
"      Kobayashi H, Uno T, Isobe K, et al. Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer. Jpn J Clin Oncol 2010; 40:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/44\">",
"      Rancati T, Ceresoli GL, Gagliardi G, et al. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003; 67:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/45\">",
"      Taghian AG, Assaad SI, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001; 93:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/46\">",
"      Urbanic JJ, Lally B, Blackstock AW. \"The best-laid plans ... often go awry ...\". J Thorac Oncol 2009; 4:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/47\">",
"      Lind JS, Senan S, Smit EF. Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer. J Clin Oncol 2012; 30:e104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/48\">",
"      Rengan R, Mick R, Pryma D, et al. A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response. J Thorac Oncol 2012; 7:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/49\">",
"      Chakravarthy A, Johnson D, Choy H. The role of radiation, with or without chemotherapy, in the management of NSCLC. Oncology (Williston Park) 1999; 13:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/50\">",
"      Arrieta O, Gallardo-Rinc&oacute;n D, Villarreal-Garza C, et al. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin. J Thorac Oncol 2009; 4:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/51\">",
"      Zinner RG, Komaki R, Cox JD, et al. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009; 73:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/52\">",
"      Wang S, Liao Z, Wei X, et al. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 2008; 3:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/53\">",
"      Choy H, Jain AK, Moughan J, et al. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy (\"ping-pong trial\") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer. J Thorac Oncol 2009; 4:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/54\">",
"      Socinski MA, Blackstock AW, Bogart JA, et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol 2008; 26:2457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/55\">",
"      Mao J, Kocak Z, Zhou S, et al. The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response. Int J Radiat Oncol Biol Phys 2007; 67:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/56\">",
"      Robnett TJ, Machtay M, Vines EF, et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000; 48:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/57\">",
"      Monson JM, Stark P, Reilly JJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 1998; 82:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/58\">",
"      Johansson S, Bjermer L, Franzen L, Henriksson R. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. Radiother Oncol 1998; 49:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/59\">",
"      Takeda A, Kunieda E, Ohashi T, et al. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy. Chest 2012; 141:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/60\">",
"      Yirmibesoglu E, Higginson DS, Fayda M, et al. Challenges scoring radiation pneumonitis in patients irradiated for lung cancer. Lung Cancer 2012; 76:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/61\">",
"      Varga Z, Cserh&aacute;ti A, Kelemen G, et al. Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2011; 80:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/62\">",
"      Katayama N, Sato S, Katsui K, et al. Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Int J Radiat Oncol Biol Phys 2009; 73:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/63\">",
"      Hochstrasser A, Benz G, Joerger M, et al. Interstitial pneumonitis after treatment with pemetrexed: a rare event? Chemotherapy 2012; 58:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/64\">",
"      Bischof M, Weber KJ, Blatter J, et al. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro. Int J Radiat Oncol Biol Phys 2002; 52:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/65\">",
"      Allen AM, Czerminska M, J&auml;nne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006; 65:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/66\">",
"      Moreno M, Aristu J, Ramos LI, et al. Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer. Clin Transl Oncol 2007; 9:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/67\">",
"      Chen S, Zhou S, Zhang J, et al. A neural network model to predict lung radiation-induced pneumonitis. Med Phys 2007; 34:3420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/68\">",
"      Zhao L, Sheldon K, Chen M, et al. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer 2008; 59:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/69\">",
"      Yuan X, Liao Z, Liu Z, et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 2009; 27:3370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/70\">",
"      Ma LD, Taylor GA, Wharam MD, Wiley JM. \"Recall\" pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993; 187:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/71\">",
"      Schweitzer VG, Juillard GJ, Bajada CL, Parker RG. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995; 76:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/72\">",
"      Schwarte S, Wagner K, Karstens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 2007; 183:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/73\">",
"      Jeter MD, J&auml;nne PA, Brooks S, et al. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys 2002; 53:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/74\">",
"      Kataoka M, Kawamura M, Nishiyama Y, et al. [A case with delayed-onset radiation pneumonitis suspected to be induced by oral etoposide]. Nihon Igaku Hoshasen Gakkai Zasshi 1992; 52:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/75\">",
"      Epperly MW, Guo H, Gretton JE, Greenberger JS. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003; 29:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/76\">",
"      Theise ND, Henegariu O, Grove J, et al. Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol 2002; 30:1333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/77\">",
"      Arbetter KR, Prakash UB, Tazelaar HD, Douglas WW. Radiation-induced pneumonitis in the \"nonirradiated\" lung. Mayo Clin Proc 1999; 74:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/78\">",
"      Kwok E, Chan CK. Corticosteroids and azathioprine do not prevent radiation-induced lung injury. Can Respir J 1998; 5:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/79\">",
"      Takigawa N, Segawa Y, Saeki T, et al. Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys 2000; 48:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/80\">",
"      Gustafson G, Vicini F, Freedman L, et al. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies. Cancer 1995; 75:2345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/81\">",
"      Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995; 33:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/82\">",
"      Gross NJ. Pulmonary effects of radiation therapy. Ann Intern Med 1977; 86:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/83\">",
"      Abratt RP, Morgan GW, Silvestri G, Willcox P. Pulmonary complications of radiation therapy. Clin Chest Med 2004; 25:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/84\">",
"      Yamashita H, Kobayashi-Shibata S, Terahara A, et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 2010; 5:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/85\">",
"      Ikezoe J, Takashima S, Morimoto S, et al. CT appearance of acute radiation-induced injury in the lung. AJR Am J Roentgenol 1988; 150:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/86\">",
"      Park KJ, Chung JY, Chun MS, Suh JH. Radiation-induced lung disease and the impact of radiation methods on imaging features. Radiographics 2000; 20:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/87\">",
"      Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 2004; 24:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/88\">",
"      Palma DA, Senan S, Haasbeek CJ, et al. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques. Int J Radiat Oncol Biol Phys 2011; 80:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/89\">",
"      Robbins ME, Brunso-Bechtold JK, Peiffer AM, et al. Imaging radiation-induced normal tissue injury. Radiat Res 2012; 177:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/90\">",
"      Cudkowicz L, Cunningham M, Haldane EV. Effects of mediastinal irradiation upon respiratory function following mastectomy for carcinoma of breast. A five-year follow-up study. Thorax 1969; 24:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/91\">",
"      Wohl ME, Griscom NT, Traggis DG, Jaffe N. Effects of therapeutic irradiation delivered in early childhood upon subsequent lung function. Pediatrics 1975; 55:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/92\">",
"      Lopez Guerra JL, Gomez D, Zhuang Y, et al. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012; 83:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/93\">",
"      Lind PA, Marks LB, Jamieson TA, et al. Predictors for pneumonitis during locoregional radiotherapy in high-risk patients with breast carcinoma treated with high-dose chemotherapy and stem-cell rescue. Cancer 2002; 94:2821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/94\">",
"      Nakayama Y, Makino S, Fukuda Y, et al. Activation of lavage lymphocytes in lung injuries caused by radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1996; 34:459.",
"     </a>",
"    </li>",
"    <li>",
"     Pickrell JA, Abdel-Mageed AB. Radiation-induced pulmonary fibrosis. In: Lung Biology in Health and Disease: Pulmonary Fibrosis, Marcel Dekker, Inc, New York 1995. p.363.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/96\">",
"      Gross NJ, Narine KR, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res 1988; 113:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/97\">",
"      Ozturk B, Egehan I, Atavci S, Kitapci M. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 2004; 58:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/98\">",
"      McCarty MJ, Lillis P, Vukelja SJ. Azathioprine as a steroid-sparing agent in radiation pneumonitis. Chest 1996; 109:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/99\">",
"      Muraoka T, Bandoh S, Fujita J, et al. Corticosteroid refractory radiation pneumonitis that remarkably responded to cyclosporin A. Intern Med 2002; 41:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/100\">",
"      Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys 2001; 51:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/101\">",
"      Vujaskovic Z, Feng QF, Rabbani ZN, et al. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity. Exp Lung Res 2002; 28:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/102\">",
"      Antonadou D. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer. Semin Radiat Oncol 2002; 12:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/103\">",
"      Gopal R. Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies. Semin Oncol 2005; 32:S55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/104\">",
"      Hensley ML, Hagerty KL, Kewalramani T, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 2009; 27:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/105\">",
"      Movsas B, Scott C, Langer C, et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 2005; 23:2145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/106\">",
"      Ward WF, Molteni A, Ts'ao CH. Radiation-induced endothelial dysfunction and fibrosis in rat lung: modification by the angiotensin converting enzyme inhibitor CL242817. Radiat Res 1989; 117:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/107\">",
"      Kharofa J, Cohen EP, Tomic R, et al. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012; 84:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/108\">",
"      Borst GR, De Jaeger K, Belderbos JS, et al. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival. Int J Radiat Oncol Biol Phys 2005; 62:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/33/24090/abstract/109\">",
"      Theuws JC, Seppenwoolde Y, Kwa SL, et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys 2000; 47:1201.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4331 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-22DD962998-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24090=[""].join("\n");
var outline_f23_33_24090=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H181566\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetic background",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Role of cytokines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hypersensitivity reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      REACTION TO RADIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Method of irradiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Volume of lung irradiated",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Dosage of radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Time-dose factor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Concurrent chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Induction chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Predicting radiation lung injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Radiation recall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180831\">",
"      - Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180885\">",
"      - Chest computed tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Nuclear medicine studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181490\">",
"      Other immunosuppressive agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H181511\">",
"      Experimental agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Pentoxifylline",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Inhibition of collagen synthesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Amifostine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Captopril",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H181566\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4331\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4331|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/8/6283\" title=\"table 1\">",
"      Thoracic effects of radiation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37961?source=related_link\">",
"      Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/18/16681?source=related_link\">",
"      Approach to the adult with interstitial lung disease: Diagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/41/25239?source=related_link\">",
"      Basic principles and technique of bronchoalveolar lavage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/31/12794?source=related_link\">",
"      Bleomycin-induced lung injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/21/34137?source=related_link\">",
"      Cardiotoxicity of radiation therapy for malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/49/19222?source=related_link\">",
"      Classification and clinical manifestations of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/10/12458?source=related_link\">",
"      Clinical manifestations and diagnosis of bronchiectasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17129?source=related_link\">",
"      Clinical manifestations and treatment of radiation-induced fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/41/30359?source=related_link\">",
"      Complications of breast and chest wall irradiation for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19402?source=related_link\">",
"      Cryptogenic organizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21990?source=related_link\">",
"      Cyclophosphamide pulmonary toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/7/16505?source=related_link\">",
"      Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/18/34087?source=related_link\">",
"      Epidemiology and causes of hypersensitivity pneumonitis (extrinsic allergic alveolitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=related_link\">",
"      Flexible bronchoscopy: Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32630?source=related_link\">",
"      Intensity-modulated radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/36/39498?source=related_link\">",
"      Management of stage III non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28234?source=related_link\">",
"      Nonsurgical local treatment strategies for colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/47/19193?source=related_link\">",
"      Overview of pulmonary hypertension in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/55/42873?source=related_link\">",
"      Radiation techniques for locally advanced breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/31/39418?source=related_link\">",
"      Radiation therapy, chemoradiotherapy, neoadjuvant approaches, and postoperative adjuvant therapy for localized cancers of the esophagus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16968?source=related_link\">",
"      Role of bronchoalveolar lavage in diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/21/43350?source=related_link\">",
"      Stereotactic body radiation therapy: Rationale and clinical experience",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32855?source=related_link\">",
"      Stereotactic cranial radiosurgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38344?source=related_link\">",
"      Taxane-induced pulmonary toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/46/39657?source=related_link\">",
"      Techniques of breast and chest wall irradiation for early stage breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/60/34762?source=related_link\">",
"      Treatment of idiopathic pulmonary fibrosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_33_24091="Web resources diabetes child";
var content_f23_33_24091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Useful resources on diabetes for parents and caregivers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       <p>",
"        Chase, H Peter, Understanding Diabetes, 10th edition, English and Spanish",
"       </p>",
"       <p>",
"        file://www.uchsc.edu/misc/diabetes/udform.html",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Travis, Luthur B, An Instructional Aid on Diabetes, 12th edition, Designer's Ink English and Spanish",
"       </p>",
"       <p>",
"        file://www.designersink.com/Diabetes/diabetes.htm",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <p>",
"        Hendel, Elisa, A Child in Your Care Has Diabetes: A Collection of Information, Third Edition, English or English-Spanish",
"       </p>",
"       <p>",
"        file://www.henhousepress.com/index.html",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Other Web sites",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.childrenwithdiabetes.com",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.ndep.nih.gov",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.diabetes.org",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.jdf.org",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.childrensdiabetesfdn.org/publications.html",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       file://www.diabetes.ca/ (Canadian Diabetes Association for information in French)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24091=[""].join("\n");
var outline_f23_33_24091=null;
var title_f23_33_24092="Common cold treatments in pregnancy 2";
var content_f23_33_24092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Agents used to treat the common cold and its symptoms, their efficacy and their safety in pregnancy, continued",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"20%\">",
"     </colgroup>",
"     <colgroup width=\"60%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect in randomly controlled trial",
"        <br/>",
"        (not pregnant)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pregnancy data",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Zinc gluconate",
"       </td>",
"       <td rowspan=\"5\">",
"        The evidence of zinc efficacy for treating the common cold is inconclusive at best, and any beneficial effect is minor.",
"       </td>",
"       <td>",
"        The use of zinc for the treatment of the common cold is probably not justified in pregnancy. The noxious taste of zinc lozenges limit their usefulness particularly in pregnant patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Animal experiments have produced variable but frequently concerning results regarding the safety of high dose zinc supplementation in pregnancy (including increased skeletal defects in mice, exencephaly in hamsters, and an increased incidence of congenital malformations in rats).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated zinc levels in the fetus have been associated with anencephaly and meningomyelocele in some studies but not in others. It is unclear whether this finding simply reflects physiologic abnormalities associated with these defects.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One recent report found one infant with a heart defect and one with microcephaly among 26 infants born to 19 mothers treated with zinc for Wilson's disease. This population is too small to estimate whether zinc exposure played any role in the observed defects.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zinc deficiency is associated with impaired fertility and low birth weight but is rare in the western world.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin C",
"       </td>",
"       <td>",
"        Current extensive literature does not appear to support the use of vitamin C therapy for the common cold.",
"       </td>",
"       <td>",
"        Little pregnancy data available however, there is concern that large doses of this vitamin may be harmful during pregnancy. Ascorbic acid appears in the fetus in concentrations higher than those in the mother and pregnant guinea pigs fed large doses of ascorbic acid gave birth to offspring with increased rates of ascorbic acid catabolism. A human parallel to this was seen in two reported cases of mothers who ingested daily high doses of vitamin C and after birth the infants developed scurvy due to an excessively rapid metabolism of vitamin C presumably induced in utero.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Echinacea",
"       </td>",
"       <td>",
"        No evidence to support efficacy.",
"       </td>",
"       <td>",
"        Recent data reporting on 206 exposed pregnancies found no increased incidence of anomalies compared with controls.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24092=[""].join("\n");
var outline_f23_33_24092=null;
var title_f23_33_24093="Chronic pain synd cancer";
var content_f23_33_24093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57573&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chronic pain syndromes directly related to cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Nociceptive pain syndromes: somatic",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Tumor-related bone pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_single\">",
"       Multifocal bone pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Bone metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Bone marrow expansion (hematologic malignancies)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Oncogenic hypophosphatemic osteomalacia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_single\">",
"       Vertebral syndromes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Atlanto-axial destruction and odontoid fracture",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       C7-T1 syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       T12-L1 syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Sacral syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Back pain secondary to spinal cord compression",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_single\">",
"       Pain syndromes related to pelvis and hip",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Pelvic metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Hip joint syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Malignant piriformis syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle3_single\">",
"       Base of skull metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Orbital syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Parasellar syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Middle cranial fossa syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Jugular foramen syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Occipital condyle syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Clivus syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent2\">",
"       Sphenoid sinus syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Tumor-related soft tissue pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Headache and facial pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Ear and eye pain syndromes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Pleural pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Paraneoplastic pain syndromes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Muscle cramps",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Hypertrophic osteoarthropathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tumor-related gynecomastia (eg, in testicular neoplasms that secrete human chorionic gonadotropin)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Paraneoplastic pemphigus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Paraneoplastic Raynaud's phenomenon",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Nociceptive pain syndromes: visceral",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hepatic distention syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Midline retroperitoneal syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chronic intestinal obstruction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Peritoneal carcinomatosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Malignant perineal pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Adrenal pain syndrome",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ureteric obstruction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Neuropathic pain syndromes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Leptomeningeal metastases",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Malignant painful radiculopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Painful cranial neuralgias",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Glossopharyngeal neuralgia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Trigeminal neuralgia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Radiculopathies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lumbosacral radiculopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cervical radiculopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Thoracic radiculopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Plexopathies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Cervical plexopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Malignant brachial plexopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Malignant lumbosacral plexopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Lower lumbosacral plexopathies, including sacral and coccygeal plexopathy and panplexopathy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Painful peripheral mononeuropathies",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_single\">",
"       Paraneoplastic sensory neuropathy",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24093=[""].join("\n");
var outline_f23_33_24093=null;
var title_f23_33_24094="Normal MAC and MAMC males";
var content_f23_33_24094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Percentiles of upper arm circumference and estimated upper arm muscle circumference for Caucasian boys in the US Health and Nutrition Examination Survey I of 1971-1974",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age, years males",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Mid arm circumference (MAC) percentiles",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Mid arm muscle circumference (MAMC)&nbsp;percentiles",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        5th",
"       </td>",
"       <td class=\"subtitle2\">",
"        50th",
"       </td>",
"       <td class=\"subtitle2\">",
"        90th",
"       </td>",
"       <td class=\"subtitle2\">",
"        95th",
"       </td>",
"       <td class=\"subtitle2\">",
"        5th",
"       </td>",
"       <td class=\"subtitle2\">",
"        50th",
"       </td>",
"       <td class=\"subtitle2\">",
"        90th",
"       </td>",
"       <td class=\"subtitle2\">",
"        95th",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1-1.9",
"       </td>",
"       <td>",
"        142",
"       </td>",
"       <td>",
"        159",
"       </td>",
"       <td>",
"        176",
"       </td>",
"       <td>",
"        183",
"       </td>",
"       <td>",
"        138",
"       </td>",
"       <td>",
"        156",
"       </td>",
"       <td>",
"        172",
"       </td>",
"       <td>",
"        177",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2-2.9",
"       </td>",
"       <td>",
"        141",
"       </td>",
"       <td>",
"        162",
"       </td>",
"       <td>",
"        178",
"       </td>",
"       <td>",
"        185",
"       </td>",
"       <td>",
"        142",
"       </td>",
"       <td>",
"        160",
"       </td>",
"       <td>",
"        176",
"       </td>",
"       <td>",
"        184",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3-3.9",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        167",
"       </td>",
"       <td>",
"        184",
"       </td>",
"       <td>",
"        190",
"       </td>",
"       <td>",
"        143",
"       </td>",
"       <td>",
"        167",
"       </td>",
"       <td>",
"        183",
"       </td>",
"       <td>",
"        189",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4-4.9",
"       </td>",
"       <td>",
"        149",
"       </td>",
"       <td>",
"        171",
"       </td>",
"       <td>",
"        186",
"       </td>",
"       <td>",
"        192",
"       </td>",
"       <td>",
"        149",
"       </td>",
"       <td>",
"        169",
"       </td>",
"       <td>",
"        184",
"       </td>",
"       <td>",
"        191",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5-5.9",
"       </td>",
"       <td>",
"        153",
"       </td>",
"       <td>",
"        175",
"       </td>",
"       <td>",
"        195",
"       </td>",
"       <td>",
"        204",
"       </td>",
"       <td>",
"        153",
"       </td>",
"       <td>",
"        175",
"       </td>",
"       <td>",
"        203",
"       </td>",
"       <td>",
"        211",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        6-6.9",
"       </td>",
"       <td>",
"        155",
"       </td>",
"       <td>",
"        179",
"       </td>",
"       <td>",
"        209",
"       </td>",
"       <td>",
"        228",
"       </td>",
"       <td>",
"        156",
"       </td>",
"       <td>",
"        176",
"       </td>",
"       <td>",
"        204",
"       </td>",
"       <td>",
"        201",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7-7.9",
"       </td>",
"       <td>",
"        162",
"       </td>",
"       <td>",
"        187",
"       </td>",
"       <td>",
"        223",
"       </td>",
"       <td>",
"        230",
"       </td>",
"       <td>",
"        164",
"       </td>",
"       <td>",
"        183",
"       </td>",
"       <td>",
"        216",
"       </td>",
"       <td>",
"        231",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8-8.9",
"       </td>",
"       <td>",
"        162",
"       </td>",
"       <td>",
"        190",
"       </td>",
"       <td>",
"        220",
"       </td>",
"       <td>",
"        245",
"       </td>",
"       <td>",
"        168",
"       </td>",
"       <td>",
"        195",
"       </td>",
"       <td>",
"        247",
"       </td>",
"       <td>",
"        261",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        9-9.9",
"       </td>",
"       <td>",
"        175",
"       </td>",
"       <td>",
"        200",
"       </td>",
"       <td>",
"        249",
"       </td>",
"       <td>",
"        257",
"       </td>",
"       <td>",
"        178",
"       </td>",
"       <td>",
"        211",
"       </td>",
"       <td>",
"        251",
"       </td>",
"       <td>",
"        260",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10-10.9",
"       </td>",
"       <td>",
"        181",
"       </td>",
"       <td>",
"        210",
"       </td>",
"       <td>",
"        262",
"       </td>",
"       <td>",
"        274",
"       </td>",
"       <td>",
"        174",
"       </td>",
"       <td>",
"        210",
"       </td>",
"       <td>",
"        251",
"       </td>",
"       <td>",
"        265",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        11-11.9",
"       </td>",
"       <td>",
"        186",
"       </td>",
"       <td>",
"        223",
"       </td>",
"       <td>",
"        261",
"       </td>",
"       <td>",
"        280",
"       </td>",
"       <td>",
"        185",
"       </td>",
"       <td>",
"        224",
"       </td>",
"       <td>",
"        276",
"       </td>",
"       <td>",
"        303",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12-12.9",
"       </td>",
"       <td>",
"        193",
"       </td>",
"       <td>",
"        232",
"       </td>",
"       <td>",
"        282",
"       </td>",
"       <td>",
"        303",
"       </td>",
"       <td>",
"        194",
"       </td>",
"       <td>",
"        237",
"       </td>",
"       <td>",
"        282",
"       </td>",
"       <td>",
"        294",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        13-13.9",
"       </td>",
"       <td>",
"        194",
"       </td>",
"       <td>",
"        247",
"       </td>",
"       <td>",
"        286",
"       </td>",
"       <td>",
"        301",
"       </td>",
"       <td>",
"        202",
"       </td>",
"       <td>",
"        243",
"       </td>",
"       <td>",
"        301",
"       </td>",
"       <td>",
"        338",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14-14.9",
"       </td>",
"       <td>",
"        220",
"       </td>",
"       <td>",
"        253",
"       </td>",
"       <td>",
"        303",
"       </td>",
"       <td>",
"        322",
"       </td>",
"       <td>",
"        214",
"       </td>",
"       <td>",
"        252",
"       </td>",
"       <td>",
"        304",
"       </td>",
"       <td>",
"        322",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        15-15.9",
"       </td>",
"       <td>",
"        222",
"       </td>",
"       <td>",
"        264",
"       </td>",
"       <td>",
"        311",
"       </td>",
"       <td>",
"        320",
"       </td>",
"       <td>",
"        208",
"       </td>",
"       <td>",
"        254",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        322",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        16-16.9",
"       </td>",
"       <td>",
"        244",
"       </td>",
"       <td>",
"        278",
"       </td>",
"       <td>",
"        324",
"       </td>",
"       <td>",
"        343",
"       </td>",
"       <td>",
"        218",
"       </td>",
"       <td>",
"        258",
"       </td>",
"       <td>",
"        312",
"       </td>",
"       <td>",
"        325",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        17-17.9",
"       </td>",
"       <td>",
"        246",
"       </td>",
"       <td>",
"        285",
"       </td>",
"       <td>",
"        336",
"       </td>",
"       <td>",
"        347",
"       </td>",
"       <td>",
"        220",
"       </td>",
"       <td>",
"        264",
"       </td>",
"       <td>",
"        324",
"       </td>",
"       <td>",
"        350",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18-18.9",
"       </td>",
"       <td>",
"        245",
"       </td>",
"       <td>",
"        297",
"       </td>",
"       <td>",
"        353",
"       </td>",
"       <td>",
"        379",
"       </td>",
"       <td>",
"        222",
"       </td>",
"       <td>",
"        258",
"       </td>",
"       <td>",
"        312",
"       </td>",
"       <td>",
"        325",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        19-24.9",
"       </td>",
"       <td>",
"        262",
"       </td>",
"       <td>",
"        308",
"       </td>",
"       <td>",
"        355",
"       </td>",
"       <td>",
"        372",
"       </td>",
"       <td>",
"        221",
"       </td>",
"       <td>",
"        265",
"       </td>",
"       <td>",
"        319",
"       </td>",
"       <td>",
"        345",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        25-34.9",
"       </td>",
"       <td>",
"        271",
"       </td>",
"       <td>",
"        319",
"       </td>",
"       <td>",
"        363",
"       </td>",
"       <td>",
"        374",
"       </td>",
"       <td>",
"        241",
"       </td>",
"       <td>",
"        290",
"       </td>",
"       <td>",
"        356",
"       </td>",
"       <td>",
"        378",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35-44.9",
"       </td>",
"       <td>",
"        278",
"       </td>",
"       <td>",
"        326",
"       </td>",
"       <td>",
"        363",
"       </td>",
"       <td>",
"        374",
"       </td>",
"       <td>",
"        241",
"       </td>",
"       <td>",
"        290",
"       </td>",
"       <td>",
"        356",
"       </td>",
"       <td>",
"        378",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        45-54.9",
"       </td>",
"       <td>",
"        267",
"       </td>",
"       <td>",
"        322",
"       </td>",
"       <td>",
"        362",
"       </td>",
"       <td>",
"        376",
"       </td>",
"       <td>",
"        242",
"       </td>",
"       <td>",
"        299",
"       </td>",
"       <td>",
"        362",
"       </td>",
"       <td>",
"        384",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        55-64.9",
"       </td>",
"       <td>",
"        258",
"       </td>",
"       <td>",
"        317",
"       </td>",
"       <td>",
"        355",
"       </td>",
"       <td>",
"        369",
"       </td>",
"       <td>",
"        243",
"       </td>",
"       <td>",
"        303",
"       </td>",
"       <td>",
"        367",
"       </td>",
"       <td>",
"        385",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65-74.9",
"       </td>",
"       <td>",
"        248",
"       </td>",
"       <td>",
"        307",
"       </td>",
"       <td>",
"        344",
"       </td>",
"       <td>",
"        355",
"       </td>",
"       <td>",
"        240",
"       </td>",
"       <td>",
"        299",
"       </td>",
"       <td>",
"        356",
"       </td>",
"       <td>",
"        373",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Frisancho AR. Am J Clin Nut 1981; 34:2540.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24094=[""].join("\n");
var outline_f23_33_24094=null;
var title_f23_33_24095="Lead line in gingival tooth border";
var content_f23_33_24095=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F68115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F68115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lead line in gingival tooth border",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This man with severe lead poisoning has a \"lead line\", a bluish-gray thin line running along the gingival tooth border, which also has considerable plaque. It is best seen at the location of the arrow. In patients with poor oral hygiene, hydrogen sulfide released by bacteria in the gingival pockets may react with lead in the gingival circulation to produce lead sulfide, a precipitate that appears as a darkly pigmented blue-gray line.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_33_24095=[""].join("\n");
var outline_f23_33_24095=null;
